SEARCH
Search Details
Maekawa Naoya
| One Health Research Center Zoobiquity Unit | Specially Appointed Associate Professor |
Researcher basic information
■ Degree■ URL
researchmap URLホームページURL■ Various IDs
J-Global ID■ Research Keywords and Fields
Research KeywordResearch Field
Career
■ CareerCareer
- Oct. 2026 - Present
Hokkaido University, One Health Research Center, 特任准教授 - Oct. 2026 - Present
パンクセラピー株式会社, 技術顧問 - Apr. 2026 - Present
Osaka Metropolitan University, 大学院工学研究科, 客員准教授 - Apr. 2026 - Sep. 2026
Hokkaido University, 大学院獣医学研究院, 招へい教員 - Apr. 2026 - Sep. 2026
パンクセラピー株式会社, 主任研究員 - Jul. 2018 - Mar. 2026
Hokkaido University, Faculty of Veterinary Medicine, Specially Appointed Assistant Professor - Jan. 2018 - Jun. 2018
Hokkaido University, 大学院獣医学研究院, 博士研究員 - Apr. 2015 - Dec. 2017
日本学術振興会, 特別研究員(DC1)
Research activity information
■ Awards- Nov. 2026, 農学会, 第25回日本農学進歩賞
前川 直也 - Sep. 2018, 日本獣医学会, 獣医学奨励賞
前川 直也 - Aug. 2016, The 11th International Veterinary Immunology Symposium, IUIS VIC/EVIG Travel Award
前川 直也 - Mar. 2014, 北海道獣医師会, 北海道獣医師会長賞
前川 直也
- Lactiplantibacillus plantarum HOKKAIDO strain drives alveolar macrophage-dependent antiviral protection against respiratory infection
Mari Ikehata; Tomohiro Okagawa; Hayato Nakamura; Maho Inoue; Masami Morimatsu; Kumiko Yoshimatsu; Takamitsu Tsukahara; Kentaro Abe; Mitsuru Honma; Naoya Maekawa; Yasuhiko Suzuki; Shiro Murata; Kazuhiko Ohashi; Satoru Konnai
Frontiers in Immunology, 17, Frontiers Media SA, 21 Sep. 2026, [Peer-reviewed]
Scientific journal, Calves’ immature immune systems make them susceptible to various infections. In particular, diarrhea and respiratory diseases impair growth and increase mortality, resulting in substantial economic losses in the cattle industry. Probiotics are living microorganisms that confer health benefits to the host and are increasingly recognized as promising preventive and supportive therapies for calf infections. Our previous study revealed that Lactiplantibacillus plantarum HOKKAIDO strain (Lp-HKD) reduces intestinal pathology and diarrhea severity in bovine rotavirus-infected calves. We also demonstrated that Lp-HKD activates bovine immune cells, including monocytes and T cells, and exerts an antiviral effect by inducing antiviral cytokines in vitro . Based on these findings, we hypothesized that Lp-HKD might also protect against respiratory viral infections. In this study, we investigated the antiviral effects of Lp-HKD against respiratory infection in a mouse model. DBA/2 mice were intragastrically administered Lp-HKD or phosphate-buffered saline for 7 days prior to intranasal inoculation with Sendai virus (SeV). Lp-HKD administration improved survival and reduced weight loss after infection. At 7 days post-infection, SeV levels in the lungs were significantly lower in Lp-HKD–treated mice. Notably, SeV infection significantly decreased alveolar macrophage numbers in control mice, but not in Lp-HKD–treated mice. Furthermore, Lp-HKD treatment reduced the production of inflammatory cytokines and chemokines in bronchoalveolar lavage fluid. Lp-HKD administration was also associated with modest changes in the gut microenvironment, including altered abundance of specific bacterial taxa and increased microbial richness. Conversely, the depletion of alveolar macrophages abolished the protective effect of Lp-HKD, demonstrating that these cells are essential mediators of Lp-HKD antiviral activity. Collectively, these findings indicate that Lp-HKD modulates host immune responses and reduces the severity of viral respiratory infection in mice, underscoring its potential as a viable preventive strategy against viral respiratory diseases. - Immune Responses to Live-Attenuated Prime-Boost Vaccination Are Independent of Injection Site in Calves.
Mari Ikehata; Tomohiro Okagawa; Hayato Nakamura; Maho Inoue; Naoya Maekawa; Yasuhiko Suzuki; Shiro Murata; Kazuhiko Ohashi; Satoru Konnai
Microbiology and immunology, 70, 9, 427, 435, Sep. 2026, [Peer-reviewed], [International Magazine]
English, Scientific journal, Vaccination is highly effective in controlling infectious diseases in calves. A prime-boost injection is often administered intramuscularly in the neck and the hip in calves. However, no guidelines have established whether the same vaccination sites could be used for booster vaccinations. This study investigated the influence of intramuscular administration sites for sequential vaccines on immune responses in calves. All calves received the primary live-attenuated viral vaccine into the left side of the neck. Four weeks later, the booster was administered at the same site as the primary vaccine (local boost group) or in the right hip (distal boost group). The neutralizing antibody titers did not differ significantly between the groups. To assess T-cell responses to viral antigens after booster vaccination, the expression levels of lymphocyte activation markers CD25 and CD69 were measured in peripheral blood mononuclear cells (PBMCs). The site of booster administration had no significant effect on the activation of CD4+ and CD8+ T cells. Furthermore, vaccine-induced production of interferon-γ, tumor necrosis factor-α, and interleukin-6 in PBMC culture supernatants did not differ significantly between the groups. This study detected no significant differences in vaccine-specific immune responses between the local and distal booster vaccination sites in calves. - Stage-dependent changes in prostaglandin E₂ in tick saliva determine its immunosuppressive effects.
Hayato Nakamura; Luís Fernando Parizi; Yamato Sajiki; Tomohiro Okagawa; Mari Ikehata; Wisa Tiyamanee; Kei Watari; Shwe Yee Win; Naoya Maekawa; Shiro Murata; Kazuhiko Ohashi; Carlos Logullo; Itabajara da Silva Vaz Jr; Satoru Konnai
Ticks and tick-borne diseases, 17, 3, 102654, 102654, 09 May 2026, [Peer-reviewed], [International Magazine]
English, Scientific journal, Tick saliva contains bioactive molecules that can modulate host immune responses and facilitate blood feeding. Among these, prostaglandin E2 (PGE2) has been implicated in host immunosuppression, but its temporal dynamics during feeding and functional relevance remain unclear. In this study, we quantified PGE2 concentrations in Rhipicephalus microplus saliva across different feeding stages and assessed its immunomodulatory effects on bovine macrophages. Salivary PGE2 levels showed stage-dependent changes, with the highest concentrations detected during the mid-feeding phase. PGE2 suppressed TNF-α production from macrophages stimulated with LPS and IFN-γ in a concentration-dependent manner. Notably, saliva samples with higher endogenous PGE2 concentrations induced stronger suppression of TNF-α. Furthermore, the immunosuppressive effect of PGE2 was replicated by selective agonists against the two PGE2 receptors EP2 and EP4, suggesting a receptor-mediated mechanism. In addition, the saliva-mediated suppression of TNF-α production was significantly reversed by pharmacological blockade of EP receptors. Our findings reveal that the temporal increase in salivary PGE2 during tick feeding is functionally linked to suppression of host macrophage activation. These results suggest that PGE2 contributes to the immunomodulatory activity of tick saliva during blood feeding. - Exhausted CD4+T cells are associated with CCL4-driven immunosuppressive macrophage accumulation in enzootic bovine leukosis
Nakamura H.; Okagawa T.; Hamaïdia M.; Tiyamanee W.; Ikehata M.; Hirose M.; Inoue M.; Willems L.; Maezono K.; Passawat P.; Kobayashi S.; Kato Y.; Suzuki Y.; Maekawa N.; Murata S.; Ohashi K.; Konnai S.
Front Immunol., 17, 1808815, 1808815, May 2026, [Peer-reviewed], [International Magazine]
English, Scientific journal, In enzootic bovine leukosis (EBL), a B-cell lymphoma caused by bovine leukemia virus (BLV) infection, immune remodeling within tumor-affected lymph nodes is currently poorly understood. Here, we analyzed chemokine production and macrophage phenotypes in tumor-affected lymph nodes in EBL, focusing on CCL4. Intracellular cytokine staining revealed that, compared with healthy lymph nodes, EBL tumor-affected lymph nodes showed increased proportions of CCL4 expressing cells, particularly among CD4+ T cells and B cells. Functional migration assays showed that recombinant CCL4 induced robust monocyte migration, with a comparatively modest T-cell migration. To identify lymph node macrophages, we characterized CD11bhiCD172a+ cells and confirmed their macrophage identity based on high expression levels of CD11c, CD14, CD16, and CD68. Using this definition, we found that the CD11bhiCD172a+ population was markedly increased in tumor-affected lymph nodes. Phenotypic analysis revealed an increased proportion of CD163+ and CD163+PD-L1+ macrophages, consistent with the acquisition of an immunosuppressive phenotype. In parallel, macrophages in tumor-affected lymph nodes showed a shift from MHC class I/IIhi to MHC I/IIlo subsets and reduced co-expression of MHC molecules with CD80 and CD86, indicating impaired antigen-presenting features. Collectively, these findings suggest that elevated CCL4 production in tumor lesions induced by EBL is associated with monocyte recruitment and the accumulation of phenotypically altered macrophages, highlighting a chemokine-driven remodeling of the tumor immune microenvironment. - Tick saliva reprograms macrophages into immunosuppressive hubs that regulate T-cell immunity in Rhipicephalus microplus infestation.
Hayato Nakamura; Tomohiro Okagawa; Naoya Maekawa; Luís Fernando Parizi; Mari Ikehata; Wisa Tiyamanee; Shwe Yee Win; Hiroto Takeuchi; Keisuke Maezono; Passawat Thammahakin; Shintaro Kobayashi; Mizuki Fukuta; Minato Hirano; Kentaro Yoshii; Shiro Murata; Kazuhiko Ohashi; Carlos Logullo; Itabajara da Silva Vaz Jr; Satoru Konnai
Communications biology, 9, 1, 30 Apr. 2026, [Peer-reviewed], [International Magazine]
English, Scientific journal, Ticks transmit diverse pathogens and secrete saliva with immunomodulatory properties that facilitates blood feeding. However, the cellular mechanisms underlying saliva-mediated immune suppression remain poorly defined. Here, we identify macrophages as the central hub through which saliva from the cattle tick Rhipicephalus microplus suppresses T-cell mediated immunity. Tick saliva inhibited IFN-γ and TNF production by CD4⁺ and CD8⁺ T cells while enhancing IL-10 and TGF-β expression, particularly in regulatory T cells. These effects were lost upon removal of CD14⁺ cells, underscoring the importance of macrophage-lineage cells in saliva-induced immunosuppression. Transcriptomic and functional analyses showed that tick saliva reprograms macrophages into an immunosuppressive state with reduced MHC class II, attenuated proinflammatory signaling, and suppressed chemokine production. Consistent with these findings, immunofluorescence analysis of tick-feeding sites showed an increased presence of IL-10-expressing macrophages and T cells. Our findings highlight a strategy by which arthropod saliva suppresses host immunity to facilitate pathogen transmission. - In Vitro Characterization of an Equinized Anti-PD-L1 Antibody for Cancer Immunotherapy in Horses.
Takeru Horikawa; Naoya Maekawa; Tomohiro Okagawa; Wisa Tiyamanee; Otgontuya Ganbaatar; Hayato Nakamura; Mari Ikehata; Maho Inoue; Takeshi Nakanishi; Taro Tachibana; Yukinari Kato; Keiichi Yamamoto; Yasuhiko Suzuki; Shiro Murata; Kazuhiko Ohashi; Satoru Konnai
Veterinary sciences, 13, 4, 01 Apr. 2026, [Peer-reviewed], [International Magazine]
English, Scientific journal, Horses develop spontaneous tumors, typically in old age. Although local tumor control can be achieved using conventional therapies, systemic therapies are required to treat recurrent and/or metastatic tumors. Immune checkpoint inhibitors, such as anti-PD-L1 antibodies, have been approved for the treatment of various tumor types in humans; however, little is known about the immunosuppressive roles of the PD-1/PD-L1 pathway in horses, and the therapeutic potential of these inhibitors remains to be elucidated. Previously, we reported that the rat monoclonal anti-PD-L1 antibody 6C11-3A11 cross-reacts with horse PD-L1 to block the PD-1/PD-L1 interaction. To further develop antibodies for therapeutic purposes, their immunogenicity must be reduced to maximize efficacy and safety. To this end, we designed an equinized (equine-ized) anti-PD-L1 antibody, Eq6C11, using the complementarity-determining regions of 6C11-3A11. Eq6C11 had antigen-binding properties comparable to those of 6C11-3A11 and inhibited equine PD-L1 binding to PD-1 in a recombinant protein-based assay. Treatment with Eq6C11 significantly increased IFN-γ and IL-2 production in equine peripheral blood mononuclear cell cultures, suggesting its stimulatory activity on T-cell activation. Although further studies are needed to clarify its immunogenicity and clinical activity, these results encourage further development of Eq6C11 as a candidate immune checkpoint inhibitor for cancer immunotherapy in horses. - Prognostic Significance of Tumour Infiltrating Lymphocytes in Canine Oral Malignant Melanoma Treated With Anti-Programmed Cell Death Ligand 1 (PD-L1) Antibody Therapy.
Shintaro Kamo; Naoya Maekawa; Ayano Kudo; Akinori Yamauchi; Sho Yoshimoto; Yuma Harada; Satoru Konnai; Tomohiro Okagawa; Hayato Nakamura; Yumiko Kagawa; Junichi Kamiie; Keiichi Yamamoto; Satoshi Takagi
Veterinary and comparative oncology, 12 Feb. 2026, [Peer-reviewed], [International Magazine]
English, Scientific journal, Immune checkpoint inhibitors (ICIs) have emerged as a promising therapeutic strategy for canine oral malignant melanoma (OMM). However, only a subset of cases have shown clinical responses. Additionally, predictive biomarkers for the efficacy of ICIs in veterinary medicine are yet to be established. Tumour-infiltrating lymphocytes (TILs) are predictive biomarkers for ICI therapy in humans. In this study, we aimed to investigate the predictive utility of TILs for canine OMM treated with ICI therapy. Immunohistochemistry was performed on pre-treatment pathological tissues to detect cells positive for CD3 (pan-T cell marker), Granzyme B (cytotoxic T lymphocyte or natural killer cell marker) and Foxp3 (regulatory T cell marker). Further, we analysed the infiltration patterns of these cells and their prognostic utility for anti-programmed cell death ligand 1 (PD-L1) antibody therapy. There were variances in the infiltration levels of each TIL subset; further, we observed several TIL infiltration patterns in canine OMM. Survival analysis revealed that high infiltration of CD3+ and Granzyme B+ cells was significantly associated with prolonged progression-free survival and overall survival. Furthermore, the immune cell composition ratio, which reflected the balance between cytotoxic and regulatory cells, was significantly associated with survival time. These findings suggest that canine OMM exhibits immunological phenotypes analogous to those observed in human cancers. Taken together, the TIL profile holds significant potential as a prognostic biomarker for canine OMM treated with anti-PD-L1 antibody therapy. - Virulence of Marek's disease virus in Japan is linked to polymorphisms in the meq oncogene.
Yoshinosuke Motai; Aoi Kurokawa; Jumpei Sato; Shunsuke Yamagami; Shwe Yee Win; Fumiya Horio; Hikaru Saeki; Naoya Maekawa; Tomohiro Okagawa; Benedikt B Kaufer; Nikolaus Osterrieder; Mark S Parcells; Satoru Konnai; Kazuhiko Ohashi; Shiro Murata
The Journal of general virology, 107, 2, Feb. 2026, [Peer-reviewed], [International Magazine]
English, Scientific journal, Marek's disease virus (MDV) causes lymphomas and neurological disorders in chickens. Although vaccination largely controls outbreaks, highly virulent strains continue to emerge. The major MDV-encoded oncoprotein is Meq, functions as a transcription factor. Amino acid polymorphisms in Meq have been reported to influence virulence. Despite routine vaccination, MD still occurs sporadically in Japan. Japanese isolates harbour characteristic Meq polymorphisms, but their impact on MDV virulence remains unclear. We investigated the transcriptional regulation by Meq from Japanese isolates and evaluated the pathogenicity of recombinant MDV (rMDV) encoding Meq from the Japanese isolate Nr-c1. Nr-c1-Meq exhibited reduced transrepression and transactivation on viral gene promoters. An rMDV encoding Nr-c1-Meq (vNr-c1-Meq) induced lower mortality and tumourigenicity than an rMDV encoding Meq from the parental very virulent RB-1B strain (vRB-1B). vNr-c1-Meq did not cause visceral tumours or neurological disorders but resulted in distinct clinical signs, including open-mouth breathing. In lymphoid tissues from vNr-c1-Meq-infected chickens, a lower proportion of CD4+ T cells, the targets of MDV transformation, and lower viral loads were observed than those in vRB-1B-infected chickens. Histopathological examination revealed increased lymphocyte infiltration in bronchus-associated lymphoid tissues (BALT) in the vNr-c1-Meq group. Additionally, flow cytometric analysis showed elevated γδ T-cell proportions, which positively correlated with IFN-γ expression in vNr-c1-Meq-infected chickens and were linked to BALT hyperplasia. In comparison to the vRB-1B, vNr-c1-Meq infection resulted in attenuated disease progression and altered clinical signs. These findings suggest that Meq polymorphisms not only influence MD virulence but also clinical presentation. - Clinical efficacy of anti-programmed death ligand 1 antibody HFC-L1/c4G12 in dogs with malignant tumors: an exploratory study.
Satoshi Takagi; Michihito Tagawa; Naoya Maekawa; Satoru Konnai; Yumiko Kagawa; Kenji Hosoya; Akinori Yamauchi; Ayano Kudo; Shintaro Kamo; Sangho Kim; Ryohei Kinoshita; Tatsuya Deguchi; Ryo Owaki; Yurika Tachibana; Madoka Yokokawa; Hiroto Takeuchi; Hayato Nakamura; Yukinari Kato; Shigeki Kanazawa; Tomoyuki Abe; Takuya Furuta; Keiichi Yamamoto; Yasuhiko Suzuki; Tomohiro Okagawa; Shiro Murata; Kazuhiko Ohashi
The Journal of veterinary medical science, 87, 12, 1419, 1425, 01 Dec. 2025, [Peer-reviewed], [Lead author], [Domestic magazines]
English, Scientific journal, Cancer in dogs remains a major challenge in modern veterinary medicine. Immunotherapy using immune checkpoint inhibitors (ICIs) is available for various human tumor types, and recent veterinary clinical studies have shown that ICIs are a promising approach for treating canine cancers. A canine chimeric anti-PD-L1 antibody, c4G12 (HFC-L1), has been investigated for canine cancer immunotherapy; however, its clinical benefits have not been well characterized in tumors other than pulmonary metastatic (stage IV) oral malignant melanoma (OMM). To explore the efficacy and safety of HFC-L1, we conducted a clinical study in dogs with stage I-III OMM or other tumor types (n=12). HFC-L1 treatment at a dose of 5 mg/kg every 2 weeks was well tolerated, and no grade 3 or higher treatment-related adverse events were reported. Among the dogs eligible for response evaluation (n=10), a partial response was observed in one dog with squamous cell carcinoma, resulting in an objective response rate of 10%. In addition, in a dog with ceruminous cell carcinoma, clinical evidence of a tumor response was observed in metastatic lung lesions. Together, these results suggest that the HFC-L1 therapy is applicable for the treatment of various tumor types, although its clinical benefits should be further evaluated in clinical studies involving a larger number of dogs with each tumor type. - Enhancement of Vaccine-Induced T-Cell Responses by Probiotics in Calves.
Mari Ikehata; Tomohiro Okagawa; Hayato Nakamura; Naoya Maekawa; Yasuhiko Suzuki; Shiro Murata; Kazuhiko Ohashi; Satoru Konnai
Vaccines, 13, 11, 31 Oct. 2025, [Peer-reviewed], [International Magazine]
English, Scientific journal, BACKGROUND/OBJECTIVES: Calves have immature immune systems, hence immunization with vaccines is essential to protect them from infectious diseases. However, immune responses to vaccines vary widely among individuals. Therefore, strategies for enhancing vaccine efficacy are needed, particularly those targeting low responders to vaccines. Probiotics have attracted attention because of their beneficial immunomodulatory effects on the host. Although probiotics may improve calf immunity, their potential to enhance immune responses to vaccines in calves remains unclear. Thus, we investigated whether immune responses to vaccines, especially T-cell responses, are enhanced when calves receive a combination of probiotic supplementation and vaccination. METHODS: Calves were divided into three feeding groups, as follows: negative control feed, live bacteria-mixed feed (Zeosapo KB), and Clostridium butyricum-only feed (CB). After weaning, all calves received two doses of a live attenuated hexavalent viral vaccine. T-cell responses to a vaccine antigen were evaluated by measuring the expression levels of lymphocyte activation markers CD25 and CD69, as well as Th1 cytokine production, in peripheral blood mononuclear cell culture assays. RESULTS: CD25 expression significantly increased in CD4+ T cells four weeks after the booster vaccination in the Zeosapo KB- and CB-fed groups. In addition, the CD25+CD69+ cell ratio in CD4+ T cells was increased in these groups. The production of Th1 cytokines in the culture supernatant was also increased in the CB-fed group. CONCLUSIONS: This clinical study demonstrates that probiotics activate CD4+ T cells and enhance Th1 cytokine responses in vaccinated calves. - Two distinct polymorphisms in the basic region of Meq protein of marek's disease virus alter pathological progression and clinical manifestations.
Jumpei Sato; Aoi Kurokawa; Yoshinosuke Motai; Shunsuke Yamagami; Shwe Yee Win; Fumiya Horio; Hikaru Saeki; Naoya Maekawa; Tomohiro Okagawa; Benedikt B Kaufer; Nikolaus Osterrieder; Mark S Parcells; Satoru Konnai; Kazuhiko Ohashi; Shiro Murata
Virology journal, 22, 1, 303, 303, 26 Sep. 2025, [Peer-reviewed], [International Magazine]
English, Scientific journal, BACKGROUND: Marek's disease virus (MDV) causes Marek's disease (MD) in chickens, which is characterized by malignant lymphomas and neurological disorders. Although MD is currently controlled using live vaccines, the virulence of field strains has continuously increased in recent decades. Polymorphisms in the MDV-encoded oncoprotein Meq are shared among field strains according to their virulence. In particular, very virulent MDV strains harbor characteristic amino acid changes in the basic region of Meq at positions 77 and 80; however, the contribution of these polymorphisms to virulence remains unclear. METHODS: To assess the impact of these polymorphisms on MDV virulence, we generated recombinant MDV (rMDV) based on the very virulent RB-1B strain, harboring K77E and D80Y substitutions in Meq found in low-virulent strains (rRB-1B_Meq77/80). Chickens were challenged with rMDVs, and survival rates and tumor incidence were evaluated. Viral loads in major organs were quantified by quantitative PCR, and the dynamics of MDV-infected cells and T cells were analyzed using flow cytometry. In addition, histopathological analysis was performed to further examine differences in pathogenesis in detail. To elucidate the mechanisms underlying pathogenesis, we conducted reporter assays to assess the effect of these polymorphisms in the basic region on its transcriptional regulatory activity. RESULTS: rRB-1B_Meq77/80 exhibited a reduced virulence but unexpectedly caused other clinical signs, including open-mouth breathing, in infected chickens. Quantitative PCR analysis showed consistently lower viral loads across all examined organs in rRB-1B_Meq77/80-infected chickens. Flow cytometric analysis revealed a reduction in MDV-infected cells, accompanied by a notable increase in CD8⁺ T cell populations. Histopathological analysis showed bronchus-associated lymphoid tissue hyperplasia in the lungs. Reporter assays revealed that most amino acid substitutions in the basic region in low-virulence strains reduced transcriptional regulatory activity. CONCLUSION: Our data indicate that polymorphisms at positions 77 and 80 in the Meq of low-virulence strains reduce MDV virulence and Meq-mediated transcription and possibly alter pathogenesis. This study improves our understanding of the mechanisms underlying MDV virulence. - Exploratory, Randomized, Dose-Response Study of the Anti-PD-L1 Antibody HFC-L1/c4G12 in Dogs with Pulmonary Metastatic Oral Malignant Melanoma.
Kenji Hosoya; Sangho Kim; Ryohei Kinoshita; Naoya Maekawa; Satoru Konnai; Satoshi Takagi; Michihito Tagawa; Yumiko Kagawa; Tatsuya Deguchi; Ryo Owaki; Yurika Tachibana; Madoka Yokokawa; Hiroto Takeuchi; Hayato Nakamura; Akinori Yamauchi; Ayano Kudo; Shintaro Kamo; Yukinari Kato; Shigeki Kanazawa; Tomoyuki Abe; Takuya Furuta; Keiichi Yamamoto; Yasuhiko Suzuki; Tomohiro Okagawa; Shiro Murata; Kazuhiko Ohashi
Veterinary sciences, 12, 9, 02 Sep. 2025, [Peer-reviewed], [Lead author], [International Magazine]
English, Scientific journal, Oral malignant melanoma (OMM) is a highly aggressive malignancy in dogs. The development of effective systemic therapies is urgently required to improve the treatment of canine OMM. Immunotherapy using immune checkpoint inhibitors (ICIs) has been investigated in canines following their dramatic success in human cancer treatment; however, there is still a need for extensive veterinary clinical studies to clarify and optimize their clinical benefits. Among the ICIs under development for canine cancer immunotherapy, c4G12 (HFC-L1), a canine chimeric anti-PD-L1 antibody, has shown promising efficacy in dogs with pulmonary metastatic OMM in previous clinical studies. However, the optimal dose of HFC-L1/c4G12 has not yet been determined. To explore the dose-response relationship of HFC-L1, a multicenter, randomized clinical study was conducted using three different doses (2, 5, or 10 mg/kg via intravenous infusion every 2 weeks) to treat dogs with pulmonary metastatic OMM (n = 8-9 per group). The safety profiles were similar among the dose groups, and numerically longer median overall survival was achieved in the higher dose groups (5 and 10 mg/kg) than in the 2 mg/kg group. Although the study was exploratory in nature with a small sample size, 5-10 mg/kg should be considered the preferred dose in future clinical studies using HFC-L1. - Evaluation of PD-L1 and TIM-3 Pathways in T Cells During Experimental Bovine Leukemia Virus Infection in Sheep.
Wisa Tiyamanee; Tomohiro Okagawa; Shinji Yamada; Mari Ikehata; Hayato Nakamura; Maho Inoue; Naoya Maekawa; Yukinari Kato; Shiro Murata; Kazuhiko Ohashi; Kenji Murakami; Satoru Konnai
Veterinary sciences, 12, 9, 26 Aug. 2025, [Peer-reviewed], [International Magazine]
English, Scientific journal, Bovine leukemia virus (BLV) infects B cells in ruminants and causes lymphoma after an extended latency period. Previous studies have demonstrated T-cell exhaustion through the upregulation of immunoinhibitory molecules, including programmed death-ligand 1 (PD-L1) and T-cell immunoglobulin and mucin domain-3 (TIM-3), in BLV-infected cattle. However, studying T-cell exhaustion across all BLV infection stages remains challenging due to the virus's prolonged latency in cattle. Sheep provide a valuable model, as they develop lymphoma more rapidly than cattle. This study examined PD-L1 and TIM-3 expression kinetics and T-cell function in BLV-infected sheep. During persistent infection, PD-L1 expression was correlated with BLV proviral load. TIM-3 expression increased in CD4+, CD8+, and γδTCR+ T cells. Functional analysis revealed that TIM-3 blockade enhanced T-cell activation markers (CD25 and CD69) in cultured PBMCs from infected sheep and increased CD69+IFN-γ+ and CD69+TNF-α+ populations, particularly among CD4+ T cells. Combined PD-L1 and TIM-3 blockade significantly enhanced cytokine production in both CD4+ and CD8+ T cells, while PD-L1 blockade alone showed limited effects. These findings demonstrate the effect of TIM-3 blockade in restoring immune function during chronic BLV infection, effective both alone and in combination. This study validates sheep as a valuable model for investigating immune checkpoint dynamics and evaluating immunotherapies for BLV infection and other chronic diseases. - Amino acid insertion in the Meq protein of Marek's disease virus, an avian oncogenic herpesvirus, accelerates tumorigenesis.
Jumpei Sato; Shiro Murata; Yoshinosuke Motai; Shwe Yee Win; Hikari Seo; Shunsuke Yamagami; Naoya Maekawa; Tomohiro Okagawa; Satoru Konnai; Kazuhiko Ohashi
Microbiology spectrum, e0336824, 17 Jul. 2025, [Peer-reviewed], [International Magazine]
English, Scientific journal, Marek's disease virus (MDV) causes lymphomas (Marek's disease) in chickens. Despite vaccination, MDV field strains exhibit increased virulence, and sporadic outbreaks are still reported. An insertion/deletion in Meq has been identified in several MDV strains, and our previous study using recombinant MDV (rMDV) demonstrated that an insertion in Meq enhanced MDV virulence, whereas a deletion reduced its virulence. However, the mechanisms by which these indels in Meq alter MDV virulence remain elusive. We aimed to clarify the impact of the insertion in Meq on pathogenesis. We compared the effects of Meq and Meq with the insertion, termed L-Meq, on transcriptional regulation, the dynamics of transformed T cells and relevant T-cell subsets, and the patterns of gene expression in tumor lesions of infected chickens. Reporter assays revealed that insertion increased the transactivation activity on the infected-cell protein 4 promoter in the MDV genome and bcl-2/cd30 promoters in the host genome. rMDV encoding L-Meq (vRB-1B_L-Meq) exhibited higher mortality and tumor incidence than rMDV encoding Meq (vRB-1B_Meq), and vRB-1B_L-Meq infection increased the proportion of CD4+ T cells, which are targets for transformation by MDV, in the early post-infection phase, compared with vRB-1B_Meq. RNA-seq analysis revealed that similar genes were modulated in tumor lesions of chickens infected with vRB-1B_Meq or vRB-1B_L-Meq. These findings suggest that although the insertion in Meq does not alter the target genes for transcriptional regulation, it accelerates the process of tumorigenesis by enhancing the transactivation activity.IMPORTANCEMarek's disease, an avian lymphoproliferative disease, is caused by Marek's disease virus (MDV). Meq, an MDV oncoprotein, regulates the expression of viral and host genes. Meq with an insertion, termed L-Meq, has been identified as a factor that enhances MDV virulence. However, the mechanisms by which the insertion in Meq alters MDV virulence remain unknown. Our study clarified that the insertion enhances the transactivation activity of Meq on the host promoters related to tumorigenesis. Notably, the transcriptomes of tumor lesions in chickens infected with recombinant MDV (rMDV) with L-Meq and those infected with rMDV encoding Meq without the insertion were similar; however, chickens infected with rMDV harboring L-Meq exhibited higher proportions of CD4+ T cells and regulatory T cells, which are targets for transformation by MDV, in the early post-infection phase, suggesting accelerated tumorigenesis. This study contributes to the current understanding of the mechanisms underlying MDV virulence. - Development of blood-brain barrier-penetrating antibodies for neutralizing tick-borne encephalitis virus in the brain.
Mizuki Fukuta; Sayo Fukano; Naoya Maekawa; Shintaro Kobayashi; Shunsuke Okamoto; Minato Hirano; Junko Nio-Kobayashi; Hiroaki Kariwa; Shigeru Kawakami; Satoru Konnai; Kentaro Yoshii
mSphere, e0018425, 07 Jul. 2025, [Peer-reviewed], [International Magazine]
English, Scientific journal, UNLABELLED: Tick-borne encephalitis virus (TBEV) belongs to the genus Flavivirus and causes tick-borne encephalitis (TBE), a disease characterized by severe neurological symptoms with a high mortality rate. Currently, no specific antiviral treatments have been developed for TBE. The blood-brain barrier (BBB) restricts drug delivery to the central nervous system, posing a major challenge in developing effective therapies targeting TBEV in the brain. In this study, we developed recombinant anti-TBEV antibodies fused with BBB-penetrating rabies virus glycoprotein (RVG) peptides to facilitate their transport across the BBB. The fusion of RVG peptides to the C-terminus of the heavy chain of whole antibodies or single-chain variable fragment had minimal impact on their neutralizing ability against TBEV. The RVG fusion enhanced antibody binding to the surface of a human brain endothelial cell line and increased permeability in an in vitro BBB model. The RVG-fused antibodies exhibited a higher transport efficiency to the brain than the non-fused antibodies following peripheral injection in mice. Notably, the peripheral administration of the RVG-fused whole antibody after viral invasion into the brain significantly neutralized TBEV in the brains of infected mice. These findings suggest that RVG-fused antibodies represent a promising therapeutic strategy for treating TBE once the virus has entered the brain. IMPORTANCE: Tick-borne encephalitis virus is a neuroinvasive pathogen that causes severe neurologic disease, significantly affecting patients' quality of life. No specific antiviral treatment is available for tick-borne encephalitis caused by virus multiplication in the brain. The delivery of drugs to the brain via peripheral administration is often obstructed by the blood-brain barrier. To develop targeted antiviral therapies for brain infections, we engineered recombinant antibodies capable of crossing the blood-brain barrier via brain-targeted ligands. These antibodies exhibited permeability across the blood-brain barrier in both in vitro and in vivo models and notably effectively neutralized the virus within the brain following peripheral administration. This study is the first to highlight the therapeutic potential of brain-targeted recombinant antibodies after viral entry into the brain, offering a promising pathway for the development of effective antiviral treatments for tick-borne encephalitis. - Amino Acid Polymorphisms in the Basic Region of Meq of Vaccine Strain CVI988 Drastically Diminish the Virulence of Marek's Disease Virus.
Jumpei Sato; Yoshinosuke Motai; Shunsuke Yamagami; Aoi Kurokawa; Shwe Yee Win; Fumiya Horio; Hikaru Saeki; Naoya Maekawa; Tomohiro Okagawa; Satoru Konnai; Kazuhiko Ohashi; Shiro Murata
Viruses, 17, 7, 26 Jun. 2025, [Peer-reviewed], [International Magazine]
English, Scientific journal, Marek's disease virus (MDV) is the etiological agent of Marek's disease (MD), a lymphoproliferative disorder in chickens. Polymorphisms in the MDV-encoded oncoprotein Meq are shared among field strains and correlate with their virulence. The attenuated vaccine strain CVI988 harbors unique amino acid polymorphisms in Meq, particularly at positions 71, 77, and 326. In this study, we investigated the impact of these polymorphisms on Meq protein function and MDV virulence. Reporter assays revealed that the substitutions, particularly A71S and K77E, markedly impaired the transcriptional regulatory activity of Meq. To evaluate their effect on virulence, we generated a recombinant MDV based on the very virulent RB-1B strain, encoding Meq with A71S and K77E substitutions (rRB-1B_Meq71/77). Chickens infected with rRB-1B_Meq71/77 developed neither clinical signs nor lymphomas. Flow cytometry revealed no expansion of infected cells in this group, but a marked increase in CD8+ T and γδ T cells during early infection. Histopathological analysis also confirmed the absence of MD-associated lesions. These findings demonstrate that the polymorphisms at positions 71 and 77 in the CVI988 strain are sufficient to abolish MDV virulence. This study provides insight into the molecular basis of MDV virulence and informs the strategy for the design of more effective vaccines. - Comprehensive analysis of immune checkpoint molecules profiles phenotype and function of exhausted T cells in enzootic bovine leukosis.
Hayato Nakamura; Satoru Konnai; Tomohiro Okagawa; Naoya Maekawa; Wisa Tiyamanee; Mari Ikehata; Koume Matsubara; Kei Watari; Kana Kamitani; Maya Saito; Yukinari Kato; Yasuhiko Suzuki; Shiro Murata; Kazuhiko Ohashi
Journal of immunology (Baltimore, Md. : 1950), 27 May 2025, [Peer-reviewed], [International Magazine]
English, Scientific journal, Bovine leukemia virus (BLV) causes enzootic bovine leukosis (EBL), a B-cell lymphoma in cattle. Previous studies have demonstrated that T cells of BLV-infected cattle show increased expression of immune checkpoint molecules, including programmed death-1 (PD-1), lymphocyte-activation gene-3 (LAG-3), cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4), and T-cell immunoglobulin domain and mucin domain-3 (TIM-3), leading to T-cell exhaustion. However, the key immune checkpoint molecules driving T-cell exhaustion in BLV-induced tumorigenesis remained unclear. In this study, we identified the key immune checkpoint molecules by performing comprehensive flow cytometric analyses of T cells from EBL cattle, and elucidated the phenotype and function of exhausted T cells using a transcriptomic analysis by RNA sequencing and cell culture assays. The comprehensive expression analysis revealed that the proportion of CD4+ and CD8+ T cells co-expressing PD-1 and TIM-3 was significantly increased in the peripheral blood and tumor tissues of EBL cattle compared to healthy cattle. Transcriptomic analysis of PD-1+TIM-3+ T cells revealed the upregulation of genes related to terminal exhaustion and the downregulation of genes related to T-cell differentiation and response in this subset. Additionally, PD-1+TIM-3+ T cells exhibited higher expression of CTLA-4, LAG-3, and Eomes, and lower expression of T-bet, suggesting a terminally exhausted phenotype. Cell culture assays revealed a significant impairment in IFN-γ production in PD-1+TIM-3+ T cells upon stimulation, reflecting severe dysfunction. These findings indicate that PD-1+TIM-3+ T cells play a central role in T-cell exhaustion during BLV-induced tumorigenesis. This study provides valuable insights for future therapeutic strategies against BLV infection. - Development of caninized anti-CTLA-4 antibody as salvage combination therapy for anti-PD-L1 refractory tumors in dogs.
Naoya Maekawa; Satoru Konnai; Kei Watari; Hiroto Takeuchi; Takeshi Nakanishi; Taro Tachibana; Kenji Hosoya; Sangho Kim; Ryohei Kinoshita; Ryo Owaki; Madoka Yokokawa; Yumiko Kagawa; Satoshi Takagi; Tatsuya Deguchi; Hiroshi Ohta; Yukinari Kato; Satoshi Yamamoto; Keiichi Yamamoto; Yasuhiko Suzuki; Tomohiro Okagawa; Shiro Murata; Kazuhiko Ohashi
Frontiers in immunology, 16, 1570717, 1570717, 20 May 2025, [Peer-reviewed], [Lead author], [International Magazine]
English, Scientific journal, Immune checkpoint inhibitors (ICIs) are widely used for cancer immunotherapy; however, the clinical efficacy of anti-PD-1/PD-L1 monotherapy is generally limited, highlighting the need to develop combination therapies. Dogs develop spontaneous tumors in immunocompetent settings, and anti-PD-1/PD-L1 antibodies exert similar clinical benefits. However, no clinically relevant anti-CTLA-4 antibody has been reported, limiting the value of canine tumors as comparative models for human ICI research. Here, canine CTLA-4 was molecularly characterized, and a caninized anti-CTLA-4 antibody (ca1C5) that blocks CTLA-4/ligand binding was developed. Treatment with ca1C5 increased cytokine production in canine immune cell cultures, and the immunostimulatory effect was enhanced when used in combination with the anti-PD-L1 antibody c4G12. As a proof-of-concept, a veterinary clinical study was conducted to demonstrate the safety and clinical efficacy of anti-CTLA-4 antibody as salvage combination therapy in dogs with advanced tumors refractory to prior c4G12 monotherapy. The combination treatment (c4G12 plus ca1C5) was well-tolerated, and evidence of antitumor activity was observed in one dog with oral malignant melanoma. Further studies are warranted to advance veterinary care for dogs and to better characterize canine ICI models for human onco-immunology research. - Programmed Cell Death-1 Expression in T-Cell Subsets in Chickens Infected with Marek's Disease Virus.
Jumpei Sato; Yoshinosuke Motai; Shunsuke Yamagami; Shwe Yee Win; Fumiya Horio; Hikaru Saeki; Naoya Maekawa; Tomohiro Okagawa; Satoru Konnai; Kazuhiko Ohashi; Shiro Murata
Pathogens (Basel, Switzerland), 14, 5, 29 Apr. 2025, [Peer-reviewed], [International Magazine]
English, Scientific journal, Marek's disease virus (MDV) causes Marek's disease (MD) in chickens, characterized by malignant lymphomas and immunosuppression. Sporadic MD outbreaks continue to occur even among vaccinated flocks in certain regions due to the increased virulence of the field strains. However, the mechanisms of tumorigenesis and immunosuppression caused by MDV remain to be fully elucidated. We previously reported that the mRNA expression of programmed cell death 1 (PD-1), an immune checkpoint molecule, was increased in tumor lesions caused by MDV, and its expression was positively correlated with the mRNA expression of Meq, an MDV-specific oncogene. In this study, we characterized PD-1-expressing T-cell subsets in the spleen and tissues of chickens that developed tumors to investigate the association between PD-1 expression and immunosuppression. Flow cytometric analysis revealed that the proportion of PD-1-expressing CD4+ T-cells, which are targets of MDV tumorigenesis, increased in the spleen and tumor tissues of chickens with MD. The proportion of PD-1+ CD4+ T-cells was higher in Meq-expressing cells than in those that were not. In the spleens of chickens with MD, the proportions of PD-1-expressing cells were increased in CD8+ and γδ T-cells, which play pivotal roles in defense against MD pathogenesis, relative to those of spleens from uninfected chickens. Moreover, the proportion of PD-1+ CD8+ T-cells expressing interferon (IFN)-γ did not increase in the spleen of chickens with MD. Additionally, no difference in the proportion of IFN-γ+ γδ T-cells expressing and not expressing PD-1 was observed in the spleens of chickens with MD, although the proportion of IFN-γ+ γδ T-cells expressing PD-1 in the spleens of uninfected chickens was higher. The function of PD-1-expressing CD8+ and γδ T-cells in chickens may be impaired after developing MD, which may cause MDV-induced immunosuppression. - Genomic characteristics and distinctive genetic polymorphisms of Marek's disease virus strains circulating in Japan.
Shunsuke Yamagami; Jumpei Sato; Yoshinosuke Motai; Naoya Maekawa; Tomohiro Okagawa; Satoru Konnai; Kazuhiko Ohashi; Shiro Murata
The Journal of veterinary medical science, 03 Apr. 2025, [Peer-reviewed], [Domestic magazines]
English, Scientific journal, Marek's disease virus (MDV) is an oncogenic herpesvirus that causes malignant lymphomas in chickens (Marek's disease, MD). Although MD is currently well controlled by vaccination, field strains of MDV tend to increase in virulence, and sporadic outbreaks have been reported worldwide, including in Japan. Previously, we determined the whole-genome sequence of a Japanese MDV strain, Kgs-c1, isolated in 2014, and analyzed its genetic characteristics. However, to date, Kgs-c1 is the only MDV strain that has been subjected to whole-genome sequencing, leaving the possibility that the key genetic features of the Japanese strains remain undiscovered. Therefore, we conducted whole-genome sequencing of two MDV strains, Kgs-c2 and Sg-c1, isolated in 2016 and 2019, respectively, and analyzed their genetic characteristics. Consistent with our previous findings, the genomic sequences of the Japanese strains were classified into the Eurasian cluster, suggesting that the Japanese strains are genetically closer to the European and Chinese strains than they are to the US strains. In contrast, the Japanese strains exhibited genetic features different from those of pathogenic European and Chinese strains. Furthermore, polymorphisms in the meq and infected cell protein 4 (ICP4) genes, which are candidates involved in the enhanced virulence of MDV, were observed among the newly isolated strains and Kgs-c1. Thus, three MDV strains isolated in Japan had different genetic features from those in other countries. These findings emphasize the necessity of periodic monitoring of MDV field strains in order to determine shifts in their characteristics and effectively control MD. - Performance evaluation of an improved RAISING method for clonality analysis of bovine leukemia virus-infected cells: a collaborative study in Japan.
Tomohiro Okagawa; Naomi Nojiri; Hazuka Yoshida-Furihata; Naganori Nao; Misono Tominaga; Junko Kohara; Satoshi Gondaira; Hidetoshi Higuchi; Yohei Takeda; Haruko Ogawa; Shinji Yamada; Kenji Murakami; Yasunori Suzuki; Shinji Takai; Masaki Maezawa; Hisashi Inokuma; Kaori Shimizu; Yasuo Inoshima; Tatsufumi Usui; Michihito Tagawa; Mari Yamamoto; Hirohisa Mekata; Mana Esaki; Makoto Ozawa; Takahiro Matsudaira; Naoya Maekawa; Shiro Murata; Kazuhiko Ohashi; Masumichi Saito; Satoru Konnai
The Journal of veterinary medical science, 28 Mar. 2025, [Peer-reviewed], [Domestic magazines]
English, Scientific journal, Bovine leukemia virus (BLV), a retrovirus that is widespread worldwide, causes enzootic bovine leukosis (EBL), a B-cell leukemia/lymphoma with a poor prognosis that ultimately results in death. In Japan, the number of cattle infected with this virus is increasing, and it is estimated more than 35% of cattle are currently infected. Since no vaccines or treatments against BLV infection are currently available, it is important to establish a method of early diagnosis for EBL to reduce economic losses caused by the disposal of EBL cattle in Japan, where a large number of expensive beef cattle are raised. We previously developed Rapid Amplification of the Integration Site without Interference by Genomic DNA Contamination (RAISING), a cost-effective, rapid, and sensitive method for the clonality analysis of BLV-infected cells. Despite its usefulness for the early diagnosis of EBL, RAISING had drawbacks preventing its practical application. Here, we report the development of an improved method, RAISING ver.2, and its performance. Compared to BLV clonality analysis using the previous method, RAISING ver.2 was found to maintain high accuracy and reproducibility despite its simplification. Moreover, its performance was also validated in a multicenter validation study. Taken together, our results strongly suggest that RAISING ver.2 can be fully utilized in clinical practice. Successful commercialization of a RAISING test kit could overcome the concerns of livestock farmers suffering from EBL, thereby promoting a stable supply of Japanese beef, both domestically and internationally. - Characterization of a lipocalin-like molecule from Dermanyssus gallinae as a potential vaccine antigen.
Fumiya Horio; Hikari Seo; Shwe Yee Win; Jumpei Sato; Yoshinosuke Motai; Shunsuke Yamagami; Takumi Sato; Eiji Ohishi; Naoya Maekawa; Tomohiro Okagawa; Satoru Konnai; Kazuhiko Ohashi; Shiro Murata
Veterinary immunology and immunopathology, 283, 110921, 110921, 24 Mar. 2025, [Peer-reviewed], [International Magazine]
English, Scientific journal, Poultry red mites (PRMs, Dermanyssus gallinae) are hematophagous ectoparasites of chickens that pose a significant threat to the egg-laying industry. The emergence of acaricide-resistant PRMs raises the demand for alternative control approaches such as vaccination. However, several vaccine antigens have failed to suppress the growth of PRM populations in field trials due to difficulties in maintaining antibody levels. In ticks, the molecules exposed to the host, such as lipocalins, can facilitate antibody production, and are therefore considered advantageous as vaccine antigens. Therefore, we focused on a lipocalin-like molecule (Dg-Lipocalin) identified from an RNA-seq analysis reported by Fujisawa et al. (2020) and analyzed its exposure to the host and potential as a vaccine antigen. Western blotting using 500-fold diluted plasma of chickens from PRM-contaminated farms revealed the presence of antibodies against Dg-Lipocalin, suggesting its exposure to the host. To evaluate its potential as a vaccine antigen, PRMs were artificially fed immune plasma with 32,000- to 64,000-fold antibody titers or plasma from PBS-inoculated control chickens, and their mortality was observed for 7 days. In experiment 1, the immune plasma significantly increased PRM mortality compared to the control plasma. However, these effects were not observed in experiment 2, although the total mortality was significantly increased in immune plasma-fed PRMs. Thus, the efficacy of Dg-Lipocalin appears to be limited; however, its exposure to the host may result in sustained antibody titers. Further investigation is required to evaluate its feasibility. - Enhancement of radio-sensitivity by inhibition of Janus kinase signaling with oclacitinib in canine tumor cell lines.
Ryo Owaki; Kenji Hosoya; Tatsuya Deguchi; Satoru Konnai; Naoya Maekawa; Tomohiro Okagawa; Hironobu Yasui; Sangho Kim; Takafumi Sunaga; Masahiro Okumura
Molecular therapy. Oncology, 33, 1, 200946, 200946, 20 Mar. 2025, [Peer-reviewed], [International Magazine]
English, Scientific journal, A combination of irradiation and oclacitinib, a Janus kinase (JAK) inhibitor used in dogs, could lead to synergistic anticancer effects in canine tumors. However, the anti-tumor effects of oclacitinib remain unclear. This study investigated the radio-sensitizing effect of oclacitinib in canine tumors and determined its underlying mechanisms using osteosarcoma (HMPOS), malignant melanoma (CMeC), and thyroid adenocarcinoma (CTAC) cell lines. A clonogenic assay and a tumor growth assessment in a xenograft mouse model (BALB/cAJcl-nu/nu) were performed to evaluate the radio-sensitizing effects of oclacitinib. Oclacitinib enhanced the radio-sensitivity of tumor cells both in vitro and in vivo. The signal transducer and activator of transcription (STAT)3 expression was activated and suppressed by oclacitinib in X-irradiation-exposed cells. Oclacitinib enhanced radiation-induced apoptosis only in HMPOS cells by inhibiting anti-apoptotic genes. In addition, oclacitinib inhibited the transcription of cell-cycle-regulating genes and arrested cell cycle progression from the G1 phase to subsequent phases. In conclusion, oclacitinib enhanced radio-sensitivity both in vitro and in vivo by triggering apoptosis and impeding cell cycle progression via STAT3 inhibition in canine tumor cell lines. This study suggested the clinical therapeutic potential of oclacitinib and radiation therapy in enhancing treatment efficacy and outcomes in canine tumors. - Potential of histamine release factor for the utilization as a universal vaccine antigen against poultry red mites, tropical fowl mites, and northern fowl mites.
Shwe Yee Win; Fumiya Horio; Jumpei Sato; Yoshinosuke Motai; Hikari Seo; Sotaro Fujisawa; Takumi Sato; Eiji Oishi; Lat Lat Htun; Saw Bawm; Tomohiro Okagawa; Naoya Maekawa; Satoru Konnai; Kazuhiko Ohashi; Shiro Murata
The Journal of veterinary medical science, 20 Nov. 2024, [Peer-reviewed], [Domestic magazines]
English, Scientific journal, Poultry red mites (PRMs, Dermanyssus gallinae), tropical fowl mites (TFMs, Ornithonyssus bursa), and northern fowl mites (NFMs, Ornithonyssus sylviarum) are hematophagous mites that are distributed worldwide which pose a serious challenge to the poultry industry and negatively impact poultry production and welfare. Vaccines represent a promising approach for controlling avian mites, and the identification of antigens with broad efficacy against multiple avian mite species is advantageous for vaccine control. This study aimed to identify histamine release factor (HRF), which was previously reported as a candidate vaccine antigen against PRMs, from TFMs and NFMs and to analyze its cross-reactivity and acaricidal effects on different avian mite species. The deduced amino acid sequences of the HRFs identified in the TFMs and NFMs were highly homologous to those of the PRMs. We generated recombinant HRF (rHRF) of TFMs, NFMs, and PRMs, and immune plasma against each rHRF was produced by immunization with each antigen. The immune plasma contained antibodies specific to each antigen and showed cross-reactivity with rHRFs from different avian mites. Moreover, PRM nymphs (protonymphs) artificially fed each immune plasma showed higher mortality rates than those fed the control plasma. These results suggest that HRFs can be used as candidate antigens for a universal vaccine with broad efficacy across avian mites. - Chimeric provirus of bovine leukemia virus/SMAD family member 3 in cattle with enzootic bovine leukosis.
Naganori Nao; Tomohiro Okagawa; Naomi Nojiri; Satoru Konnai; Honami Shimakura; Misono Tominaga; Hazuka Yoshida-Furihata; Eri Nishiyama; Takahiro Matsudaira; Naoya Maekawa; Shiro Murata; Masamichi Muramatsu; Kazuhiko Ohashi; Masumichi Saito
Archives of virology, 169, 3, 47, 47, 16 Feb. 2024, [Peer-reviewed], [International Magazine]
English, Scientific journal, Bovine leukemia virus (BLV) is a member of the family Retroviridae that causes enzootic bovine leukemia (EBL). However, the association between BLV infection and EBL development remains unclear. In this study, we identified a BLV/SMAD3 chimeric provirus within CC2D2A intron 30 in monoclonal expanded malignant cells from a cow with EBL. The chimeric provirus harbored a spliced SMAD3 sequence composed of exons 3-9, encoding the short isoform protein, and the BLV-SMAD3 chimeric transcript was detectable in cattle with EBL. This is the first report of a BLV chimeric provirus that might be involved in EBL tumorigenesis. - In Vivo Characterization of the Anti-Glutathione S-Transferase Antibody Using an In Vitro Mite Feeding Model
Shwe Yee Win; Hikari Seo; Fumiya Horio; Sotaro Fujisawa; Jumpei Sato; Yoshinosuke Motai; Takumi Sato; Eiji Oishi; Akira Taneno; Lat Lat Htun; Saw Bawm; Tomohiro Okagawa; Naoya Maekawa; Satoru Konnai; Kazuhiko Ohashi; Shiro Murata
Vaccines, 12, 2, 148, 148, MDPI AG, 30 Jan. 2024, [Peer-reviewed]
Scientific journal, Poultry red mites (Dermanyssus gallinae, PRMs), tropical fowl mites (Ornithonyssus bursa, TFMs), and northern fowl mites (O. sylviarum, NFMs) are blood-feeding pests that debilitate poultry worldwide. Glutathione S-transferase (GST) plays an important role in the detoxification and drug metabolism of mites. However, research on avian mite GSTs as vaccine antigens is still lacking. Therefore, we aimed to evaluate the potential of avian mite GSTs for vaccine development. We identified GST genes from TFMs and NFMs. We prepared recombinant GST (rGST) from TFMs, NFMs, and PRMs, and assessed their protein functions. Moreover, we evaluated the cross-reactivity and acaricidal effect of immune plasma against each rGST on TFMs, NFMs, and PRMs. The deduced amino acid sequences of GSTs from TFMs and NFMs were 80% similar to those of the PRMs. The rGSTs exhibited catalytic activity in conjugating glutathione to the 1-chloro-2,4-dinitrobenzene substrate. Immune plasma against each rGST showed cross-reactivity with rGST from different mite species. Moreover, the survival rate of PRMs fed with immune plasma against the rGST of TFMs and NFMs was significantly lower than that of the control plasma. These results demonstrate the potential application of GST as an antigen for the development of a broad-spectrum vaccine against avian mites. - Characterization of a Very Short Meq Protein Isoform in a Marek's Disease Virus Strain in Japan.
Yoshinosuke Motai; Shiro Murata; Jumpei Sato; Akihito Nishi; Naoya Maekawa; Tomohiro Okagawa; Satoru Konnai; Kazuhiko Ohashi
Veterinary sciences, 11, 1, 20 Jan. 2024, [Peer-reviewed], [International Magazine]
English, Scientific journal, Marek's disease virus (MDV) causes malignant lymphoma (Marek's disease; MD) in chickens. The Meq protein is essential for tumorigenesis since it regulates the expression of host and viral genes. Previously, we reported that the deletion of the short isoform of Meq (S-Meq) decreases the pathogenicity of MDV. Recently, we identified a further short isoform of Meq (very short isoform of Meq, VS-Meq) in chickens with MD in Japan. A 64-amino-acid deletion was confirmed at the C-terminus of VS-Meq. We measured the transcriptional regulation by VS-Meq in three gene promoters to investigate the effect of VS-Meq on protein function. Wild-type VS-Meq decreased the transrepression of the pp38 promoter but did not alter the transactivation activity of the Meq and Bcl-2 promoters. The deletion in VS-Meq did not affect the activity of the pp38 promoter but enhanced the transactivation activities of the Meq and Bcl-2 promoters. Collectively, the deletion of VS-Meq potentially enhanced the activity of the Meq promoter, while other amino acid sequences in wild-type VS-Meq seemed to affect the weak transrepression of the pp38 promoter. Further investigation is required to clarify the effects of these changes on pathogenicity. - Safety and clinical efficacy of an anti-PD-L1 antibody (c4G12) in dogs with advanced malignant tumours.
Naoya Maekawa; Satoru Konnai; Kenji Hosoya; Sangho Kim; Ryohei Kinoshita; Tatsuya Deguchi; Ryo Owaki; Yurika Tachibana; Madoka Yokokawa; Hiroto Takeuchi; Yumiko Kagawa; Satoshi Takagi; Hiroshi Ohta; Yukinari Kato; Satoshi Yamamoto; Keiichi Yamamoto; Yasuhiko Suzuki; Tomohiro Okagawa; Shiro Murata; Kazuhiko Ohashi
PloS one, 18, 10, e0291727, 04 Oct. 2023, [Peer-reviewed], [Lead author], [International Magazine]
English, Scientific journal, Immune checkpoint inhibitors (ICIs) have been developed for canine tumour treatment, and pilot clinical studies have demonstrated their antitumour efficacy in dogs with oral malignant melanoma (OMM). Although ICIs have been approved for various human malignancies, their clinical benefits in other tumour types remain to be elucidated in dogs. Here, we conducted a clinical study of c4G12, a canine chimeric anti-PD-L1 antibody, to assess its safety and efficacy in dogs with various advanced malignant tumours (n = 12) at the Veterinary Teaching Hospital of Hokkaido University from 2018 to 2023. Dogs with digit or foot pad malignant melanoma (n = 4), osteosarcoma (n = 2), hemangiosarcoma (n = 1), transitional cell carcinoma (n = 1), nasal adenocarcinoma (n = 1), B-cell lymphoma (n = 1), or undifferentiated sarcoma (n = 2) were treated with 2 or 5 mg/kg c4G12 every 2 weeks. Treatment-related adverse events of any grade were observed in eight dogs (66.7%), including elevated aspartate aminotransferase (grade 3) in one dog (8.3%) and thrombocytopenia (grade 4) in another dog (8.3%). Among dogs with target disease at baseline (n = 8), as defined by the response evaluation criteria for solid tumours in dogs (cRECIST), one dog with nasal adenocarcinoma and another with osteosarcoma experienced a partial response (PR), with an objective response rate of 25.0% (2 PR out of 8 dogs; 95% confidence interval: 3.2-65.1%). These results suggest that c4G12 is safe and tolerable and shows antitumor effects in dogs with malignant tumours other than OMM. Further clinical studies are warranted to identify the tumour types that are most likely to benefit from c4G12 treatment. - Development of a high-affinity anti-bovine PD-1 rabbit-bovine chimeric antibody using an efficient selection and large production system.
Tomohiro Okagawa; Satoru Konnai; Shinya Goto; Yamato Sajiki; Otgontuya Ganbaatar; Kei Watari; Hayato Nakamura; Cai-Xia Wang; Taro Tachibana; Yukinari Kato; Yayoi Kameda; Junko Kohara; Nobuhiro Terasaki; Manabu Kubota; Akira Takeda; Hirofumi Takahashi; Yasuhiko Suzuki; Naoya Maekawa; Shiro Murata; Kazuhiko Ohashi
Veterinary research, 54, 1, 82, 82, 27 Sep. 2023, [Peer-reviewed], [International Magazine]
English, Scientific journal, Immune checkpoint molecules PD-1/PD-L1 cause T-cell exhaustion and contribute to disease progression in chronic infections of cattle. We established monoclonal antibodies (mAbs) that specifically inhibit the binding of bovine PD-1/PD-L1; however, conventional anti-PD-1 mAbs are not suitable as therapeutic agents because of their low binding affinity to antigen. In addition, their sensitivity for the detection of bovine PD-1 is low and their use for immunostaining PD-1 is limited. To address these issues, we established two anti-bovine PD-1 rabbit mAbs (1F10F1 and 4F5F2) and its chimeric form using bovine IgG1 (Boch1D10F1), which exhibit high binding affinity. One of the rabbit mAb 1D10F1 binds more strongly to bovine PD-1 compared with a conventional anti-PD-1 mAb (5D2) and exhibits marked inhibitory activity on the PD-1/PD-L1 interaction. In addition, PD-1 expression in bovine T cells could be detected with higher sensitivity by flow cytometry using 1D10F1. Furthermore, we established higher-producing cells of Boch1D10F1 and succeeded in the mass production of Boch1D10F1. Boch1D10F1 exhibited a similar binding affinity to bovine PD-1 and the inhibitory activity on PD-1/PD-L1 binding compared with 1D10F1. The immune activation by Boch1D10F1 was also confirmed by the enhancement of IFN-γ production. Finally, Boch1D10F1 was administered to bovine leukemia virus-infected cows to determine its antiviral effect. In conclusion, the high-affinity anti-PD-1 antibody developed in this study represents a powerful tool for detecting and inhibiting bovine PD-1 and is a candidate for PD-1-targeted immunotherapy in cattle. - Detection of disease-associated microglia among various microglia phenotypes induced by West Nile virus infection in mice.
Passawat Thammahakin; Keisuke Maezono; Naoya Maekawa; Hiroaki Kariwa; Shintaro Kobayashi
Journal of neurovirology, 29, 4, 367, 375, Aug. 2023, [Peer-reviewed], [International Magazine]
English, Scientific journal, West Nile virus (WNV) has emerged as a significant cause of viral encephalitis in humans and horses. However, the pathogenesis of the West Nile encephalitis remains unclear. Microglia are activated by WNV infection, and the pathogenic involvement of their phenotypes is controversial. In this study, we examined the diversity of microglia phenotypes caused by WNV infection by assessing various microglia markers and identified disease-associated microglia in WNV-infected mouse brain tissue. Cells positive for general microglia markers such as Iba1, P2RY12, or TMEM119 were detected in the control and WNV-infected brain tissue. The morphology of the positive cells in brain tissue infected by WNV was different from that of control brain tissue, indicating that WNV infection induced activation of microglia. The activated microglia were classified into various phenotypes by investigation of specific marker expression. Among the activated microglia, disease-associated microglia that were positive for CD11c and weakly positive for TMEM119 were detected close to the WNV-infected cells. These results indicate that WNV infection induces activation of diverse microglia phenotypes and that disease-associated microglia may be associated with the pathogenicity of WNV infection in the mouse brain. - Characterization of cysteine proteases from poultry red mite, tropical fowl mite, and northern fowl mite to assess the feasibility of developing a broadly efficacious vaccine against multiple mite species.
Shwe Yee Win; Shiro Murata; Sotaro Fujisawa; Hikari Seo; Jumpei Sato; Yoshinosuke Motai; Takumi Sato; Eiji Oishi; Akira Taneno; Lat Lat Htun; Saw Bawm; Tomohiro Okagawa; Naoya Maekawa; Satoru Konnai; Kazuhiko Ohashi
PloS one, 18, 7, e0288565, 13 Jul. 2023, [Peer-reviewed], [International Magazine]
English, Scientific journal, Infestation with poultry red mites (PRM, Dermanyssus gallinae) causes anemia, reduced egg production, and death in serious cases, resulting in significant economic losses to the poultry industry. As a novel strategy for controlling PRMs, vaccine approaches have been focused upon and several candidate vaccine antigens against PRMs have been reported. Tropical (TFM, Ornithonyssus bursa) and northern (NFM, Ornithonyssus sylviarum) fowl mites are also hematophagous and cause poultry industry problems similar to those caused by PRM. Therefore, ideal antigens for anti-PRM vaccines are molecules that cross-react with TFMs and NFMs, producing pesticidal effects similar to those against PRMs. In this study, to investigate the potential feasibility of developing vaccines with broad efficacy across mite species, we identified and characterized cysteine proteases (CPs) of TFMs and NFMs, which were previously reported to be effective vaccine antigens of PRMs. The open reading frames of CPs from TFMs and NFMs had the same sequences, which was 73.0% similar to that of PRMs. Phylogenetic analysis revealed that the CPs of TFMs and NFMs clustered in the same clade as CPs of PRMs. To assess protein functionality, we generated recombinant peptidase domains of CPs (rCP-PDs), revealing all rCP-PDs showed CP-like activities. Importantly, the plasma obtained from chickens immunized with each rCP-PD cross-reacted with rCP-PDs of different mites. Finally, all immune plasma of rCP-PDs reduced the survival rate of PRMs, even when the plasma was collected from chickens immunized with rCP-PDs derived from TFM and NFM. Therefore, CP antigen is a promising, broadly efficacious vaccine candidate against different avian mites. - Enhanced Systemic Antitumour Immunity by Hypofractionated Radiotherapy and Anti-PD-L1 Therapy in Dogs with Pulmonary Metastatic Oral Malignant Melanoma.
Tatsuya Deguchi; Naoya Maekawa; Satoru Konnai; Ryo Owaki; Kenji Hosoya; Keitaro Morishita; Motoji Nakamura; Tomohiro Okagawa; Hiroto Takeuchi; Sangho Kim; Ryohei Kinoshita; Yurika Tachibana; Madoka Yokokawa; Satoshi Takagi; Yukinari Kato; Yasuhiko Suzuki; Shiro Murata; Kazuhiko Ohashi
Cancers, 15, 11, 01 Jun. 2023, [Peer-reviewed], [Lead author], [International Magazine]
English, Scientific journal, Although immune checkpoint inhibitors (ICIs), such as the anti-programmed death-ligand 1 (PD-L1) antibody, have been developed for the treatment of canine malignant melanoma, desirable clinical efficacies have not been achieved. Recent studies in humans have suggested that radiation therapy (RT) combined with ICIs induces robust systemic antitumour immunity in patients with cancer. This study retrospectively examined the therapeutic efficacy of combination therapy (hypofractionated RT and anti-PD-L1 antibody [c4G12]) in dogs with pulmonary metastatic oral malignant melanoma. The intrathoracic clinical benefit rate (CBR)/median overall survival (OS) in the no RT (n = 20, free from the effect of RT), previous RT (n = 9, received RT ≤8 weeks prior to the first c4G12 dose), and concurrent RT (n = 10, c4G12 therapy within ±1 week of the first RT fraction) groups were 10%/185 days, 55.6%/283.5 days (p < 0.05 vs. no RT group), and 20%/129 days (p > 0.05 vs. no RT group), respectively. The adverse events were considered to be tolerable in the combination therapy. Thus, hypofractionated RT before the initiation of c4G12 therapy can be an effective approach for enhancing the therapeutic efficacy of immunotherapy, with acceptable safety profiles. Further prospective clinical studies are required to confirm the findings of this study. - Molecular characterization of immunoinhibitory factors PD-1/PD-L1 in sheep.
Wisa Tiyamanee; Satoru Konnai; Tomohiro Okagawa; Yutaro Nojima; Otgontuya Ganbaatar; Naoya Maekawa; Rie Hasebe; Yumiko Kagawa; Yukinari Kato; Yasuhiko Suzuki; Shiro Murata; Kazuhiko Ohashi
Veterinary immunology and immunopathology, 261, 110609, 110609, 11 May 2023, [Peer-reviewed], [International Magazine]
English, Scientific journal, Sheep have been used as a large animal experimental model for studying infectious diseases. However, due to a lack of staining antibodies and reagents, immunological studies on sheep have not progressed. The immunoinhibitory receptor programmed death-1 (PD-1) is expressed on T lymphocytes. The interaction of PD-1 with its ligand PD-ligand 1 (PD-L1) delivers inhibitory signals and impairs proliferation, cytokine production, and cytotoxicity of T cells. We previously reported that the PD-1/PD-L1 pathway was closely associated with T-cell exhaustion and disease progression in bovine chronic infections using anti-bovine PD-L1 monoclonal antibodies (mAbs). Furthermore, we found that blocking antibodies against PD-1 and PD-L1 restore T-cell functions and could be used in immunotherapy of cattle. However, the immunological role of the PD-1/PD-L1 pathway in chronic diseases of sheep remains unknown. In this study, we identified cDNA sequences of ovine PD-1 and PD-L1 and examined the cross-activity of anti-bovine PD-L1 mAbs against ovine PD-L1 as well as the expression of PD-L1 in ovine listeriosis. The amino acid sequences of ovine PD-1 and PD-L1 share a high degree of identity and similarity with homologs from ruminants and other mammalian species. Anti-bovine PD-L1 mAb recognized ovine PD-L1 on lymphocytes in the flow cytometric assay. Furthermore, an immunohistochemical staining confirmed the PD-L1 expression on macrophages in the brain lesions of ovine listeriosis. These findings indicated that our anti-PD-L1 mAb would be useful for analyzing the ovine PD-1/PD-L1 pathway. Further research is needed to determine the immunological role of PD-1/PD-L1 in chronic diseases such as BLV infection through experimental infection of sheep. - Potential of ferritin 2 as an antigen for the development of a universal vaccine for avian mites, poultry red mites, tropical fowl mites, and northern fowl mites.
Shwe Yee Win; Shiro Murata; Sotaro Fujisawa; Hikari Seo; Jumpei Sato; Yoshinosuke Motai; Takumi Sato; Eiji Oishi; Akira Taneno; Lat Lat Htun; Saw Bawm; Tomohiro Okagawa; Naoya Maekawa; Satoru Konnai; Kazuhiko Ohashi
Frontiers in veterinary science, 10, 1182930, 1182930, 17 Apr. 2023, [Peer-reviewed], [International Magazine]
English, Scientific journal, INTRODUCTION: Poultry red mites (PRMs, Dermanyssus gallinae), blood-sucking ectoparasites, are a threat to the poultry industry because of reduced production caused by infestation. In addition, tropical fowl mites (TFMs, Ornithonyssus bursa) and northern fowl mites (NFMs, Ornithonyssus sylviarum) are hematophagous, distributed in various regions, genetically and morphologically close to PRMs, and cause similar problems to the poultry industry. Vaccine approaches have been studied for PRM control, and several molecules have been identified in PRMs as candidates for effective vaccine antigens. The development of an anti-PRM vaccine as a universal vaccine with broad efficacy against avian mites could improve the productivity of poultry farms worldwide. Molecules that are highly conserved among avian mites and have critical functions in the physiology and growth of mites could be ideal antigen candidates for the development of universal vaccines. Ferritin 2 (FER2), an iron-binding protein, is critical for the reproduction and survival of PRMs and has been reported as a useful vaccine antigen for the control of PRMs and a candidate for the universal vaccine antigen in some tick species. METHOD AND RESULTS: Herein, we identified and characterized FER2 in TFMs and NFM. Compared with the sequence of PRM, the ferroxidase centers of the heavy chain subunits were conserved in FER2 of TFMs and NFMs. Phylogenetic analysis revealed that FER2 belongs to clusters of secretory ferritins of mites and other arthropods. Recombinant FER2 (rFER2) proteins from PRMs, TFMs, and NFMs exhibited iron-binding abilities. Immunization with each rFER2 induced strong antibody responses in chickens, and each immune plasma cross-reacted with rFER2 from different mites. Moreover, mortality rates of PRMs fed with immune plasma against rFER2 from TFMs or NFMs, in addition to PRMs, were higher than those of control plasma. DISCUSSION: rFER2 from each avian mite exhibited anti-PRM effects. This data suggests that it has the potential to be used as an antigen candidate for a universal vaccine against avian mites. Further studies are needed to access the usefulness of FER2 as a universal vaccine for the control of avian mites. - In vitro evaluation of Lactiplantibacillus plantarum HOKKAIDO strain, effective lactic acid bacteria for calf diarrhea.
Mari Ikehata; Satoru Konnai; Tomohiro Okagawa; Kentaro Abe; Mitsuru Honma; Toru Kitamura; Naoya Maekawa; Yasuhiko Suzuki; Shiro Murata; Kazuhiko Ohashi
Frontiers in veterinary science, 10, 1145445, 1145445, 05 Apr. 2023, [Peer-reviewed], [International Magazine]
English, Scientific journal, Calf diarrhea adversely affects growth and sometimes results in mortality, leading to severe economic losses to the cattle industry. Antibiotics are useful in the treatment against bacterial diarrhea, but not against viral, protozoan, and antibiotic-resistant bacterial diarrhea. Therefore, there are growing requirements for a novel control method for calf diarrhea. Probiotics have been considered promising candidates for preventive and supportive therapy for calf diarrhea for many years. A recent study has revealed that Lactiplantibacillus plantarum HOKKAIDO strain (Lp-HKD) reduces intestinal pathology and the severity of diarrhea in bovine rotavirus (BRV)-infected calves. Lp-HKD is known to enhance the function of human immune cells and expected to be used as probiotics for humans. Therefore, it is hypothesized that Lp-HKD modulates antiviral immune response in cattle and provide the clinical benefits in BRV-infected calves. However, the detailed mechanism of Lp-HKD-induced immunomodulation remains unknown. Thus, this study aimed to elucidate the immunomodulatory and antiviral effects of Lp-HKD in cattle. Cultivation assay of bovine peripheral blood mononuclear cells (PBMCs) showed that live and heat-killed Lp-HKD stimulates the production of interleukin-1β (IL-1β), IL-6, IL-10, and interferon-γ (IFN-γ) from PBMCs. Stimulation by heat-killed Lp-HKD yielded stronger cytokine production than stimulation by the live Lp-HKD. Additionally, CD14+ monocytes were identified as major producers of IL-1β, IL-6, and IL-10 under Lp-HKD stimulation; however, IFN-γ was mainly produced from immune cells other than CD14+ monocytes. Depletion of CD14+ monocytes from the PBMCs cultivation strongly decreased cytokine production induced by heat-killed Lp-HKD. The inhibition of toll-like receptor (TLR) 2/4 signaling decreased IL-1β and IL-6 production induced by live Lp-HKD and IL-1β, IL-6, and IFN-γ production induced by heat-killed Lp-HKD. Furthermore, live or heat-killed Lp-HKD also activated T cells and their production of IFN-γ and tumor necrosis factor-α. Then, culture supernatants of bovine PBMCs treated with heat-killed Lp-HKD demonstrated antiviral effects against BRV in vitro. In conclusion, this study demonstrated that Lp-HKD activates the functions of bovine immune cells via TLR2/4 signaling and exerts an antiviral effect against BRV through the induction of antiviral cytokines. Lp-HKD could be useful for the prevention and treatment of calf diarrhea through its immune activating effect. - Analysis of gene expression in poultry red mite, Dermanyssus gallinae, by RNAscope in situ hybridization.
Hikari Seo; Shiro Murata; Osamu Ichii; Takashi Namba; Shwe Yee Win; Takumi Sato; Eiji Oishi; Akira Taneno; Naoya Maekawa; Tomohiro Okagawa; Satoru Konnai; Kazuhiko Ohashi
The Journal of veterinary medical science, 85, 5, 532, 535, 14 Mar. 2023, [Peer-reviewed], [Domestic magazines]
English, Scientific journal, The poultry red mite (PRM; Dermanyssus gallinae) is a hematophagous ectoparasite that mainly infests chickens, and its infestation causes significant economic losses to the poultry industry. In this study, we examined the use of RNAscope-based in situ hybridization (ISH) to characterize gene expression in PRM. We analyzed the mRNA expression of Dermanyssus gallinaecathepsin D-1 (Dg-CatD-1) and Dermanyssus gallinae cystatin (Dg-Cys). RNAscope ISH analysis revealed that mRNA expression of Dg-CatD-1 was observed in the digestive tract, and Dg-Cystatin mRNA was expressed in the ovaries in addition to the digestive tract. RNAscope ISH could be applicable for the analysis of gene expression in each tissue of PRM and is an effective method to investigate the characteristics of target genes. - Enhancement of Vaccine-Induced T-Cell Responses by PD-L1 Blockade in Calves.
Tomohiro Okagawa; Satoru Konnai; Hayato Nakamura; Otgontuya Ganbaatar; Yamato Sajiki; Kei Watari; Haruka Noda; Mitsuru Honma; Yukinari Kato; Yasuhiko Suzuki; Naoya Maekawa; Shiro Murata; Kazuhiko Ohashi
Vaccines, 11, 3, 01 Mar. 2023, [Peer-reviewed], [International Magazine]
English, Scientific journal, Interactions between programmed death 1 (PD-1) and PD-ligand 1 (PD-L1) cause functional exhaustion of T cells by inducing inhibitory signals, thereby attenuating effector functions of T cells. We have developed an anti-bovine PD-L1 blocking antibody (Ab) and have demonstrated that blockade of the interaction between PD-1 and PD-L1 reactivates T-cell responses in cattle. In the present study, we examined the potential utility of PD-1/PD-L1-targeted immunotherapy in enhancing T-cell responses to vaccination. Calves were inoculated with a hexavalent live-attenuated viral vaccine against bovine respiratory infections in combination with treatment with an anti-PD-L1 Ab. The expression kinetics of PD-1 in T cells and T-cell responses to viral antigens were measured before and after vaccination to evaluate the adjuvant effect of anti-PD-L1 Ab. PD-1 expression was upregulated in vaccinated calves after the administration of a booster vaccination. The activation status of CD4+, CD8+, and γδTCR+ T cells was enhanced by the combination of vaccination and PD-L1 blockade. In addition, IFN-γ responses to viral antigens were increased following combinatorial vaccination with PD-L1 blockade. In conclusion, the blockade of the PD-1/PD-L1 interaction enhances T-cell responses induced by vaccination in cattle, indicating the potential utility of anti-PD-L1 Ab in improving the efficacy of current vaccination programs. - Regulation of programmed death ligand 1 expression by interferon-γ and tumour necrosis factor-α in canine tumour cell lines.
Ryo Owaki; Tatsuya Deguchi; Satoru Konnai; Naoya Maekawa; Tomohiro Okagawa; Kenji Hosoya; Sangho Kim; Takafumi Sunaga; Masahiro Okumura
Veterinary and comparative oncology, 21 Feb. 2023, [Peer-reviewed], [International Magazine]
English, Scientific journal, Expression of programmed death ligand 1 (PD-L1) on tumor cells provides an immune evasion mechanism by inducing suppression of cytotoxic T cells. Various regulatory mechanisms of PD-L1 expression have been described in human tumours, however, little is known in canine tumours. To investigate whether inflammatory signaling is involved in PD-L1 regulation in canine tumours, the effects of interferon (IFN)-γ and tumour necrosis factor (TNF)-α treatment were examined in canine malignant melanoma cell lines (CMeC and LMeC) and an osteosarcoma cell line (HMPOS). The protein level of PD-L1 expression was upregulated by IFN-γ and TNF-α stimulation. Upon IFN-γ stimulation, all cell lines showed an increase in expression of PD-L1, signal transducer and activator of transcription (STAT)1, STAT3 and genes regulated by STAT activation. Upregulated expression of these genes was suppressed by the addition of a JAK inhibitor, oclacitinib. Contrastingly, upon TNF-α stimulation, all cell lines exhibited higher gene expression of the nuclear factor kappa B (NF-κB) gene RELA and genes regulated by NF-κB activation, whereas expression of PD-L1 was upregulated in LMeC only. Upregulated expression of these genes was suppressed by the addition of an NF-κB inhibitor, BAY 11-7082. The expression level of cell surface PD-L1 induced by IFN-γ and TNF-α treatment was reduced by oclacitinib and BAY 11-7082, respectively, indicating that upregulation of PD-L1 expression by IFN-γ and TNF-α stimulation is regulated via the JAK-STAT and NF-κB signaling pathways, respectively. These results provide insights into the role of inflammatory signaling in PD-L1 regulation in canine tumours. This article is protected by copyright. All rights reserved. - Suppressive modulation of host immune responses by Dermanyssus gallinae infestation.
Sotaro Fujisawa; Shiro Murata; Masayoshi Isezaki; Shwe Yee Win; Takumi Sato; Eiji Oishi; Akira Taneno; Naoya Maekawa; Tomohiro Okagawa; Satoru Konnai; Kazuhiko Ohashi
Poultry science, 102, 4, 102532, 102532, 26 Jan. 2023, [Peer-reviewed], [International Magazine]
English, Scientific journal, The poultry red mite (Dermanyssus gallinae, PRM) is a blood-sucking ectoparasite in chickens and is one of the most serious threats to poultry farms. Mass infestation with PRMs causes various health problems in chickens, resulting in significant productivity reduction in the poultry industry. Infestation with hematophagous ectoparasites, such as ticks, induces host inflammatory and hemostatic reactions. On the other hand, several studies have reported that hematophagous ectoparasites secrete various immunosuppressants from their saliva to suppress host immune responses to maintain blood sucking. Here, we examined the expression of cytokines in peripheral blood cells to investigate whether PRM infestation affects immunological states in chickens. In PRM-infested chickens, anti-inflammatory cytokines, IL-10 and TGF-β1, and immune checkpoint molecules, CTLA-4 and PD-1, were highly expressed compared to noninfested chickens. PRM-derived soluble mite extracts (SME) upregulated the gene expression of IL-10 in peripheral blood cells and HD-11 chicken macrophages. In addition, SME suppressed the expression of interferons and inflammatory cytokines in HD-11 chicken macrophages. Moreover, SME induces the polarization of macrophages into anti-inflammatory phenotypes. Collectively, PRM infestation could affect host immune responses, especially suppress the inflammatory responses. Further studies are warranted to fully understand the influence of PRM infestation on host immunity. - Characterization of SpsQ from Staphylococcus pseudintermedius as an affinity chromatography ligand for canine therapeutic antibodies.
Hiroto Takeuchi; Chie Nakajima; Satoru Konnai; Naoya Maekawa; Tomohiro Okagawa; Masaru Usui; Yutaka Tamura; Yasuhiko Suzuki; Shiro Murata; Kazuhiko Ohashi
PloS one, 18, 1, e0281171, 26 Jan. 2023, [Peer-reviewed], [International Magazine]
English, Scientific journal, Coagulase-positive Staphylococci express protein A, which binds to host antibodies, to evade the immune system. Taking advantage of its specific binding to antibodies, protein A from Staphylococcus aureus, which is called SpA, is commonly used as an affinity chromatography ligand for human therapeutic antibodies. However, among four canine IgG subclasses (A, B, C, and D), only IgG-B binds to SpA strongly and establishing an efficient and robust purification scheme for canine therapeutic antibodies whose IgG subclass is A, C, or D remains difficult and depends on finding a suitable substitute to SpA. S. pseudintermedius, a major coagulase-positive Staphylococci found in dogs, expresses spsQ gene which is orthologous to S. aureus spa. We hypothesized that to serve S. pseudintermedius to better adapt to the dog immune system, SpsQ would bind to canine IgGs stronger than SpA, making it a better affinity chromatography ligand for canine therapeutic antibodies. To characterize SpsQ, we first determined the spsQ nucleotide sequence from S. pseudintermedius isolates. Based on the identified sequence, we prepared recombinant proteins containing the immunoglobulin-binding domains of SpA (r-SpA) and SpsQ (r-SpsQ) and determined their binding capacity for each canine IgG subclass. The binding capacity of r-SpsQ for IgG-B was almost as high as that of r-SpA. Interestingly, while both r-SpsQ and r-SpA showed no binding to IgG-C, the binding capacity of r-SpsQ for IgG-A and IgG-D was significantly higher than that of r-SpA. Finally, we performed affinity chromatography using r-SpsQ- or r-SpA-immobilized resin and revealed that the recovery rates of IgG-A and IgG-D using r-SpsQ were significantly higher than those using r-SpA. Our findings indicate that SpsQ has a strong potential to be used as an affinity chromatography ligand for canine therapeutic antibodies of subclass A, B, and D. - Molecular characterization of feline immune checkpoint molecules and establishment of PD-L1 immunohistochemistry for feline tumors.
Naoya Maekawa; Satoru Konnai; Yumie Asano; Takumi Otsuka; Eri Aoki; Hiroto Takeuchi; Yukinari Kato; Mika K Kaneko; Shinji Yamada; Yumiko Kagawa; Maki Nishimura; Satoshi Takagi; Tatsuya Deguchi; Hiroshi Ohta; Takayuki Nakagawa; Yasuhiko Suzuki; Tomohiro Okagawa; Shiro Murata; Kazuhiko Ohashi
PloS one, 18, 1, e0281143, 26 Jan. 2023, [Peer-reviewed], [Lead author], [International Magazine]
English, Scientific journal, Spontaneous tumors are a major cause of death in cats. Treatment of human tumors has progressed dramatically in the past decade, partly due to the success of immunotherapies using immune checkpoint inhibitors, such as anti-programmed death 1 (PD-1) and anti-PD-ligand 1 (PD-L1) antibodies. However, little is known about the PD-1 pathway and its association with tumor disease in cats. This study investigated the applicability of anti-PD-1/PD-L1 therapy in feline tumors. We first determined the complete coding sequence of feline PD-L1 and PD-L2, and found that the deduced amino acid sequences of feline PD-L1/PD-L2 share high sequence identities (66-83%) with orthologs in other mammalian species. We prepared recombinant feline PD-1, PD-L1, and PD-L2 proteins and confirmed receptor-ligand binding between PD-1 and PD-L1/PD-L2 using flow cytometry. Next, we established an anti-feline PD-L1 monoclonal antibody (clone CL1Mab-7) to analyze the expression of PD-L1. Flow cytometry using CL1Mab-7 revealed the cell surface expression of PD-L1 in a feline macrophage (Fcwf-4) and five mammary adenocarcinoma cell lines (FKNp, FMCm, FYMp, FONp, and FONm), and showed that PD-L1 expression was upregulated by interferon-γ stimulation. Finally, immunohistochemistry using CL1Mab-7 also showed PD-L1 expression in feline squamous cell carcinoma (5/5, 100%), mammary adenocarcinoma (4/5, 80%), fibrosarcoma (5/5, 100%), and renal cell carcinoma (2/2, 100%) tissues. Our results strongly encourage further investigations of the PD-1/PD-L1 pathway as a potential therapeutic target for feline tumors. - Combined Immune Checkpoint Blockade Enhances Antiviral Immunity against Bovine Leukemia Virus.
Hayato Nakamura; Satoru Konnai; Tomohiro Okagawa; Naoya Maekawa; Yamato Sajiki; Kei Watari; Kana Kamitani; Maya Saito; Yukinari Kato; Yasuhiko Suzuki; Shiro Murata; Kazuhiko Ohashi
Journal of virology, 97, 1, e0143022, 04 Jan. 2023, [Peer-reviewed], [International Magazine]
English, Scientific journal, Bovine leukemia virus (BLV) is a retrovirus that causes enzootic bovine leukosis (EBL) in cattle and is widespread in many countries, including Japan. Recent studies have revealed that the expression of immunoinhibitory molecules, such as programmed death-1 (PD-1) and PD-ligand 1, plays a critical role in immunosuppression and disease progression during BLV infection. In addition, a preliminary study has suggested that another immunoinhibitory molecule, T-cell immunoglobulin domain and mucin domain-3 (TIM-3), is involved in immunosuppression during BLV infection. Therefore, this study was designed to further elucidate the immunoinhibitory role of immune checkpoint molecules in BLV infection. TIM-3 expression was upregulated on peripheral CD4+ and CD8+ T cells in BLV-infected cattle. Interestingly, in EBL cattle, CD4+ and CD8+ T cells infiltrating lymphomas expressed TIM-3. TIM-3 and PD-1 were upregulated and coexpressed in peripheral CD4+ and CD8+ T cells from BLV-infected cattle. Blockade by anti-bovine TIM-3 monoclonal antibody increased CD69 expression on T cells and gamma interferon (IFN-γ) production from peripheral blood mononuclear cells from BLV-infected cattle. A syncytium formation assay also demonstrated the antiviral effects of TIM-3 blockade against BLV infection. The combined inhibition of TIM-3 and PD-1 pathways significantly enhanced IFN-γ production and antiviral efficacy compared to inhibition alone. In conclusion, the combined blockade of TIM-3 and PD-1 pathways shows strong immune activation and antiviral effects and has potential as a novel therapeutic method for BLV infection. IMPORTANCE Enzootic bovine leukosis caused by bovine leukemia virus (BLV) is an important viral disease in cattle, causing severe economic losses to the cattle industry worldwide. The molecular mechanisms of BLV-host interactions are complex. Previously, it was found that immune checkpoint molecules, such as PD-1, suppress BLV-specific Th1 responses as the disease progresses. To date, most studies have focused only on how PD-1 facilitates escape from host immunity in BLV-infected cattle and the antiviral effects of the PD-1 blockade. In contrast, how T-cell immunoglobulin domain and mucin domain-3 (TIM-3), another immune checkpoint molecule, regulates anti-BLV immune responses is rarely reported. It is also unclear why PD-1 inhibition alone was insufficient to exert anti-BLV effects in previous clinical studies. In this study, the expression profile of TIM-3 in T cells derived from BLV-infected cattle suggested that TIM-3 upregulation is a cause of immunosuppression in infected cattle. Based on these results, anti-TIM-3 antibody was used to experimentally evaluate its function in influencing immunity against BLV. Results indicated that TIM-3 upregulation induced by BLV infection suppressed T-cell activation and antiviral cytokine production. Some T cells coexpressed PD-1 and TIM-3, indicating that simultaneous inhibition of PD-1 and TIM-3 with their respective antibodies synergistically restored antiviral immunity. This study could open new avenues for treating bovine chronic infections. - Diagnosis and Early Prediction of Lymphoma Using High-Throughput Clonality Analysis of Bovine Leukemia Virus-Infected Cells.
Tomohiro Okagawa; Honami Shimakura; Satoru Konnai; Masumichi Saito; Takahiro Matsudaira; Naganori Nao; Shinji Yamada; Kenji Murakami; Naoya Maekawa; Shiro Murata; Kazuhiko Ohashi
Microbiology spectrum, 10, 6, e0259522, 13 Oct. 2022, [Peer-reviewed], [International Magazine]
English, Scientific journal, Bovine leukemia virus (BLV), a retrovirus, infects B cells of ruminants and is integrated into the host genome as a provirus for lifelong infection. After a long latent period, 1% to 5% of BLV-infected cattle develop aggressive lymphoma, enzootic bovine leukosis (EBL). Since the clonal expansion of BLV-infected cells is essential for the development of EBL, the clonality of proviral integration sites could be a molecular marker for diagnosis and early prediction of EBL. Recently, we developed Rapid Amplification of the Integration Site without Interference by Genomic DNA Contamination (RAISING) and an analysis software of clonality value (CLOVA) to analyze the clonality of transgene-integrated cells. RAISING-CLOVA is capable of assessing the risk of adult T-cell leukemia/lymphoma development in human T-cell leukemia virus-I-infected individuals through the clonality analysis of proviral integration sites. Thus, we herein examined the performance of RAISING-CLOVA for the clonality analysis of BLV-infected cells and conducted a comprehensive clonality analysis by RAISING-CLOVA in EBL and non-EBL cattle. RAISING-CLOVA targeting BLV was a highly accurate and reproducible method for measuring the clonality value. The comprehensive clonality analysis successfully distinguished EBL from non-EBL specimens with high sensitivity and specificity. A longitudinal clonality analysis in BLV-infected sheep, an experimental model of lymphoma, also confirmed the effectiveness of RAISING-CLOVA for early detection of EBL development. Therefore, our study emphasizes the usefulness of RAISING-CLOVA as a routine clinical test for monitoring virus-related cancers. IMPORTANCE Bovine leukemia virus (BLV) infection causes aggressive B-cell lymphoma in cattle and sheep. The virus has spread to farms around the world, causing significant economic damage to the livestock industry. Thus, the identification of high-risk asymptomatic cattle before they develop lymphoma can be effective in reducing the economic damage. Clonal expansion of BLV-infected cells is a promising marker for the development of lymphoma. Recently, we have developed a high-throughput method to amplify random integration sites of transgenes in host genomes and analyze their clonality, named as RAISING-CLOVA. As a new application of our technology, in this study, we demonstrate the value of the RAISING-CLOVA method for the diagnosis and early prediction of lymphoma development by BLV infection in cattle. RAISING-CLOVA is a reliable technology for monitoring the clonality of BLV-infected cells and would contribute to reduce the economic losses by EBL development. - Prostaglandin E2-Induced Immune Suppression via Cytotoxic T-Lymphocyte Antigen 4 in Paratuberculosis.
Yamato Sajiki; Satoru Konnai; Kei Watari; Tomohiro Okagawa; Akina Tanaka; Satoko Kawaji; Reiko Nagata; Naoya Maekawa; Yasuhiko Suzuki; Yukinari Kato; Shiro Murata; Yasuyuki Mori; Kazuhiko Ohashi
Infection and immunity, 90, 10, e0021022, 14 Sep. 2022, [Peer-reviewed], [International Magazine]
English, Scientific journal, Paratuberculosis is a chronic enteritis of ruminants caused by the facultative intracellular pathogen Mycobacterium avium subsp. paratuberculosis. The Th1 response inhibits the proliferation of M. avium subsp. paratuberculosis during the early subclinical stage. However, we have previously shown that immune inhibitory molecules, such as prostaglandin E2 (PGE2), suppress M. avium subsp. paratuberculosis-specific Th1 responses as the disease progresses. To date, the mechanism underlying immunosuppression during M. avium subsp. paratuberculosis infection has not been elucidated. Therefore, in the present study, we investigated the function of cytotoxic T-lymphocyte antigen 4 (CTLA-4) expressed by peripheral blood mononuclear cells (PBMCs) from cattle with paratuberculosis because CTLA-4 expression is known to be elevated in T cells under an M. avium subsp. paratuberculosis experimental infection. M. avium subsp. paratuberculosis antigen induced CTLA-4 expression in T cells from cattle experimentally infected with M. avium subsp. paratuberculosis. Interestingly, both PGE2 and an E prostanoid 4 agonist also induced CTLA-4 expression in T cells. In addition, a functional assay with a bovine CTLA-4-immunogobulin fusion protein (CTLA-4-Ig) indicated that CTLA-4 inhibited gamma interferon (IFN-γ) production in M. avium subsp. paratuberculosis-stimulated PBMCs, while blockade by anti-bovine CTLA-4 monoclonal antibody increased the secretion of IFN-γ and tumor necrosis factor alpha production in these PBMCs. These preliminary findings show that PGE2 has immunosuppressive effects via CTLA-4 to M. avium subsp. paratuberculosis. Therefore, it is necessary to clarify in the future whether CTLA-4-mediated immunosuppression facilitates disease progression of paratuberculosis in cattle. - Necroptosis of neuronal cells is related to the neuropathology of tick-borne encephalitis.
Dai Tsujino; Kentaro Yoshii; Misa Kajiyama; Yuji Takahashi; Naoya Maekawa; Hiroaki Kariwa; Shintaro Kobayashi
Virus research, 321, 198914, 198914, 03 Sep. 2022, [Peer-reviewed], [International Magazine]
English, Scientific journal, Tick-borne encephalitis virus (TBEV) is a zoonotic virus that causes tick-borne encephalitis (TBE) in humans. Infections of Sapporo-17-Io1 (Sapporo) and Oshima 5-10 (Oshima) TBEV strains showed different pathogenic effects in mice. However, the differences between the two strains are unknown. In this study, we examined neuronal degeneration and death, and activation of glial cells in mice inoculated with each strain to investigate the pathogenesis of TBE. Viral growth was similar between Sapporo and Oshima, but neuronal degeneration and death, and activation of glial cells, was more prominent with Oshima. In human neuroblastoma cells, apoptosis and pyroptosis were not observed after TBEV infection. However, the expression of the necroptosis marker, mixed lineage kinase domain-like (MLKL) protein, was upregulated by TBEV infection, and this upregulation was more pronounced in Oshima than Sapporo infections. As necroptosis is a pro-inflammatory type of cell death, differences in necroptosis induction might be involved in the differences in neuropathogenicity of TBE. - Suppressive effects of Ixodes persulcatus sialostatin L2 against Borrelia miyamotoi-stimulated immunity.
Yamato Sajiki; Satoru Konnai; Tomohiro Okagawa; Naoya Maekawa; Masayoshi Isezaki; Shinji Yamada; Takuya Ito; Kozue Sato; Hiroki Kawabata; Carlos Logullo; Itabajara da Silva Vaz Jr; Shiro Murata; Kazuhiko Ohashi
Ticks and tick-borne diseases, 13, 4, 101963, 101963, Jul. 2022, [Peer-reviewed], [International Magazine]
English, Scientific journal, Borrelia miyamotoi infection is an emerging tick-borne disease that causes hard tick-borne relapsing fever. B. miyamotoi is transmitted through the bite of ticks, including Ixodes persulcatus. Although accumulating evidence suggests that tick salivary proteins enhance the infectivity of other tick-borne pathogens, the association of B. miyamotoi with tick-derived proteins remains unknown. In this study, the effect of I. persulcatus sialostatin L2 (Ip-sL2), a tick-derived cystatin, on specific immunity to B. miyamotoi was preliminarily investigated in vitro. Mice were immunized with heat-killed B. miyamotoi and in vitro analyses of the splenocytes of the immunized mice indicated that the expression levels of the activation markers of CD11c+ and CD3+ cells were significantly upregulated by B. miyamotoi stimulation. Spleen cells from B. miyamotoi-immunized mice were used to determine whether Ip-sL2 regulates murine immune responses against B. miyamotoi. Treatment with Ip-sL2 in vitro inhibited the activation of CD11c+ and CD3+ cells as well as inflammatory cytokine production by cultured splenocytes. These findings show that Ip-sL2 has modulatory effects on murine immune responses to B. miyamotoi. Therefore, it is necessary to clarify in the future whether Ip-sL2 is involved in the enhanced infectivity of B. miyamotoi. - Clarifying expression patterns by renal lesion using transcriptome analysis and vanin-1 as a potential novel biomarker for renal injury in chickens.
Chihiro Ishii; Yusuke K Kawai; Yoshinori Ikenaka; Naoya Maekawa; Osamu Ichii; Shouta M M Nakayama; Mayumi Ishizuka
Poultry science, 101, 9, 102011, 102011, 16 Jun. 2022, [Peer-reviewed], [International Magazine]
English, Scientific journal, Bird death is often caused by renal lesions induced by chemicals. The avian kidney has a renal portal system with significant blood flow that is sensitive to many chemicals. However, early avian biomarkers for kidney injury are yet to be identified. This study aimed to identify novel renal biomarkers. Acute kidney injury (AKI) can be divided into acute interstitial nephritis (AIN) and acute tubular necrosis (ATN). A chicken model of kidney damage was created by an injection of diclofenac or cisplatin, which caused either AIN or ATN, respectively. Microarray analysis was performed to profile the gene expression patterns in the chickens with nephropathy. A gene enrichment analysis suggested that the genes related to responses to external stimuli showed expression changes in both AIN and ATN. However, hierarchical clustering analyses suggested that gene expression patterns differed between AIN and ATN, and the number of biomarkers relating to renal damage was low. To identify early biomarkers for nephropathy, we focused on genes that were induced at various levels of renal damage. The gene, vanin-1 (VNN1) was highly induced in the early stages of renal damage. A quantitative real-time PCR analysis supported this finding. These results suggest VNN1 could be a useful early biomarker of kidney injury in avian species. - Exploration of serum biomarkers in dogs with malignant melanoma receiving anti-PD-L1 therapy and potential of COX-2 inhibition for combination therapy.
Naoya Maekawa; Satoru Konnai; Yumie Asano; Yamato Sajiki; Tatsuya Deguchi; Tomohiro Okagawa; Kei Watari; Hiroto Takeuchi; Satoshi Takagi; Kenji Hosoya; Sangho Kim; Hiroshi Ohta; Yukinari Kato; Yasuhiko Suzuki; Shiro Murata; Kazuhiko Ohashi
Scientific reports, 12, 1, 9265, 9265, 03 Jun. 2022, [Peer-reviewed], [Lead author], [International Magazine]
English, Scientific journal, Immune checkpoint inhibitors (ICIs) such as anti-PD-L1 antibodies are widely used to treat human cancers, and growing evidence suggests that ICIs are promising treatments for canine malignancies. However, only some canine oral malignant melanoma (OMM) cases respond to ICIs. To explore biomarkers predictive of survival in dogs with pulmonary metastatic OMM receiving the anti-PD-L1 antibody c4G12 (n = 27), serum concentrations of prostaglandin E2 (PGE2), cytokines, chemokines, and growth factors were measured prior to treatment initiation. Among 12 factors tested, PGE2, interleukin (IL)-12p40, IL-8, monocyte chemotactic protein-1 (MCP-1), and stem cell factor (SCF) were higher in OMM dogs compared to healthy dogs (n = 8). Further, lower baseline serum PGE2, MCP-1, and vascular endothelial growth factor (VEGF)-A concentrations as well as higher IL-2, IL-12, and SCF concentrations predicted prolonged overall survival. These observations suggest that PGE2 confers resistance against anti-PD-L1 therapy through immunosuppression and thus is a candidate target for combination therapy. Indeed, PGE2 suppressed IL-2 and interferon (IFN)-γ production by stimulated canine peripheral blood mononuclear cells (PBMCs), while inhibition of PGE2 biosynthesis using the COX-2 inhibitor meloxicam in combination with c4G12 enhanced Th1 cytokine production by PBMCs. Thus, serum PGE2 may be predictive of c4G12 treatment response, and concomitant use of COX-2 inhibitors may enhance ICI antitumor efficacy. - Estradiol-induced immune suppression via prostaglandin E2 during parturition in bovine leukemia virus-infected cattle.
Yamato Sajiki; Satoru Konnai; Tomohiro Okagawa; Naoya Maekawa; Shinya Goto; Junko Kohara; Atsushi Nitanai; Hirofumi Takahashi; Kentaro Kubota; Hiroshi Takeda; Shiro Murata; Kazuhiko Ohashi
PloS one, 17, 3, e0263660, 09 May 2022, [Peer-reviewed], [International Magazine]
English, Scientific journal, Immune suppression during pregnancy and parturition is considered a risk factor that is related to the progression of bovine chronic diseases, such as bovine leukosis, which is caused by bovine leukemia virus (BLV). Our previous studies have demonstrated that prostaglandin E2 (PGE2) suppresses BLV-specific Th1 responses and contributes to the disease progression during BLV infection. Although PGE2 reportedly plays important roles in the induction of parturition, PGE2 involvement in immune suppression during parturition is unknown. To investigate its involvement, we analyzed PGE2 kinetics and Th1 responses in BLV-infected pregnant cattle. PGE2 concentrations in sera were increased, whereas IFN-γ responses were decreased before delivery. PGE2 is known to suppress Th1 immune responses in cattle. Thus, these data suggest that PGE2 upregulation inhibits Th1 responses during parturition. We also found that estradiol was important for PGE2 induction in pregnant cattle. In vitro analyses indicated that estradiol suppressed IFN-γ production, at least in part, via PGE2/EP4 signaling. In vivo analyses showed that estradiol administration significantly influenced the induction of PGE2 production and impaired Th1 responses. Our data suggest that estradiol-induced PGE2 is involved in the suppression of Th1 responses during pregnancy and parturition in cattle, which could contribute to the progression of BLV infection. - In vitro evaluation of a cysteine protease from poultry red mites, Demanyssus gallinae, as a vaccine antigen for chickens.
Takuma Ariizumi; Shiro Murata; Sotaro Fujisawa; Masayoshi Isezaki; Takumi Sato; Eiji Oishi; Akira Taneno; Osamu Ichii; Naoya Maekawa; Tomohiro Okagawa; Satoru Konnai; Kazuhiko Ohashi
Poultry science, 101, 3, 101638, 101638, Mar. 2022, [Peer-reviewed], [International Magazine]
English, Scientific journal, Poultry red mites (PRMs, Dermanyssus gallinae) are hematophagous ectoparasites that negatively affect egg production, which causes serious economic losses to the poultry industry worldwide. Currently, the emergence of acaricide-resistant PRMs has impeded PRM control in poultry farms. Several alternatives for acaricide use have been described for managing PRM-caused problems. Vaccination is among the methods for controlling PRMs in poultry houses. Currently, several candidates for vaccine antigens have been identified. This study identified a cysteine protease, Deg-CPR-2, which differs from 2 other previously reported cysteine proteases in PRMs, from previously obtained data from RNA-sequencing (RNA-seq) analysis. We investigated the characteristics of Deg-CPR-2 and assessed its efficacy as a vaccine antigen in vitro. Phylogenetic analysis revealed that Deg-CPR-2 belonged to a different cluster from those of other cysteine proteases in PRMs. This cluster also included cathepsin L-like proteases, enzymes thought to be involved in hemoglobin digestion in ticks. Expression analysis revealed Deg-CPR-2 expression in midguts and all the life-stages; however, there were differences in the expression levels across the life-stages. The enzyme activity of recombinant Deg-CPR-2 was inhibited in the presence of a cysteine protease inhibitor, which suggests that Deg-CPR-2 functions as a cysteine protease in PRMs. Finally, there was an in vitro increase in the mortality of PRMs, mainly protonymphs that were artificially fed with plasma from chickens immunized with Deg-CPR-2. These findings suggest that Deg-CPR-2 may contribute to protein digestion in the midgut of PRMs and is crucially involved in physiological processes in PRMs. Additionally, immunization with Deg-CPR-2 may reduce the number of protonymphs, and Deg-CPR-2 should be considered as a candidate antigen for anti-PRM vaccine development. - Effect of Insertion and Deletion in the Meq Protein Encoded by Highly Oncogenic Marek's Disease Virus on Transactivation Activity and Virulence.
Jumpei Sato; Shiro Murata; Zhiyuan Yang; Benedikt B Kaufer; Sotaro Fujisawa; Hikari Seo; Naoya Maekawa; Tomohiro Okagawa; Satoru Konnai; Nikolaus Osterrieder; Mark S Parcells; Kazuhiko Ohashi
Viruses, 14, 2, 14 Feb. 2022, [Peer-reviewed], [International Magazine]
English, Scientific journal, Marek's disease virus (MDV) causes malignant lymphoma in chickens (Marek's disease, MD). Although MD is currently controlled by vaccination, MDV strains have continuously increased in virulence over the recent decades. Polymorphisms in Meq, an MDV-encoded oncoprotein that serves as a transcription factor, have been associated with the enhanced virulence of the virus. In addition, insertions and deletions in Meq have been observed in MDV strains of higher virulence, but their contribution to said virulence remains elusive. In this study, we investigated the contribution of an insertion (L-Meq) and a deletion in the Meq gene (S-Meq) to its functions and MDV pathogenicity. Reporter assays revealed that both insertion and deletion enhanced the transactivation potential of Meq. Additionally, we generated RB-1B-based recombinant MDVs (rMDVs) encoding each Meq isoform and analyzed their pathogenic potential. rMDV encoding L-Meq indueced the highest mortality and tumor incidence in infected animals, whereas the rMDV encoding S-Meq exhibited the lowest pathogenicity. Thus, insertion enhanced the transactivation activity of Meq and MDV pathogenicity, whereas deletion reduced pathogenicity despite having increased transactivation activity. These data suggest that other functions of Meq affect MDV virulence. These data improve our understanding of the mechanisms underlying the evolution of MDV virulence. - Enhancement of interleukin-2 production by bovine peripheral blood mononuclear cells treated with the combination of anti-programmed death-ligand 1 and cytotoxic T lymphocyte antigen 4 chimeric monoclonal antibodies.
Kei Watari; Satoru Konnai; Tomohiro Okagawa; Naoya Maekawa; Yamato Sajiki; Yukinari Kato; Yasuhiko Suzuki; Shiro Murata; Kazuhiko Ohashi
The Journal of veterinary medical science, 84, 1, 6, 15, 07 Jan. 2022, [Peer-reviewed], [Domestic magazines]
English, Scientific journal, Our previous studies demonstrate the therapeutic efficacy against bovine diseases of an anti-bovine programmed death-ligand 1 (PD-L1) chimeric antibody. In humans, PD-1 and PD-L1 antibodies are more effective when combined with an antibody targeting cytotoxic T lymphocyte antigen 4 (CTLA-4) and these combination therapies are therefore clinically used. Here we generated an anti-bovine CTLA-4 chimeric antibody (chAb) to enhance the therapeutic efficacy of the PD-L1 antibody. We further analyzed the effects of dual blockade of CTLA-4 and PD-1 pathways on T-cell responses. The established anti-bovine CTLA-4 chAb showed comparable blocking activity on the binding of bovine CTLA-4 to CD80 and CD86 as the anti-bovine CTLA-4 mouse monoclonal antibody. Anti-bovine CTLA-4 chAb also significantly increased IL-2 production from bovine peripheral blood mononuclear cells (PBMCs). Further, the combination of anti-CTLA-4 chAb with anti-PD-L1 chAb significantly upregulated IL-2 production by PBMCs. These results suggest that the combination of antibodies have higher potential to enhance immune responses against pathogens compared with single administration. - Characterization of a Novel Cysteine Protease Inhibitor from Poultry Red Mites: Potential Vaccine for Chickens.
Sotaro Fujisawa; Shiro Murata; Masayoshi Isezaki; Takuma Ariizumi; Takumi Sato; Eiji Oishi; Akira Taneno; Naoya Maekawa; Tomohiro Okagawa; Osamu Ichii; Satoru Konnai; Kazuhiko Ohashi
Vaccines, 9, 12, 13 Dec. 2021, [Peer-reviewed], [International Magazine]
English, Scientific journal, Poultry red mite (PRM; Dermanyssus gallinae) is a hazardous, blood-sucking ectoparasite of birds that constitutes a threat to poultry farming worldwide. Acaricides, commonly used in poultry farms to prevent PRMs, are not effective because of the rapid emergence of acaricide-resistant PRMs. However, vaccination may be a promising strategy to control PRM. We identified a novel cystatin-like molecule in PRMs: Dg-Cys. Dg-Cys mRNA expression was detected in the midgut and ovaries, in all stages of life. The PRM nymphs that were artificially fed with the plasma from chickens that were immunized with Dg-Cys in vitro had a significantly reduced reproductive capacity and survival rate. Moreover, combination of Dg-Cys with other antigen candidates, like copper transporter 1 or adipocyte plasma membrane-associated protein, enhanced vaccine efficacies. vaccination and its application as an antigen for cocktail vaccines could be an effective strategy to reduce the damage caused by PRMs in poultry farming. - In vitro characterization of adipocyte plasma membrane-associated protein from poultry red mites, Dermanyssus gallinae, as a vaccine antigen for chickens.
Sotaro Fujisawa; Shiro Murata; Masaki Takehara; Julia Aoyama; Ayu Morita; Masayoshi Isezaki; Shwe Yee Win; Takuma Ariizumi; Takumi Sato; Eiji Oishi; Akira Taneno; Naoya Maekawa; Tomohiro Okagawa; Osamu Ichii; Satoru Konnai; Kazuhiko Ohashi
Vaccine, 39, 41, 6057, 6066, 01 Oct. 2021, [Peer-reviewed], [International Magazine]
English, Scientific journal, The poultry red mite (Dermanyssus gallinae; PRM) is a blood-sucking ectoparasite of chickens that is a threat to poultry farming worldwide and significantly reduces productivity in the egg-laying industry. Chemical acaricides that are widely used in poultry farms for the prevention of PRMs are frequently ineffective due to the emergence of acaricide-resistant PRMs. Therefore, alternative control methods are needed, and vaccination is a promising strategy for controlling PRMs. A novel adipocyte-plasma membrane-associated protein-like molecule (Dg-APMAP) is highly expressed in blood-fed PRMs according to a previous RNA sequencing analysis. Here, we attempted to identify the full sequence of Dg-APMAP, study its expression in different life stages of PRMs, and evaluate its potential as a vaccine antigen. Dg-APMAP mRNA was expressed in the midgut and ovaries, and in all life stages regardless of feeding states. Importantly, in vitro feeding of PRMs with plasma derived from chickens immunized with the recombinant protein of the extracellular region of Dg-APMAP significantly reduced their survival rate in nymphs and adults, which require blood meals. Our data suggest that the host immune responses induced by vaccination with Dg-APMAP could be an effective strategy to reduce the suffering caused by PRMs in the poultry industry. - Research Note: Characterization of S-Meq containing the deletion in Meq protein's transactivation domain in a Marek's disease virus strain in Japan.
Shiro Murata; Eiji Yamamoto; Natsumi Sakashita; Naoya Maekawa; Tomohiro Okagawa; Satoru Konnai; Kazuhiko Ohashi
Poultry science, 100, 11, 101461, 101461, 02 Sep. 2021, [Peer-reviewed], [International Magazine]
English, Scientific journal, Marek's disease virus (MDV) causes malignant lymphomas in chickens (Marek's disease; MD). Although MD has caused significant economic losses to the poultry industry, currently, its occurrence in the field is effectively controlled by vaccination. However, the genetic characteristics of MDV strains have changed, and the poultry industry has experienced MD outbreaks in vaccinated chickens because of enhanced virulence. Meq, an oncoprotein of MDV, is a key transcription factor correlated with the tumorigenesis in MD. Animal experiments using recombinant MDV revealed that distinct polymorphisms in Meq affect the virulence of MDV strains. Meq containing an insertion or deletion is present in some MDV strains. In the 2010s, field strains that encode Meq containing the deletion (S-Meq) were reported. In this study, we characterized the genetic features of S-Meq detected in a Japanese MDV strain and analyzed its transactivation activity to investigate S-Meq's protein function. S-Meq lacked 41 amino acids, and the deletion was at the same position as those observed in other countries. In addition, S-Meq exhibited higher transactivation activity than Meq from other MDV strains circulating in Japan. These results suggest that the deletion in the transactivation domain may enhance the Meq protein's function. Further investigation is needed to clarify whether the deletion in the transactivation domain of Meq affects MDV's virulence. - Programmed death-ligand 1 expression in swine chronic infections and enhancement of interleukin-2 production via programmed death-1/programmed death-ligand 1 blockade.
Otgontuya Ganbaatar; Satoru Konnai; Tomohiro Okagawa; Yutaro Nojima; Naoya Maekawa; Yoshiki Ichikawa; Atsushi Kobayashi; Tomoyuki Shibahara; Yojiro Yanagawa; Hidetoshi Higuchi; Yukinari Kato; Yasuhiko Suzuki; Shiro Murata; Kazuhiko Ohashi
Immunity, inflammation and disease, 9, 4, 1573, 1583, 20 Aug. 2021, [Peer-reviewed], [International Magazine]
English, Scientific journal, INTRODUCTION: Chronic infections lead to the functional exhaustion of T cells. Exhausted T cells are phenotypically differentiated by the surface expression of the immunoinhibitory receptor, such as programmed death-1 (PD-1). The inhibitory signal is produced by the interaction between PD-1 and its PD-ligand 1 (PD-L1) and impairs the effector functions of T cells. However, the expression dynamics of PD-L1 and the immunological functions of the PD-1/PD-L1 pathway in chronic diseases of pigs are still poorly understood. In this study, we first analyzed the expression of PD-L1 in various chronic infections in pigs, and then evaluated the immune activation by the blocking assay targeting the swine PD-1/PD-L1 pathway. METHODS: In the initial experiments, anti-bovine PD-L1 monoclonal antibodies (mAbs) were tested for cross-reactivity with swine PD-L1. Subsequently, immunohistochemical analysis was conducted using the anti-PD-L1 mAb. Finally, we assessed the immune activation of swine peripheral blood mononuclear cells (PBMCs) by the blockade with anti-PD-L1 mAb. RESULTS: Several anti-PD-L1 mAbs tested recognized swine PD-L1-expressing cells. The binding of swine PD-L1 protein to swine PD-1 was inhibited by some of these cross-reactive mAbs. In addition, immunohistochemical analysis revealed that PD-L1 was expressed at the site of infection in chronic infections of pigs. The PD-L1 blockade increased the production of interleukin-2 from swine PBMCs. CONCLUSIONS: These findings suggest that the PD-1/PD-L1 pathway could be also involved in immunosuppression in chronic infections in pigs. This study provides a new perspective on therapeutic strategies for chronic diseases in pigs by targeting immunosuppressive pathways. - Hemangiosarcoma cells induce M2 polarization and PD-L1 expression in macrophages
Kevin Christian M. Gulay; Keisuke Aoshima; Naoya Maekawa; Satoru Konnai; Atsushi Kobayashi; Takashi Kimura
Scientific reports, 12, 1, 2124, 2124, Cold Spring Harbor Laboratory, 01 Aug. 2021, [Peer-reviewed], [International Magazine]
English, Scientific journal,Abstract Hemangiosarcoma (HSA) is a malignant tumor derived from endothelial cells. Tumor-associated macrophages are one of the major components of tumor microenvironment and crucial for cancer development. The presence and function of macrophages in HSA have not been studied because there is no syngeneic model for HSA. In this study, we evaluated two mouse HSA cell lines and one immortalized mouse endothelial cells for their usefulness as syngeneic models for canine HSA. Our results show that the ISOS-1 cell line develops tumors with similar morphology to canine HSA. ISOS-1 cells highly express KDM2B and have similar KDM2B target expression patterns with canine HSA. Moreover, we determine that in both ISOS-1 and canine HSA tumors, macrophages are present as a major constituent of the tumor microenvironment. These macrophages are positive for CD204, an M2 macrophage marker, and express PD-L1. ISOS-1-conditioned medium can induce M2 polarization and PD-L1 expression in RAW264.7 mouse macrophage cell line. These results show that ISOS-1 can be used as a syngenic model for canine HSA and suggest that macrophages play an important role in immune evasion in HSA. Using the syngeneic mouse model for canine HSA, we can further study the role of immune cells in the pathology of HSA. - Prostaglandin-related immune suppression in cattle
Y. Sajiki; S. Konnai; Y. Ikenaka; T. Okagawa; N. Maekawa; C. Logullo; I. da Silva Vaz; S. Murata; K. Ohashi
Veterinary Immunology and Immunopathology, 236, Jun. 2021, [Peer-reviewed]
Scientific journal - PD-L1 immunohistochemistry for canine cancers and clinical benefit of anti-PD-L1 antibody in dogs with pulmonary metastatic oral malignant melanoma.
Naoya Maekawa; Satoru Konnai; Maki Nishimura; Yumiko Kagawa; Satoshi Takagi; Kenji Hosoya; Hiroshi Ohta; Sangho Kim; Tomohiro Okagawa; Yusuke Izumi; Tatsuya Deguchi; Yukinari Kato; Satoshi Yamamoto; Keiichi Yamamoto; Mikihiro Toda; Chie Nakajima; Yasuhiko Suzuki; Shiro Murata; Kazuhiko Ohashi
NPJ precision oncology, 5, 1, 10, 10, 12 Feb. 2021, [Peer-reviewed], [Lead author], [International Magazine]
English, Scientific journal, Immunotherapy targeting programmed cell death 1 (PD-1) and PD-ligand 1 (PD-L1) represents promising treatments for human cancers. Our previous studies demonstrated PD-L1 overexpression in some canine cancers, and suggested the therapeutic potential of a canine chimeric anti-PD-L1 monoclonal antibody (c4G12). However, such evidence is scarce, limiting the clinical application in dogs. In the present report, canine PD-L1 expression was assessed in various cancer types, using a new anti-PD-L1 mAb, 6C11-3A11, and the safety and efficacy of c4G12 were explored in 29 dogs with pulmonary metastatic oral malignant melanoma (OMM). PD-L1 expression was detected in most canine malignant cancers including OMM, and survival was significantly longer in the c4G12 treatment group (median 143 days) when compared to a historical control group (n = 15, median 54 days). In dogs with measurable disease (n = 13), one dog (7.7%) experienced a complete response. Treatment-related adverse events of any grade were observed in 15 dogs (51.7%). Here we show that PD-L1 is a promising target for cancer immunotherapy in dogs, and dogs could be a useful large animal model for human cancer research. - Selection of reference genes for quantitative PCR analysis in poultry red mite (Dermanyssus gallinae).
Takuma Ariizumi; Shiro Murata; Sotaro Fujisawa; Masayoshi Isezaki; Naoya Maekawa; Tomohiro Okagawa; Takumi Sato; Eiji Oishi; Akira Taneno; Satoru Konnai; Kazuhiko Ohashi
The Journal of veterinary medical science, 83, 4, 558, 565, 11 Feb. 2021, [Peer-reviewed], [Domestic magazines]
English, Scientific journal, Poultry red mites (PRMs, Dermanyssus gallinae) are harmful ectoparasites that affect farmed chickens and cause serious economic losses in the poultry industry worldwide. Acaricides are used for PRM control; however, some PRMs have developed acaricide-resistant properties, which have indicated the need for different approaches for PRM control. Therefore, it is necessary to elucidate the biological status of PRMs to develop alternative PRM control strategies. Quantitative polymerase chain reaction (qPCR) allows analysis of the biological status at the transcript level. However, reference genes are preferable for accurate comparison of expression level changes given the large variation in the quality of the PRM samples collected in each farm. This study aimed to identify candidate reference genes with stable expression levels in the different blood feeding states and life stages of PRMs. First, we selected candidates based on the following criteria: sufficient expression intensity and no significant expression difference between fed and starved states. We selected and characterized seven candidate reference genes. Among them, we evaluated the gene expression stability between the starved and fed states using RefFinder; moreover, we compared their expression levels in each life-stage and identified two reference genes, Elongation factor 1-alpha (ELF1A)-like and apolipophorins-like. Finally, we evaluated the utility of the candidates as reference genes, and the use of ELF1A-like and apolipophorins-like successfully normalized ATP synthase subunit g -like gene expression. Thus, ELF1A-like and apolipophorins-like could be suitable reference genes in PRMs. - Intrauterine infection with Mycobacterium avium subsp. paratuberculosis in pregnant cattle diagnosed with Johne's disease
Yukiko Taniguchi; Satoru Konnai; Shinichi Sakakibara; Ayano Yamamoto; Tomohiro Okagawa; Naoya Maekawa; Shiro Murata; Kazuhiko Ohashi
JAPANESE JOURNAL OF VETERINARY RESEARCH, 69, 1, 51, 55, Feb. 2021, [Peer-reviewed]
English, Scientific journal - Cross-species reactivity of antibodies against Ixodes persulcatus ferritin 2 to Rhipicephalus microplus
Marina Amaral Xavier; Satoru Konnai; Luis Fernando Parizi; Naftaly Wangombe Githaka; Masayoshi Isezaki; Shinya Goto; Sotaro Fujisawa; Shinji Yamada; Tomohiro Okagawa; Naoya Maekawa; Carlos Logullo; Itabajara da Silva Vaz Jr; Shiro Murata; Kazuhiko Ohashi
JAPANESE JOURNAL OF VETERINARY RESEARCH, 69, 1, 57, 65, Feb. 2021, [Peer-reviewed]
English, Scientific journal - Tick saliva-induced programmed death-1 and PD-ligand 1 and its related host immunosuppression.
Yamato Sajiki; Satoru Konnai; Yoshinori Ikenaka; Kevin Christian Montecillo Gulay; Atsushi Kobayashi; Luís Fernando Parizi; Benvindo Capela João; Kei Watari; Sotaro Fujisawa; Tomohiro Okagawa; Naoya Maekawa; Carlos Logullo; Itabajara da Silva Vaz Jr; Shiro Murata; Kazuhiko Ohashi
Scientific reports, 11, 1, 1063, 1063, 13 Jan. 2021, [Peer-reviewed], [International Magazine]
English, Scientific journal, The tick Rhipicephalus microplus is a harmful parasite of cattle that causes considerable economic losses to the cattle breeding industry. Although R. microplus saliva (Rm-saliva) contains several immunosuppressants, any association between Rm-saliva and the expression of immunoinhibitory molecules, such as programmed death (PD)-1 and PD-ligand 1 (PD-L1), has not been described. In this study, flow cytometric analyses revealed that Rm-saliva upregulated PD-1 expression in T cells and PD-L1 expression in CD14+ and CD11c+ cells in cattle. Additionally, Rm-saliva decreased CD69 expression in T cells and Th1 cytokine production from peripheral blood mononuclear cells. Furthermore, PD-L1 blockade increased IFN-γ production in the presence of Rm-saliva, suggesting that Rm-saliva suppresses Th1 responses via the PD-1/PD-L1 pathway. To reveal the upregulation mechanism of PD-1/PD-L1 by Rm-saliva, we analyzed the function of prostaglandin E2 (PGE2), which is known as an inducer of PD-L1 expression, in Rm-saliva. We found that Rm-saliva contained a high concentration of PGE2, and PGE2 treatment induced PD-L1 expression in CD14+ cells in vitro. Immunohistochemical analyses revealed that PGE2 and PD-L1 expression was upregulated in tick-attached skin in cattle. These data suggest that PGE2 in Rm-saliva has the potential to induce the expression of immunoinhibitory molecules in host immune cells. - Direct evidence of the preventive effect of milk replacer-based probiotic feeding in calves against severe diarrhea.
Fumi Kayasaki; Tomohiro Okagawa; Satoru Konnai; Junko Kohara; Yamato Sajiki; Kei Watari; Otgontuya Ganbaatar; Shinya Goto; Hayato Nakamura; Honami Shimakura; Erina Minato; Atsushi Kobayashi; Manabu Kubota; Nobuhiro Terasaki; Akira Takeda; Haruka Noda; Mitsuru Honma; Naoya Maekawa; Shiro Murata; Kazuhiko Ohashi
Veterinary microbiology, 254, 108976, 108976, 05 Jan. 2021, [Peer-reviewed], [International Magazine]
English, Scientific journal, Diarrhea is a major cause of death in calves and this is linked directly to economic loss in the cattle industry. Fermented milk replacer (FMR) has been used widely in clinical settings for calf feeding to improve its health and growth. However, the protective efficacy of FMR on calf diarrhea remains unclear. In this study, we verified the preventive effects of FMR feeding on calf diarrhea using an experimental infection model of bovine rotavirus (BRV) in newborn calves and a field study in dairy farms with calf diarrhea. In addition, we evaluated the protective efficacy of lactic acid bacteria-supplemented milk replacer (LAB-MR) in an experimental infection model. In the experimental infection, calves fed FMR or high-concentrated LAB-MR had diarrhea, but the water content of feces was lower and more stable than that of calves fed normal milk replacer. The amount of milk intake also decreased temporarily, but recovered immediately in the FMR- and LAB-MR-fed calves. As compared with the control calves, FMR- or LAB-MR-fed calves showed less severe or reduced histopathological lesions of enteritis in the intestinal mucosa. In a field study using dairy calves, FMR feeding significantly reduced the incidence of enteritis, mortality from enteritis, duration of a series of treatment for enteritis, number of consultations, and cost of medical care for the disease. These results suggest that feeding milk replacer-based probiotics to calves reduces the severity of diarrhea and tissue damage to the intestinal tract caused by BRV infection and provides significant clinical benefits to the prevention and treatment of calf diarrhea. - Characterization of a copper transporter 1 from Dermanyssus gallinae as a vaccine antigen
Sotaro Fujisawa; Shiro Murata; Masayoshi Isezaki; Takuma Ariizumi; Takumi Sato; Eiji Oishi; Akira Taneno; Naoya Maekawa; Tomohiro Okagawa; Osamu Ichii; Satoru Konnai; Kazuhiko Ohashi
Parasitology, 149, 1, 105, 115, 2021, [Peer-reviewed], [International Magazine]
English, Scientific journal - Canine Transforming Growth Factor-β Receptor 2-Ig: A Potential Candidate Biologic for Melanoma Treatment That Reverses Transforming Growth Factor-β1 Immunosuppression.
Hiroto Takeuchi; Satoru Konnai; Naoya Maekawa; Satoshi Takagi; Hiroshi Ohta; Noboru Sasaki; Sangho Kim; Tomohiro Okagawa; Yasuhiko Suzuki; Shiro Murata; Kazuhiko Ohashi
Frontiers in veterinary science, 8, 656715, 656715, 2021, [Peer-reviewed], [International Magazine]
English, Scientific journal, Cancer cells can evade host immune systems via multiple mechanisms. Transforming growth factor beta 1 (TGF-β1) is an immunosuppressive cytokine that induces regulatory T cell (Tregs) differentiation and is involved in immune evasion mechanisms in cancer. The inhibition of the TGF-β1 signaling pathway can suppress cancer progression and metastasis through the modulation of anticancer immune responses. However, to best of our knowledge, no implementation of treatments targeting TGF-β1 has been reported in dog cancers. This study aimed to examine whether TGF-β1 is upregulated in canine cancers. We measured TGF-β1 concentrations in culture supernatants of canine melanoma cell lines and in serum samples from dogs with oral malignant melanoma. TGF-β1 production was observed in several cell lines, and serum TGF-β1 levels were elevated in dogs with oral malignant melanoma. Interestingly, the addition of recombinant TGF-β1 to canine peripheral blood mononuclear cell cultures decreased Th1 cytokine production and increased differentiation of CD4+CD25+Foxp3+ lymphocytes, suggesting that TGF-β1 is immunosuppressive in canine immune systems. We developed a decoy receptor for TGF-β, namely TGF-βRII-Ig, by identifying an open reading frame of the canine TGFBR2 gene. TGF-βRII-Ig was prepared as a recombinant fusion protein of the extracellular region of canine TGF-βRII and the Fc region of canine IgG-B. As expected, TGF-βRII-Ig bound to TGF-β1. In the presence of TGF-β1, the treatment with TGF-βRII-Ig increased Th1 cytokine production and decreased the differentiation of CD4+CD25+Foxp3+ lymphocytes. Our results suggest that TGF-βRII-Ig competitively inhibits the immunosuppressive effects of TGF-β1 and thereby activates immune responses. This study demonstrated the potential of TGF-βRII-Ig as a novel biologic for canine melanoma. - Characterisation of a cysteine protease from poultry red mites and its potential use as a vaccine for chickens.
Shiro Murata; Ayaka Taniguchi; Masayoshi Isezaki; Sotaro Fujisawa; Eishi Sakai; Akira Taneno; Osamu Ichii; Takuya Ito; Naoya Maekawa; Tomohiro Okagawa; Satoru Konnai; Kazuhiko Ohashi
Parasite (Paris, France), 28, 9, 9, 2021, [Peer-reviewed], [International Magazine]
English, Scientific journal, Poultry red mites (PRMs, Dermanyssus gallinae) are ectoparasites that negatively affect farmed chickens, leading to serious economic losses worldwide. Acaricides have been used to control PRMs in poultry houses. However, some PRMs have developed resistance to acaricides, and therefore different approaches are required to manage the problems caused by PRMs. Vaccination of chickens is one of the methods being considered to reduce the number of PRMs in poultry houses. In a previous study, a cysteine protease, Deg-CPR-1, was identified as a candidate vaccine against PRMs distributed in Europe. In this study, we investigated the characteristics of Deg-CPR-1. A phylogenetic analysis revealed that Deg-CPR-1 is closely related to the digestive cysteine proteases of other mite species, and it was classified into a cluster different from that of chicken cathepsins. Deg-CPR-1 of PRMs in Japan has an amino acid substitution compared with that of PRMs in Europe, but it showed efficacy as a vaccine, consistent with previous findings. Deg-CPR-1 exhibited cathepsin L-like enzyme activity. In addition, the Deg-CPR-1 mRNA was expressed in the midgut and in all stages of PRMs that feed on blood. These results imply that Deg-CPR-1 in the midgut may have important functions in physiological processes, and the inhibition of its expression may contribute to the efficacy of a Deg-CPR-1-based vaccine. Further research is required to fully understand the mechanisms of vaccine efficacy. - A TLR7 agonist activates bovine Th1 response and exerts antiviral activity against bovine leukemia virus.
Yamato Sajiki; Satoru Konnai; Tomohiro Okagawa; Naoya Maekawa; Hayato Nakamura; Yukinari Kato; Yasuhiko Suzuki; Shiro Murata; Kazuhiko Ohashi
Developmental and comparative immunology, 114, 103847, 103847, Jan. 2021, [Peer-reviewed], [International Magazine]
English, Scientific journal, Bovine leukemia virus (BLV) infection is a bovine chronic infection caused by BLV, a member of the genus Deltaretrovirus. In this study, we examined the immunomodulatory effects of GS-9620, a toll-like receptor (TLR) 7 agonist, in cattle (Bos taurus) and its therapeutic potential for treating BLV infection. GS-9620 induced cytokine production in peripheral blood mononuclear cells (PBMCs) as well as CD80 expression in CD11c+ cells and increased CD69 and interferon (IFN)-γ expressions in T cells. Removing CD11c+ cells from PBMCs decreased CD69 expression in T cells in the presence of GS-9620. These results suggest that TLR7 agonism promotes T-cell activation via CD11c+ cells. Analyses using PBMCs from BLV-infected cattle revealed that TLR7 expression in CD11c+ cells was upregulated during late-stage BLV infection. Furthermore, GS-9620 increased IFN-γ and TNF-α production and inhibited syncytium formation in vitro, suggesting that GS-9620 may be used to treat BLV infection. - Enhanced Immunotherapeutic Efficacy of Anti-PD-L1 Antibody in Combination with an EP4 Antagonist.
Yamato Sajiki; Satoru Konnai; Zimeng Cai; Kensuke Takada; Tomohiro Okagawa; Naoya Maekawa; Sotaro Fujisawa; Yukinari Kato; Yasuhiko Suzuki; Shiro Murata; Kazuhiko Ohashi
ImmunoHorizons, 4, 12, 837, 850, 21 Dec. 2020, [Peer-reviewed], [International Magazine]
English, Scientific journal, Combination treatment approaches are increasingly considered to overcome resistance to immunotherapy targeting immunoinhibitory molecules such as programmed death (PD)-1 and PD-ligand 1 (PD-L1). Previous studies have demonstrated that the therapeutic efficacy of anti-PD-L1 Abs is enhanced by combination treatment with cyclooxygenase-2 inhibitors, through downregulation of the immunosuppressive eicosanoid PGE2, although the underlying mechanism remains unclear. In this study, we show that serum PGE2 levels are upregulated after anti-PD-L1 Ab administration in a bovine model of immunotherapy and that PGE2 directly inhibits T cell activation via its receptor E prostanoid (EP) 4. Additionally, anti-PD-L1 Ab induces TNF-α production and TNF-α blockade reduces PGE2 production in the presence of anti-PD-L1 Ab, suggesting that anti-PD-L1 Ab-induced TNF-α impairs T cell activation by PGE2 upregulation. Our studies examining the therapeutic potential of the dual blockade of PD-L1 and EP4 in bovine and murine immune cells reveal that the dual blockade of PD-L1 and EP4 significantly enhances Th1 cytokine production in vitro. Finally, we show that the dual blockade decreases tumor volume and prolongs survival in mice inoculated with the murine lymphoma cell line EG7. Altogether, these results suggest that TNF-α induced by anti-PD-L1 Ab treatment is associated with T cell dysfunction via PGE2/EP4 pathway and that the dual blockade of PD-L1 and EP4 should be considered as a novel immunotherapy for cancer. - The enhancement of Th1 immune response by anti-PD-L1 antibody in cattle infected with Mycobacterium avium subsp. paratuberculosis.
Yamato Sajiki; Satoru Konnai; Reiko Nagata; Satoko Kawaji; Hayato Nakamura; Sotaro Fujisawa; Tomohiro Okagawa; Naoya Maekawa; Yukinari Kato; Yasuhiko Suzuki; Shiro Murata; Yasuyuki Mori; Kazuhiko Ohashi
The Journal of veterinary medical science, 83, 2, 162, 166, 07 Dec. 2020, [Peer-reviewed], [Domestic magazines]
English, Scientific journal, Johne's disease, caused by Mycobacterium avium subsp. paratuberculosis (MAP), is a chronic enteritis of ruminants. Previous studies have shown that programmed death-ligand 1 (PD-L1) is associated with the disease progression, and PD-L1 blockade activates MAP-specific Th1 responses in vitro. Here, we performed anti-PD-L1 antibody administration using 2 MAP-infected cattle at the late subclinical stage of infection. After administration, bacterial shedding was reduced or maintained at a low level after administration. Additionally, MAP-specific Th1 cytokine production was upregulated, and CD69 expression was increased in T cells. Collectively, the treatment has a potential as a novel control method against Johne's disease. - Genetic characterization of a Marek's disease virus strain isolated in Japan.
Shiro Murata; Yuka Machida; Masayoshi Isezaki; Naoya Maekawa; Tomohiro Okagawa; Satoru Konnai; Kazuhiko Ohashi
Virology journal, 17, 1, 186, 186, 23 Nov. 2020, [Peer-reviewed], [International Magazine]
English, Scientific journal, BACKGROUND: Marek's disease virus (MDV) causes malignant lymphomas in chickens (Marek's disease, MD). MD is currently controlled by vaccination; however, MDV strains have a tendency to develop increased virulence. Distinct diversity and point mutations are present in the Meq proteins, the oncoproteins of MDV, suggesting that changes in protein function induced by amino acid substitutions might affect MDV virulence. We previously reported that recent MDV isolates in Japan display distinct mutations in Meq proteins from those observed in traditional MDV isolates in Japan, but similar to those in MDV strains isolated from other countries. METHODS: To further investigate the genetic characteristics in Japanese field strains, we sequenced the whole genome of an MDV strain that was successfully isolated from a chicken with MD in Japan. A phylogenetic analysis of the meq gene was also performed. RESULTS: Phylogenetic analysis revealed that the Meq proteins in most of the Japanese isolates were similar to those of Chinese and European strains, and the genomic sequence of the Japanese strain was classified into the Eurasian cluster. Comparison of coding region sequences among the Japanese strain and MDV strains from other countries revealed that the genetic characteristics of the Japanese strain were similar to those of Chinese and European strains. CONCLUSIONS: The MDV strains distributed in Asian and European countries including Japan seem to be genetically closer to each other than to MDV strains from North America. These findings indicate that the genetic diversities of MDV strains that emerged may have been dependent on the different vaccination-based control approaches. - Identification and functional analysis of ferritin 2 from the Taiga tick Ixodes persulcatus Schulze.
Naftaly Wang'ombe Githaka; Satoru Konnai; Masayoshi Isezaki; Shinya Goto; Marina Amaral Xavier; Sotaro Fujisawa; Shinji Yamada; Tomohiro Okagawa; Naoya Maekawa; Carlos Logullo; Itabajara da Silva Vaz Jr; Shiro Murata; Kazuhiko Ohashi
Ticks and tick-borne diseases, 11, 6, 101547, 101547, Nov. 2020, [Peer-reviewed], [International Magazine]
English, Scientific journal, Ferritin 2 (FER2) is an iron storage protein, which has been shown to be critical for iron homeostasis during blood feeding and reproduction in ticks and is therefore suitable as a component for anti-tick vaccines. In this study, we identified the FER2 of Ixodes persulcatus, a major vector for zoonotic diseases such as Lyme borreliosis and tick-borne relapsing fever in Japan, and investigated its functions. Ixodes persulcatus-derived ferritin 2 (Ip-FER2) showed concentration-dependent iron-binding ability and high amino acid conservation, consistent with FER2s of other tick species. Vaccines containing the recombinant Ip-FER2 elicited a significant reduction of the engorgement weight of adult I. persulcatus. Interestingly, the reduction of engorgement weight was also observed in Ixodes ovatus, a sympatric species of I. persulcatus. In silico analyses of FER2 sequences of I. persulcatus and other ticks showed a greater similarity with I. scapularis and I. ricinus and lesser similarity with Hyalomma anatolicum, Haemaphysalis longicornis, Rhipicephalus microplus, and R. appendiculatus. Moreover, it was observed that the tick FER2 sequences possess conserved regions within the primary structures, and in silico epitope mapping analysis revealed that antigenic regions were also conserved, particularly among Ixodes spp ticks. In conclusion, the data support further protective tick vaccination applications using the Ip-FER2 antigens identified herein. - Transcriptome dynamics of blood-fed and starved poultry red mites, Dermanyssus gallinae.
Sotaro Fujisawa; Shiro Murata; Masayoshi Isezaki; Eiji Oishi; Akira Taneno; Naoya Maekawa; Tomohiro Okagawa; Satoru Konnai; Kazuhiko Ohashi
Parasitology international, 78, 102156, 102156, Oct. 2020, [Peer-reviewed], [International Magazine]
English, Scientific journal - Immunosuppressive effects of sialostatin L1 and L2 isolated from the taiga tick Ixodes persulcatus Schulze.
Yamato Sajiki; Satoru Konnai; Akie Ochi; Tomohiro Okagawa; Naftaly Githaka; Masayoshi Isezaki; Shinji Yamada; Takuya Ito; Shuji Ando; Hiroki Kawabata; Carlos Logullo; Itabajara da Silva Vaz Jr; Naoya Maekawa; Shiro Murata; Kazuhiko Ohashi
Ticks and tick-borne diseases, 11, 2, 101332, 101332, Mar. 2020, [Peer-reviewed], [International Magazine]
English, Scientific journal, Tick saliva contains immunosuppressants which are important to obtain a blood meal and enhance the infectivity of tick-borne pathogens. In Japan, Ixodes persulcatus is a major vector for Lyme borreliosis pathogens, such as Borrelia garinii, as well as for those causing relapsing fever, such as B. miyamotoi. To date, little information is available on bioactive salivary molecules, produced by this tick. Thus, in this study, we identified two proteins, I. persulcatus derived sialostatin L1 (Ip-sL1) and sL2 (Ip-sL2), as orthologs of I. scapularis derived sL1 and sL2. cDNA clones of Ip-sL1 and Ip-sL2 shared a high identity with sequences of sL1 and sL2 isolated from the salivary glands of I. scapularis. Semi-quantitative PCR revealed that Ip-sL1 and Ip-sL2 were expressed in the salivary glands throughout the life of the tick. In addition, Ip-sL1 and Ip-sL2 were expressed even before the ticks started feeding, and their expression continued during blood feeding. Recombinant Ip-sL1 and Ip-sL2 were developed to characterize the proteins via biological and immunological analyses. These analyses revealed that both Ip-sL1 and Ip-sL2 had inhibitory effects on cathepsins L and S. Ip-sL1 and Ip-sL2 inhibited the production of IP-10, TNFα, and IL-6 by LPS-stimulated bone-marrow-derived dendritic cells (BMDCs). Additionally, Ip-sL1 significantly impaired BMDC maturation. Taken together, these results suggest that Ip-sL1 and Ip-sL2 confer immunosuppressive functions and appear to be involved in the transmission of pathogens by suppressing host immune responses, such as cytokine production and dendritic cell maturation. Therefore, further studies are warranted to investigate the immunosuppressive functions of Ip-sL1 and Ip-sL2 in detail to clarify their involvement in pathogen transmission via I. persulcatus. - The Suppression of Th1 Response by Inducing TGF-β1 From Regulatory T Cells in Bovine Mycoplasmosis.
Yamato Sajiki; Satoru Konnai; Shinya Goto; Tomohiro Okagawa; Kosuke Ohira; Honami Shimakura; Naoya Maekawa; Satoshi Gondaira; Hidetoshi Higuchi; Motoshi Tajima; Yuki Hirano; Junko Kohara; Shiro Murata; Kazuhiko Ohashi
Frontiers in veterinary science, 7, 609443, 609443, 2020, [Peer-reviewed], [International Magazine]
English, Scientific journal, Regulatory T cells (Tregs) regulate immune responses and maintain host immune homeostasis. Tregs contribute to the disease progression of several chronic infections by oversuppressing immune responses via the secretion of immunosuppressive cytokines, such as transforming growth factor (TGF)-β and interleukin-10. In the present study, we examined the association of Tregs with Mycoplasma bovis infection, in which immunosuppression is frequently observed. Compared with uninfected cattle, the percentage of Tregs, CD4+CD25highFoxp3+ T cells, was increased in M. bovis-infected cattle. Additionally, the plasma of M. bovis-infected cattle contained the high concentrations of TGF-β1, and M. bovis infection induced TGF-β1 production from bovine immune cells in in vitro cultures. Finally, we analyzed the immunosuppressive effects of TGF-β1 on bovine immune cells. Treatment with TGF-β1 significantly decreased the expression of CD69, an activation marker, in T cells, and Th1 cytokine production in vitro. These results suggest that the increase in Tregs and TGF-β1 secretion could be one of the immunosuppressive mechanisms and that lead to increased susceptibility to other infections in terms of exacerbation of disease during M. bovis infection. - PD-L1 expression in equine malignant melanoma and functional effects of PD-L1 blockade.
Otgontuya Ganbaatar; Satoru Konnai; Tomohiro Okagawa; Yutaro Nojima; Naoya Maekawa; Erina Minato; Atsushi Kobayashi; Ryo Ando; Nobuya Sasaki; Daisuke Miyakoshi; Osamu Ichii; Yukinari Kato; Yasuhiko Suzuki; Shiro Murata; Kazuhiko Ohashi
PloS one, 15, 11, e0234218, 2020, [Peer-reviewed], [International Magazine]
English, Scientific journal, Programmed death-1 (PD-1) is an immunoinhibitory receptor expressed on lymphocytes. Interaction of PD-1 with its ligand PD-ligand 1 (PD-L1) delivers inhibitory signals and impairs proliferation, cytokine production, and cytotoxicity of T cells. In our previous studies, we have developed anti-bovine PD-L1 monoclonal antibodies (mAbs) and reported that the PD-1/PD-L1 pathway was closely associated with T-cell exhaustion and disease progression in bovine chronic infections and canine tumors. Furthermore, we found that blocking antibodies that target PD-1 and PD-L1 restore T-cell functions and could be used in immunotherapy in cattle and dogs. However, the immunological role of the PD-1/PD-L1 pathway for chronic equine diseases, including tumors, remains unclear. In this study, we identified cDNA sequences of equine PD-1 (EqPD-1) and PD-L1 (EqPD-L1) and investigated the role of anti-bovine PD-L1 mAbs against EqPD-L1 using in vitro assays. In addition, we evaluated the expression of PD-L1 in tumor tissues of equine malignant melanoma (EMM). The amino acid sequences of EqPD-1 and EqPD-L1 share a considerable identity and similarity with homologs from non-primate species. Two clones of the anti-bovine PD-L1 mAbs recognized EqPD-L1 in flow cytometry, and one of these cross-reactive mAbs blocked the binding of equine PD-1/PD-L1. Of note, immunohistochemistry confirmed the PD-L1 expression in EMM tumor tissues. A cultivation assay revealed that PD-L1 blockade enhanced the production of Th1 cytokines in equine immune cells. These findings showed that our anti-PD-L1 mAbs would be useful for analyzing the equine PD-1/PD-L1 pathway. Further research is warranted to discover the immunological role of PD-1/PD-L1 in chronic equine diseases and elucidate a future application in immunotherapy for horses. - Expression Analysis of Canine CMTM6 and CMTM4 as Potential Regulators of the PD-L1 Protein in Canine Cancers.
Hiroto Takeuchi; Satoru Konnai; Naoya Maekawa; Erina Minato; Yoshiki Ichikawa; Atsushi Kobayashi; Tomohiro Okagawa; Shiro Murata; Kazuhiko Ohashi
Frontiers in veterinary science, 7, 330, 330, 2020, [Peer-reviewed], [International Magazine]
English, Scientific journal, Cancer is one of the most significant causes of death in dogs. Antibody drugs targeting the PD-1/PD-L1 axis represent a promising immunotherapy for both human and canine cancers. However, the regulation mechanisms of PD-L1 expression in canine cancers require further investigation to better understand the resistance mechanisms to anti-PD-L1 therapy. Recent reports have shown that CMTM6 and CMTM4 are critical regulators of PD-L1 protein expression in human cancer cells. By preventing PD-L1 from lysosome-mediated degradation, CMTM6 maintains PD-L1 expression on the cell surface. However, the literature has not reported on CMTM6 and CMTM4 in dogs, and their functions are completely unknown. To reveal a regulation mechanism of PD-L1 in canine cancers, this study firstly identified the gene sequences of CMTM6 and CMTM4. Then, the expression analysis of these proteins was performed by immunohistochemistry. Furthermore, the functions of CMTM6 and CMTM4 in regulating PD-L1 expression were examined by gene knockdown of CMTM6 and CMTM4. Canine CMTM6 and CMTM4 displayed high amino acid sequence identities compared with those of humans and mice. An immunohistochemical analysis using cross-reactive antibodies revealed that canine malignant melanoma and osteosarcoma express CMTM6, CMTM4, and PD-L1 simultaneously. Gene knockdown of CMTM6 and CMTM4 with RNA interference significantly reduced the cell surface expression of PD-L1 in a canine cell line. These results suggest that CMTM6 and CMTM4 are regulators of PD-L1 expression in canine cancers and could serve as potential therapeutic targets to enhance antitumor immunity. - Upregulation of PD-L1 Expression by Prostaglandin E2 and the Enhancement of IFN-γ by Anti-PD-L1 Antibody Combined With a COX-2 Inhibitor in Mycoplasma bovis Infection.
Shinya Goto; Satoru Konnai; Yuki Hirano; Junko Kohara; Tomohiro Okagawa; Naoya Maekawa; Yamato Sajiki; Kei Watari; Erina Minato; Atsuhi Kobayashi; Satoshi Gondaira; Hidetoshi Higuchi; Masateru Koiwa; Motoshi Tajima; Eiji Taguchi; Ryoko Uemura; Shinji Yamada; Mika K Kaneko; Yukinari Kato; Keiichi Yamamoto; Mikihiro Toda; Yasuhiko Suzuki; Shiro Murata; Kazuhiko Ohashi
Frontiers in veterinary science, 7, 12, 12, 2020, [Peer-reviewed], [International Magazine]
English, Scientific journal, Bovine mycoplasmosis caused by Mycoplasma bovis results in pneumonia and mastitis in cattle. We previously demonstrated that the programmed death 1 (PD-1)/PD-ligand 1 (PD-L1) pathway is involved in immune dysfunction during M. bovis infection and that prostaglandin E2 (PGE2) suppressed immune responses and upregulated PD-L1 expression in Johne's disease, a bacterial infection in cattle. In this study, we investigated the role of PGE2 in immune dysfunction and the relationship between PGE2 and the PD-1/PD-L1 pathway in M. bovis infection. In vitro stimulation with M. bovis upregulated the expressions of PGE2 and PD-L1 presumably via Toll-like receptor 2 in bovine peripheral blood mononuclear cells (PBMCs). PGE2 levels of peripheral blood in infected cattle were significantly increased compared with those in uninfected cattle. Remarkably, plasma PGE2 levels were positively correlated with the proportions of PD-L1+ monocytes in M. bovis-infected cattle. Additionally, plasma PGE2 production in infected cattle was negatively correlated with M. bovis-specific interferon (IFN)-γ production from PBMCs. These results suggest that PGE2 could be one of the inducers of PD-L1 expression and could be involved in immunosuppression during M. bovis infection. In vitro blockade assays using anti-bovine PD-L1 antibody and a cyclooxygenase 2 inhibitor significantly upregulated the M. bovis-specific IFN-γ response. Our study findings might contribute to the development of novel therapeutic strategies for bovine mycoplasmosis that target PGE2 and the PD-1/PD-L1 pathway. - Clinical efficacy of the combined treatment of anti-PD-L1 rat-bovine chimeric antibody with a COX-2 inhibitor in calves infected with Mycoplasma bovis
Goto S; Konnai S; Hirano Y; Kohara J; Okagawa T; Maekawa N; Sajiki Y; Watari K; Minato E; Kobayashi A; Gondaira S; Higuchi H; Koiwa M; Tajima M; Taguchi E; Ishida M; Uemura R; Yamada S; Kaneko M; Kato Y; Yamamoto K; Toda M; Suzuki Y; Murata S; Ohashi K
Jpn J Vet Res, 68, 2, 77, 90, 2020, [Peer-reviewed]
English, Scientific journal - Immune inhibitory function of bovine CTLA-4 and the effects of its blockade in IFN-γ production.
Kei Watari; Satoru Konnai; Naoya Maekawa; Tomohiro Okagawa; Yasuhiko Suzuki; Shiro Murata; Kazuhiko Ohashi
BMC veterinary research, 15, 1, 380, 380, 29 Oct. 2019, [Peer-reviewed], [International Magazine]
English, Scientific journal, BACKGROUND: Cytotoxic T-lymphocyte antigen 4 (CTLA-4) is known as an immune inhibitory receptor that is expressed on activated effector T cells and regulatory T cells. When CTLA-4 binds to CD80 or CD86, immunoinhibitory signals are transmitted to retain a homeostasis of the immune response. Recent studies have reported that CTLA-4 is upregulated in chronic infections and malignant neoplasms, contributing to host immune dysfunction. On the other hand, the blockade of CTLA-4 and CD80 or CD86 binding by antibody restores the immune response against these diseases. In a previous report, we indicated that the expression of CTLA-4 was closely associated with disease progression in cattle infected with the bovine leukemia virus (BLV). In this study, we established an anti-bovine CTLA-4 antibody to confirm its immune enhancing effect. RESULTS: Bovine CTLA-4-Ig binds to bovine CD80 and CD86 expressing cells. Additionally, CD80 and CD86 bind to CTLA-4 expressing cells in an expression-dependent manner. Bovine CTLA-4-Ig significantly inhibited interferon-gamma (IFN-γ) production from bovine peripheral blood mononuclear cells (PBMCs) activated by Staphylococcus enterotoxin B (SEB). An established specific monoclonal antibody (mAb) for bovine CTLA-4 specifically recognized only with bovine CTLA-4, not CD28, and the antibody blocked the binding of CTLA-4-Ig to both CD80 and CD86 in a dose-dependent manner. The bovine CTLA-4 mAb significantly restored the inhibited IFN-γ production from the CTLA-4-Ig treated PBMCs. In addition, the CTLA-4 mAb significantly enhanced IFN-γ production from CTLA-4 expressing PBMCs activated by SEB. Finally, we examined whether a CTLA-4 blockade by CTLA-4 mAb could restore the immune reaction during chronic infection; the blockade assay was performed using PBMCs from BLV-infected cattle. The CTLA-4 blockade enhanced IFN-γ production from the PBMCs in response to BLV-antigens. CONCLUSIONS: Collectively, these results suggest that anti-bovine CTLA-4 antibody can reactivate lymphocyte functions and could be applied for a new therapy against refractory chronic diseases. Further investigation is required for future clinical applications. - Prostaglandin E2-Induced Immune Exhaustion and Enhancement of Antiviral Effects by Anti-PD-L1 Antibody Combined with COX-2 Inhibitor in Bovine Leukemia Virus Infection.
Yamato Sajiki; Satoru Konnai; Tomohiro Okagawa; Asami Nishimori; Naoya Maekawa; Shinya Goto; Kei Watari; Erina Minato; Atsushi Kobayashi; Junko Kohara; Shinji Yamada; Mika K Kaneko; Yukinari Kato; Hirofumi Takahashi; Nobuhiro Terasaki; Akira Takeda; Keiichi Yamamoto; Mikihiro Toda; Yasuhiko Suzuki; Shiro Murata; Kazuhiko Ohashi
Journal of immunology (Baltimore, Md. : 1950), 203, 5, 1313, 1324, 01 Sep. 2019, [Peer-reviewed], [International Magazine]
English, Scientific journal, Bovine leukemia virus (BLV) infection is a chronic viral infection of cattle and endemic in many countries, including Japan. Our previous study demonstrated that PGE2, a product of cyclooxygenase (COX) 2, suppresses Th1 responses in cattle and contributes to the progression of Johne disease, a chronic bacterial infection in cattle. However, little information is available on the association of PGE2 with chronic viral infection. Thus, we analyzed the changes in plasma PGE2 concentration during BLV infection and its effects on proviral load, viral gene transcription, Th1 responses, and disease progression. Both COX2 expression by PBMCs and plasma PGE2 concentration were higher in the infected cattle compared with uninfected cattle, and plasma PGE2 concentration was positively correlated with the proviral load. BLV Ag exposure also directly enhanced PGE2 production by PBMCs. Transcription of BLV genes was activated via PGE2 receptors EP2 and EP4, further suggesting that PGE2 contributes to disease progression. In contrast, inhibition of PGE2 production using a COX-2 inhibitor activated BLV-specific Th1 responses in vitro, as evidenced by enhanced T cell proliferation and Th1 cytokine production, and reduced BLV proviral load in vivo. Combined treatment with the COX-2 inhibitor meloxicam and anti-programmed death-ligand 1 Ab significantly reduced the BLV proviral load, suggesting a potential as a novel control method against BLV infection. Further studies using a larger number of animals are required to support the efficacy of this treatment for clinical application. - Vector transmission of bovine leukemia virus during summer season in Northern Hokkaido
Inagaki H; Konnai S; Kaburagi H; Murota H; Takabatake N; Watari K; Okagawa T; Maekawa N; Murata S; Ohashi K
Jpn. J. Vet. Res, 67, 3, 235, 239, Aug. 2019, [Peer-reviewed]
English, Scientific journal - Haematophagous mites on poultry farms in the Republic of the Union of Myanmar.
Masaki Takehara; Shiro Murata; Ken Katakura; Sotaro Fujisawa; Myint Myint Hmoon; Shwe Yee Win; Saw Bawm; Lat Lat Htun; Ye Htut Aung; Mar Mar Win; Masayoshi Isezaki; Naoya Maekawa; Tomohiro Okagawa; Satoru Konnai; Kazuhiko Ohashi
Heliyon, 5, 4, e01544, Apr. 2019, [Peer-reviewed], [International Magazine]
English, Scientific journal, Haematophagous ectoparasites of poultry, such as Ornithonyssus sylviarum, northern fowl mites (NFMs), Dermanyssus gallinae, poultry red mites (PRMs), and Ornithonyssus bursa, tropical fowl mites (TFMs) are prevalent worldwide. Although poultry farming is a major industry in Southeast Asia, there are only a few reports concerning the prevalence of avian mites in this region. In this study, we sampled twenty farms in four major poultry farming areas in Myanmar. We detected the mites on six farms, and they showed morphological similarities to NFMs and TFMs. The nucleotide sequences of cytochrome c oxidase subunit I indicated that some mites were NFMs. This is the first report confirming the presence of NFMs and TFMs among the hematophagous mites infesting chickens on Myanmar poultry farms. - The mouse-canine chimeric anti-dog podoplanin antibody P38B exerts antitumor activity in mouse xenograft models.
Yukinari Kato; Tomokazu Ohishi; Manabu Kawada; Naoya Maekawa; Satoru Konnai; Shunsuke Itai; Shinji Yamada; Mika K Kaneko
Biochemistry and biophysics reports, 17, 23, 26, Mar. 2019, [Peer-reviewed], [International Magazine]
English, Scientific journal, Podoplanin (PDPN) is a type I transmembrane heavily glycosylated sialoglycoprotein that is expressed in normal tissues such as pulmonary type I alveolar cells, renal podocytes, and lymphatic endothelial cells. PDPN overexpression in cancerous tissue is associated with hematogenous metastasis through interactions with the C-type lectin-like receptor 2 (CLEC-2). Previously, we have reported the development of a mouse monoclonal antibody (mAb), PMab-38 (IgG1, kappa) against dog PDPN (dPDPN). PMab-38 was found to strongly react with canine squamous cell carcinomas (SCCs) and melanomas; however, it showed no reaction with lymphatic endothelial cells. Recently, we have developed and produced the mouse-canine mAb of subclass B, P38B that showed antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity against Chinese hamster ovary (CHO)/dPDPN cells. In the present study, we investigated the antitumor activity using mouse xenograft model. To induce ADCC activity by P38B, canine mononuclear cells were injected surrounding the tumors in a xenograft model. It was demonstrated that P38B exerted antitumor activity against the mouse xenograft model using CHO/dPDPN. These results suggest that P38B is useful for antibody therapy against dPDPN-expressing canine SCCs and melanomas. - Effects of bovine tumor necrosis factor alpha decoy receptors on cell death and inflammatory cytokine kinetics: potential for bovine inflammation therapy.
Sotaro Fujisawa; Satoru Konnai; Tomohiro Okagawa; Naoya Maekawa; Akina Tanaka; Yasuhiko Suzuki; Shiro Murata; Kazuhiko Ohashi
BMC veterinary research, 15, 1, 68, 68, 28 Feb. 2019, [Peer-reviewed], [International Magazine]
English, Scientific journal, BACKGROUND: Refractory diseases, including bacterial infections, are causing huge economic losses in dairy farming. Despite efforts to prevent and treat those diseases in cattle, including the use of antimicrobials, it is not well controlled in the field. Several inflammatory cytokines, including tumor necrosis factor alpha (TNF-α), play important roles in disease progression; thus, blocking these cytokines can attenuate the acute and sever inflammation and may be a novel strategy for treatment. However, biological drugs targeting inflammatory cytokines have not been used in cattle. Therefore, in this study, bovine sTNFR1 and sTNFR2 IgG1 Fc-fusion proteins (TNFR1-Ig and TNFR2-Ig) were produced, and their anti-inflammatory functions were analyzed in vitro, to develop decoy receptors for bovine TNF-α. RESULTS: Both TNFR1-Ig and TNFR2-Ig were shown to bind with TNF-α, and TNFR2-Ig showed higher affinity toward TNF-α than TNFR1-Ig. We next stimulated murine fibroblast-derived cells (L929 cells) with TNF-α to induce cell death and analyzed cell viability in the presence of TNFR-Ig proteins. Both TNFR1-Ig and TNFR2-Ig suppressed TNF-α-induced cell death, significantly improving cell viability. In addition, cell death induced by TNF-α was suppressed, even at low TNFR2-Ig concentrations, suggesting TNFR2-Ig has higher activity to suppress TNF-α functions than TNFR1-Ig. Finally, to examine TNFR2-Ig's anti-inflammatory, we cultured peripheral blood mononuclear cells from cattle with TNF-α in the presence of TNFR2-Ig and analyzed the gene expression and protein production of the inflammatory cytokines IL-1β and TNF-α. TNFR2-Ig significantly reduced the gene expression and protein production of these cytokines. Our results suggest that TNFR2-Ig inhibits inflammatory cytokine kinetics by blocking TNF-α to transmembrane TNFR, thereby attenuating excessive inflammation induced by TNF-α. CONCLUSIONS: Collectively, the findings of this study demonstrated the potential of TNFR2-Ig as a novel therapeutic for inflammatory diseases, such as bovine clinical mastitis. Further investigation is required for future clinical application. - Identification of immuno-inhibitory molecules in Mongolian native cattle and yak
Ochirkhuu N; Konnai S; Odbileg R; Okagawa T; Maekawa N; Murata S; Ohashi K
Jpn J Vet Res, 66, 3, 177, 192, Aug. 2018, [Peer-reviewed]
English, Scientific journal - Cooperation of PD-1 and LAG-3 in the exhaustion of CD4+ and CD8+ T cells during bovine leukemia virus infection.
Tomohiro Okagawa; Satoru Konnai; Asami Nishimori; Naoya Maekawa; Shinya Goto; Ryoyo Ikebuchi; Junko Kohara; Yasuhiko Suzuki; Shinji Yamada; Yukinari Kato; Shiro Murata; Kazuhiko Ohashi
Veterinary research, 49, 1, 50, 50, 19 Jun. 2018, [Peer-reviewed], [International Magazine]
English, Scientific journal, Bovine leukemia virus (BLV) is a retrovirus that infects B cells in cattle and causes bovine leukosis after a long latent period. Progressive exhaustion of T cell functions is considered to facilitate disease progression of BLV infection. Programmed death-1 (PD-1) and lymphocyte activation gene-3 (LAG-3) are immunoinhibitory receptors that contribute to T-cell exhaustion caused by BLV infection in cattle. However, it is unclear whether the cooperation of PD-1 and LAG-3 accelerates disease progression of BLV infection. In this study, multi-color flow cytometric analyses of PD-1- and LAG-3-expressing T cells were performed in BLV-infected cattle at different stages of the disease. The frequencies of PD-1+LAG-3+ heavily exhausted T cells among CD4+ and CD8+ T cells was higher in the blood of cattle with B-cell lymphoma over that of BLV-uninfected and BLV-infected cattle without lymphoma. In addition, blockade assays of peripheral blood mononuclear cells were performed to examine whether inhibition of the interactions between PD-1 and LAG-3 and their ligands by blocking antibodies could restore T-cell function during BLV infection. Single or dual blockade of the PD-1 and LAG-3 pathways reactivated the production of Th1 cytokines, interferon-γ and tumor necrosis factor-α, from BLV-specific T cells of the infected cattle. Taken together, these results indicate that PD-1 and LAG-3 cooperatively mediate the functional exhaustion of CD4+ and CD8+ T cells and are associated with the development of B-cell lymphoma in BLV-infected cattle. - Prostaglandin E2 Induction Suppresses the Th1 Immune Responses in Cattle with Johne's Disease.
Yamato Sajiki; Satoru Konnai; Tomohiro Okagawa; Asami Nishimori; Naoya Maekawa; Shinya Goto; Ryoyo Ikebuchi; Reiko Nagata; Satoko Kawaji; Yumiko Kagawa; Shinji Yamada; Yukinari Kato; Chie Nakajima; Yasuhiko Suzuki; Shiro Murata; Yasuyuki Mori; Kazuhiko Ohashi
Infection and immunity, 86, 5, May 2018, [Peer-reviewed], [International Magazine]
English, Scientific journal, Johne's disease, caused by Mycobacterium avium subsp. paratuberculosis, is a bovine chronic infection that is endemic in Japan and many other countries. The expression of immunoinhibitory molecules is upregulated in cattle with Johne's disease, but the mechanism of immunosuppression is poorly understood. Prostaglandin E2 (PGE2) is immunosuppressive in humans, but few veterinary data are available. In this study, functional and kinetic analyses of PGE2 were performed to investigate the immunosuppressive effect of PGE2 during Johne's disease. In vitro PGE2 treatment decreased T-cell proliferation and Th1 cytokine production and upregulated the expression of immunoinhibitory molecules such as interleukin-10 and programmed death ligand 1 (PD-L1) in peripheral blood mononuclear cells (PBMCs) from healthy cattle. PGE2 was upregulated in sera and intestinal lesions of cattle with Johne's disease. In vitro stimulation with Johnin purified protein derivative (J-PPD) induced cyclooxygenase-2 (COX-2) transcription, PGE2 production, and upregulation of PD-L1 and immunoinhibitory receptors in PBMCs from cattle infected with M. avium subsp. paratuberculosis Therefore, Johnin-specific Th1 responses could be limited by the PGE2 pathway in cattle. In contrast, downregulation of PGE2 with a COX-2 inhibitor promoted J-PPD-stimulated CD8+ T-cell proliferation and Th1 cytokine production in PBMCs from the experimentally infected cattle. PD-L1 blockade induced J-PPD-stimulated CD8+ T-cell proliferation and interferon gamma production in vitro Combined treatment with a COX-2 inhibitor and anti-PD-L1 antibodies enhanced J-PPD-stimulated CD8+ T-cell proliferation in vitro, suggesting that the blockade of both pathways is a potential therapeutic strategy to control Johne's disease. The effects of COX-2 inhibition warrant further study as a novel treatment of Johne's disease. - Molecular detection and phylogenetic analysis of Ehrlichia canis in a Philippine dog.
Naoya Maekawa; Satoru Konnai; Michelle M Balbin; Claro N Mingala; Karlo R B Gicana; Francis A E M Bernando; Shiro Murata; Kazuhiko Ohashi
Ticks and tick-borne diseases, 9, 2, 266, 269, Feb. 2018, [Peer-reviewed], [Lead author], [International Magazine]
English, Scientific journal, Canine monocytic ehrlichiosis (CME), caused by a rickettsial bacterium, Ehrlichia canis, is distributed worldwide, particularly in tropical and subtropical regions. Transmission of E. canis is primarily mediated by the vector tick, Rhipicephalus sanguineus sensu lato and the bacteria then infect and replicate in monocytes and macrophages. Many cases are seen in veterinary hospitals and treated routinely; however, the genetic variation of E. canis strains found in the Philippines has been poorly investigated to date. In this study, the 16S rRNA gene and the gp200 gene of E. canis were detected by polymerase chain reaction from an infected dog in the Philippines, and the deduced amino acid sequence of the gp200 gene was subjected to a phylogenetic analysis. The Philippine genotype formed a cluster with the Taiwan genotype, and was somewhat divergent from the USA and Brazil strains. This suggested that E. canis underwent evolution in East and Southeast Asia, confirming the utility of the gp200 gene for the assessment of genetic relationships among strains. - Evaluation of costimulatory molecules in dogs with B cell high grade lymphoma.
Michihito Tagawa; Chihiro Kurashima; Satoshi Takagi; Naoya Maekawa; Satoru Konnai; Genya Shimbo; Kotaro Matsumoto; Hisashi Inokuma; Keiko Kawamoto; Kazuro Miyahara
PloS one, 13, 7, e0201222, 2018, [Peer-reviewed], [International Magazine]
English, Scientific journal, B cell high grade lymphoma is the most common hematopoietic malignancy in dogs. Although the immune checkpoint molecules, programmed death-1 (PD-1) and cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4), and immune checkpoint inhibitors have been evaluated for the treatment of various human lymphoid malignancies, the expression of those molecules and their relationship with prognosis remain unknown in canine lymphoma. The objective of this study was to evaluate the expression of costimulatory molecules on peripheral blood lymphocytes and tumor infiltrating lymphocytes, in addition to associated ligand expression in the lymph nodes of patients with B cell multicentric high grade lymphoma. Eighteen patients diagnosed with B cell high grade lymphoma and nine healthy control dogs were enrolled. Flow cytometric analysis revealed that the expression of PD-1 on CD4+ peripheral and tumor infiltrating lymphocytes and CTLA-4 on CD4+ peripheral lymphocytes was significantly higher in the lymphoma group than in the control group. The expression level of CD80 mRNA was significantly lower in the lymphoma group than in the control group. In contrast, there were no significant differences in PD-L1, PD-L2, and CD86 expression between the groups. Dogs with CTLA-4 levels below the cutoff values, which were determined based on receiver operating characteristic curves, on peripheral CD4+, CD8+, and tumor infiltrating CD4+ lymphocytes had significantly longer survival than dogs with values above the cutoff. Although it is uncertain whether the expression of immune checkpoint molecules affect the biological behavior of canine lymphoma, one possible explanation is that PD-1 and CTLA-4 might be associated with the suppression of antitumor immunity in dogs with B cell high grade lymphoma, particularly through CD4+ T cells. - Intrauterine infection with bovine leukemia virus in pregnant dam with high viral load.
Yamato Sajiki; Satoru Konnai; Asami Nishimori; Tomohiro Okagawa; Naoya Maekawa; Shinya Goto; Masashi Nagano; Junko Kohara; Nana Kitano; Toshihiko Takahashi; Motoshi Tajima; Hirohisa Mekata; Yoichiro Horii; Shiro Murata; Kazuhiko Ohashi
The Journal of veterinary medical science, 79, 12, 2036, 2039, 22 Dec. 2017, [Peer-reviewed], [Domestic magazines]
English, Scientific journal, Enzootic bovine leukemia is caused by the bovine leukemia virus (BLV). BLV is transmitted vertically or horizontally through the transfer of infected cells via direct contact, through milk, insect bites and contaminated iatrogenic procedures. However, we lacked direct evidence of intrauterine infection. The purpose of this study was to confirm intrauterine BLV infection in two pregnant dams with high viral load by cesarean delivery. BLV was detected in cord and placental blood, and the BLV in the newborns showed 100% nucleotide identity with the BLV-env sequence from the dams. Notably, a newborn was seropositive for BLV but had no colostral antibodies. In this study, we presented a direct evidence of intrauterine BLV transmission in pregnant dam with a high proviral load. These results could aid the development of BLV control measures targeting viral load. - Increase of cells expressing PD-1 and PD-L1 and enhancement of IFN-γ production via PD-1/PD-L1 blockade in bovine mycoplasmosis.
Shinya Goto; Satoru Konnai; Tomohiro Okagawa; Asami Nishimori; Naoya Maekawa; Satoshi Gondaira; Hidetoshi Higuchi; Masateru Koiwa; Motoshi Tajima; Junko Kohara; Satoshi Ogasawara; Yukinari Kato; Yasuhiko Suzuki; Shiro Murata; Kazuhiko Ohashi
Immunity, inflammation and disease, 5, 3, 355, 363, Sep. 2017, [Peer-reviewed], [International Magazine]
English, Scientific journal, INTRODUCTION: Bovine mycoplasma, chiefly Mycoplasma bovis, is a pathogen that causes pneumonia, mastitis, arthritis, and otitis media in cattle. This pathogen exerts immunosuppressive effects, such as the inhibition of interferon production. However, the mechanisms involved in bovine mycoplasmosis have not been fully elucidated. In this study, we investigated the role of the programmed death-1 (PD-1)/programmed death-ligand 1 (PD-L1) pathway in immunosuppression in bovine mycoplasmosis. METHODS: In the initial experiments, we used enzyme-linked immunosorbent assay to measure interferon-γ (IFN-γ) from peripheral blood mononuclear cells (PBMCs) isolated from cattle with mycoplasmosis. RESULTS: Expectedly, IFN-γ production significantly decreased in cattle with mycoplasmosis compared with that in clinically healthy cattle. Concomitantly, flow cytometric analysis revealed that the proportions of PD-1+ CD4+ and PD-L1+ CD14+ cells significantly increased in peripheral blood of the infected cattle. Interestingly, the number of PD-1+ CD4+ and PD-1+ CD8+ T cells were negatively correlated with IFN-γ production from PBMCs in bovine mycoplasmosis. Additionally, blockade of the PD-1/PD-L1 pathway in vitro by anti-bovine PD-1- and anti-bovine PD-L1 antibodies significantly upregulated the production of IFN-γ from anti-mycoplasma-specific cells. CONCLUSIONS: These results suggest that the PD-1/PD-L1 pathway could be involved in immune exhaustion of bovine mycoplasma-specific T cells. In conclusion, our study opens up a new perspective in the therapeutic strategy for bovine mycoplasmosis by targeting the immunoinhibitory receptor pathways. - Identification of an Atypical Enzootic Bovine Leukosis in Japan by Using a Novel Classification of Bovine Leukemia Based on Immunophenotypic Analysis.
Asami Nishimori; Satoru Konnai; Tomohiro Okagawa; Naoya Maekawa; Shinya Goto; Ryoyo Ikebuchi; Ayako Nakahara; Yuzumi Chiba; Masaho Ikeda; Shiro Murata; Kazuhiko Ohashi
Clinical and vaccine immunology : CVI, 24, 9, Sep. 2017, [Peer-reviewed], [International Magazine]
English, Scientific journal - A canine chimeric monoclonal antibody targeting PD-L1 and its clinical efficacy in canine oral malignant melanoma or undifferentiated sarcoma.
Naoya Maekawa; Satoru Konnai; Satoshi Takagi; Yumiko Kagawa; Tomohiro Okagawa; Asami Nishimori; Ryoyo Ikebuchi; Yusuke Izumi; Tatsuya Deguchi; Chie Nakajima; Yukinari Kato; Keiichi Yamamoto; Hidetoshi Uemura; Yasuhiko Suzuki; Shiro Murata; Kazuhiko Ohashi
Scientific reports, 7, 1, 8951, 8951, 21 Aug. 2017, [Peer-reviewed], [Lead author], [International Magazine]
English, Scientific journal - In vitro and in vivo antivirus activity of an anti-programmed death-ligand 1 (PD-L1) rat-bovine chimeric antibody against bovine leukemia virus infection.
Asami Nishimori; Satoru Konnai; Tomohiro Okagawa; Naoya Maekawa; Ryoyo Ikebuchi; Shinya Goto; Yamato Sajiki; Yasuhiko Suzuki; Junko Kohara; Satoshi Ogasawara; Yukinari Kato; Shiro Murata; Kazuhiko Ohashi
PloS one, 12, 4, e0174916, 2017, [Peer-reviewed], [International Magazine]
English, Scientific journal - Anti-Bovine Programmed Death-1 Rat-Bovine Chimeric Antibody for Immunotherapy of Bovine Leukemia Virus Infection in Cattle.
Tomohiro Okagawa; Satoru Konnai; Asami Nishimori; Naoya Maekawa; Ryoyo Ikebuchi; Shinya Goto; Chie Nakajima; Junko Kohara; Satoshi Ogasawara; Yukinari Kato; Yasuhiko Suzuki; Shiro Murata; Kazuhiko Ohashi
Frontiers in immunology, 8, 650, 650, 2017, [Peer-reviewed], [International Magazine]
English, Scientific journal - Bovine leukemia virus reduces anti-viral cytokine activities and NK cytotoxicity by inducing TGF-β secretion from regulatory T cells.
Kosuke Ohira; Ayako Nakahara; Satoru Konnai; Tomohiro Okagawa; Asami Nishimori; Naoya Maekawa; Ryoyo Ikebuchi; Junko Kohara; Shiro Murata; Kazuhiko Ohashi
Immunity, inflammation and disease, 4, 1, 52, 63, Mar. 2016, [Peer-reviewed], [International Magazine]
English, Scientific journal, CD4(+)CD25(high)Foxp3(+) T cells suppress excess immune responses that lead to autoimmune and/or inflammatory diseases, and maintain host immune homeostasis. However, CD4(+)CD25(high)Foxp3(+) T cells reportedly contribute to disease progression by over suppressing immune responses in some chronic infections. In this study, kinetic and functional analyses of CD4(+)CD25(high)Foxp3(+) T cells were performed in cattle with bovine leukemia virus (BLV) infections, which have reported immunosuppressive characteristics. In initial experiments, production of the Th1 cytokines IFN-γ and TNF-α was reduced in BLV-infected cattle compared with uninfected cattle, and numbers of IFN-γ or TNF-α producing CD4(+) T cells decreased with disease progression. In contrast, IFN-γ production by NK cells was inversely correlated with BLV proviral loads in infected cattle. Additionally, during persistent lymphocytosis disease stages, NK cytotoxicity was depressed as indicated by low expression of the cytolytic protein perforin. Concomitantly, total CD4(+)CD25(high)Foxp3(+) T cell numbers and percentages of TGF-β(+) cells were increased, suggesting that TGF-β plays a role in the functional declines of CD4(+) T cells and NK cells. In further experiments, recombinant bovine TGF-β suppressed IFN-γ and TNF-α production by CD4(+) T cells and NK cytotoxicity in cultured cells. These data suggest that TGF-β from CD4(+)CD25(high)Foxp3(+) T cells is immunosuppressive and contributes to disease progression and the development of opportunistic infections during BLV infection. - Evaluation of Costimulatory Molecules in Peripheral Blood Lymphocytes of Canine Patients with Histiocytic Sarcoma.
Michihito Tagawa; Naoya Maekawa; Satoru Konnai; Satoshi Takagi
PloS one, 11, 2, e0150030, 2016, [Peer-reviewed], [International Magazine]
English, Scientific journal - Immunohistochemical Analysis of PD-L1 Expression in Canine Malignant Cancers and PD-1 Expression on Lymphocytes in Canine Oral Melanoma.
Naoya Maekawa; Satoru Konnai; Tomohiro Okagawa; Asami Nishimori; Ryoyo Ikebuchi; Yusuke Izumi; Satoshi Takagi; Yumiko Kagawa; Chie Nakajima; Yasuhiko Suzuki; Yukinari Kato; Shiro Murata; Kazuhiko Ohashi
PloS one, 11, 6, e0157176, 2016, [Peer-reviewed], [Lead author], [International Magazine]
English, Scientific journal - Expression of PD-L1 on canine tumor cells and enhancement of IFN-γ production from tumor-infiltrating cells by PD-L1 blockade.
Naoya Maekawa; Satoru Konnai; Ryoyo Ikebuchi; Tomohiro Okagawa; Mami Adachi; Satoshi Takagi; Yumiko Kagawa; Chie Nakajima; Yasuhiko Suzuki; Shiro Murata; Kazuhiko Ohashi
PloS one, 9, 6, e98415, 2014, [Peer-reviewed], [Lead author], [International Magazine]
English, Scientific journal
- プロバイオティクスを応用した子牛のワクチン応答増強実証試験
池端 麻里; 岡川 朋弘; 中村 隼人; 前川 直也; 村田 史郎; 大橋 和彦; 今内 覚, 臨床とウイルス, 53, 3, 194, 194, Sep. 2025
日本臨床ウイルス学会, Japanese - 新規クローナリティ解析技術RAISINGを用いた牛伝染性リンパ腫の診断法と発症予測法の開発
岡川 朋弘; 嶋倉 穂南; 富永 みその; 松原 幸芽; 斎藤 益満; 松平 崇弘; 直 享則; 前川 直也; 村田 史郎; 大橋 和彦; 今内 覚, 臨床とウイルス, 53, 3, 211, 211, Sep. 2025
日本臨床ウイルス学会, Japanese - 猫伝染性腹膜炎における血清中サイトカイン/ケモカインの解析と抗ウイルス薬治療の奏効を予測するバイオマーカーの探索
前川 直也; 西田 暁子; 田村 昌大; 中村 隼人; 岡川 朋弘; 村田 史郎; 大橋 和彦; 今内 覚, 臨床とウイルス, 53, 3, 250, 250, Sep. 2025
日本臨床ウイルス学会, Japanese - イヌ常在菌Staphylococcus pseudintermedius由来SpsQとイヌIgGとの結合性の評価
竹内 寛人; 中島 千絵; 今内 覚; 前川 直也; 岡川 朋弘; 臼井 優; 田村 豊; 鈴木 定彦; 村田 史郎; 大橋 和彦, 日本獣医学会学術集会講演要旨集, 168回, 208, 208, Sep. 2025
(公社)日本獣医学会, Japanese - 抗PD-L1ウマキメラ抗体の樹立およびウマの悪性腫瘍に対する抗腫瘍効果の検証
堀川 壮琉; 岡川 朋弘; Ganbaatar Otgontuya; Tiyamanee Wisa; 前川 直也; 北内 諒; 山家 崇史; 鈴木 定彦; 賀川 由美子; 村田 史郎; 大橋 和彦; 加藤 幸成; 加藤 史樹; 今内 覚, 日本獣医学会学術集会講演要旨集, 168回, 215, 215, Sep. 2025
(公社)日本獣医学会, Japanese - 乳酸菌Lactiplantibacillus plantarum HOKKAIDO株の呼吸器感染症に対する抗ウイルス効果の検証
池端 麻里; 岡川 朋弘; 中村 隼人; 井上 真帆; 阿部 健太郎; 本間 満; 森松 正美; 前川 直也; 村田 史郎; 大橋 和彦; 今内 覚, 日本獣医学会学術集会講演要旨集, 168回, 217, 217, Sep. 2025
(公社)日本獣医学会, Japanese - マレック病ウイルス日本分離株のゲノム特性と遺伝子多型の解析
山上 竣裕; 佐藤 純平; もたい 吉之介; 前川 直也; 岡川 朋弘; 今内 覚; 大橋 和彦; 村田 史郎, 日本獣医学会学術集会講演要旨集, 168回, 220, 220, Sep. 2025
(公社)日本獣医学会, Japanese - マレック病ウイルスMeqタンパク質塩基性領域のアミノ酸多型による病原性への影響
佐藤 純平; 黒川 葵; もたい 吉之介; Win Shwe Yee; 山上 竣裕; 堀尾 文彌; 佐伯 彩; 前川 直也; 岡川 朋弘; 今内 覚; 大橋 和彦; 村田 史郎, 日本獣医学会学術集会講演要旨集, 168回, 234, 234, Sep. 2025
(公社)日本獣医学会, Japanese - STAR cloning法を用いた組換え七面鳥ヘルペスウイルスの作製
佐伯 彩; 佐藤 純平; もたい 吉之介; 山上 竣祐; ウィン シューイン; 堀尾 文彌; 前川 直也; 岡川 朋弘; 今内 覚; 大橋 和彦; 村田 史郎, 日本獣医学会学術集会講演要旨集, 168回, 252, 252, Sep. 2025
(公社)日本獣医学会, Japanese - 母子ともにリンパ腫を呈した牛におけるRAISING法を用いたクローナリティ解析
廣瀬 海鳳; 岡川 朋弘; 斎藤 益満; 松平 崇弘; 直 亨則; 前川 直也; 村田 史郎; 大橋 和彦; 今内 覚, 日本獣医学会学術集会講演要旨集, 168回, 295, 295, Sep. 2025
(公社)日本獣医学会, Japanese - イヌ化抗PD-L1抗体治療を実施した犬の口腔内悪性腫瘍17例
齋藤 奏; 出口 辰弥; 前川 直也; 今内 覚; 岡川 朋弘; 村田 史郎; 大橋 和彦; 大田 寛, 日本獣医学会学術集会講演要旨集, 168回, 307, 307, Sep. 2025
(公社)日本獣医学会, Japanese - 馬精上皮腫に対する免疫チェックポイント阻害剤を用いた臨床試験研究の1例
堀川壮琉; 岡川朋弘; 岡川朋弘; 前川直也; 北内諒; 山家崇史; 村田史郎; 大橋和彦; 加藤史樹; 今内覚; 今内覚, 北海道獣医師会雑誌, 69, 8, 2025 - 子牛における地方病性牛伝染性リンパ腫発症は母牛由来の腫瘍細胞が原因か?
廣瀬 海凪; 今内 覚; 岡川 朋弘; 富永 みその; 松原 幸芽; 前川 直也; 村田 史郎; 大橋 和彦, 北海道獣医師会雑誌, 68, 8, 278, 278, Aug. 2024
(公社)北海道獣医師会, Japanese - Chimeric provirus of bovine leukemia virus/SMAD family member 3 in cattle with enzootic bovine leukosis.
Naganori Nao; Tomohiro Okagawa; Naomi Nojiri; Satoru Konnai; Honami Shimakura; Misono Tominaga; Hazuka Yoshida-Furihata; Eri Nishiyama; Takahiro Matsudaira; Naoya Maekawa; Shiro Murata; Masamichi Muramatsu; Kazuhiko Ohashi; Masumichi Saito, Archives of virology, 169, 3, 47, 47, 16 Feb. 2024, [International Magazine]
Bovine leukemia virus (BLV) is a member of the family Retroviridae that causes enzootic bovine leukemia (EBL). However, the association between BLV infection and EBL development remains unclear. In this study, we identified a BLV/SMAD3 chimeric provirus within CC2D2A intron 30 in monoclonal expanded malignant cells from a cow with EBL. The chimeric provirus harbored a spliced SMAD3 sequence composed of exons 3-9, encoding the short isoform protein, and the BLV-SMAD3 chimeric transcript was detectable in cattle with EBL. This is the first report of a BLV chimeric provirus that might be involved in EBL tumorigenesis., English - Development of therapeutic molecules across Blood-Brain Barrier for treatment of TBE
福田美津紀; 深野紗代; 小林進太郎; 前川直也; 平野港; 今内覚; 今内覚; 好井健太朗; 好井健太朗, 日本ウイルス学会学術集会プログラム・予稿集(Web), 71st, 2024 - Effect of polymorphisms in the meq gene of Marek’s disease virus distributed in Japan on the pathogenicity and transcriptional regulation
もたい吉之介; 村田史郎; 村田史郎; 佐藤純平; 山上竣裕; SHWE Win Yee; 堀尾文彌; 前川直也; 岡川朋弘; 今内覚; 今内覚; 今内覚; 大橋和彦; 大橋和彦; 大橋和彦, 日本ウイルス学会学術集会プログラム・予稿集(Web), 71st, 2024 - Effect of polymorphisms in the basic region of Meq protein of Marek’s disease, an avian oncogenic herpesvirus, on virulence
佐藤純平; 村田史郎; 村田史郎; もたい吉之介; 山上竣裕; 堀尾文彌; SHWE Win Yee; 前川直也; 岡川朋弘; 今内覚; 今内覚; 今内覚; 大橋和彦; 大橋和彦; 大橋和彦, 日本ウイルス学会学術集会プログラム・予稿集(Web), 71st, 2024 - 非典型的な地方病性牛伝染性リンパ腫症例のRAISING法を用いた性状解析
松原幸芽; 岡川朋弘; 斎藤益満; 松平崇弘; 直亨則; 神谷可菜; 齋藤麻矢; 前川直也; 村田史郎; 大橋和彦; 今内覚, 日本獣医学会学術集会講演要旨集, 167th, 2024 - 抗PD-L1抗体により治療した悪性黒色腫の犬における血清バイオマーカーの探索
飯高早紀子; 前川直也; 今内覚; 出口辰弥; 岡川朋弘; 高木哲; 高木哲; 鈴木定彦; 鈴木定彦; 村田史郎; 大橋和彦, 日本獣医学会学術集会講演要旨集, 167th, 2024 - プロバイオティクスによる子牛のワクチン効果増強作用の検証
池端麻里; 岡川朋弘; 中村隼人; 前川直也; 村田史郎; 大橋和彦; 今内覚; 今内覚, 日本獣医学会学術集会講演要旨集, 167th, 2024 - 日本に分布するマレック病ウイルスmeq遺伝子による病原性への影響
もたい吉之介; 村田史郎; 佐藤純平; 山上竣裕; WIN Shwe Yee; 堀尾文彌; 前川直也; 岡川朋弘; 今内覚; 今内覚; 大橋和彦, 日本獣医学会学術集会講演要旨集, 167th, 2024 - ワクモ曝露型抗原による抗ワクモワクチン抗原としての評価
堀尾文彌; 村田史郎; ウィン シュウェ・イー; 佐藤純平; もたい吉之介; 山上竣裕; 佐藤匠; 大石英司; 前川直也; 岡川朋弘; 今内覚; 大橋和彦, 日本獣医学会学術集会講演要旨集, 167th, 2024 - マレック病ウイルスmeq遺伝子の転写活性化調節ドメインの多型と病原性との関連
山上竣裕; 村田史郎; 佐藤純平; もたい吉之介; WIN Shwe Yee; 堀尾文彌; 前川直也; 岡川朋弘; 今内覚; 大橋和彦, 日本獣医学会学術集会講演要旨集, 167th, 2024 - 牛伝染性リンパ腫の診断と早期発症予測法の開発
富永みその; 今内覚; 岡川朋弘; 神谷可菜; 齋藤麻矢; 安富一郎; 目堅博久; 前川直也; 村田史郎; 大橋和彦, 北海道獣医師会雑誌, 67, 8, 2023 - 免疫チェックポイント分子Programmed death-ligand1(PD-L1)を標的とした抗体薬による犬の鼻腔内腺癌に対する免疫療法の検討
多田佳史; 前川直也; 今内覚; 細谷謙次; 大脇稜; 竹内寛人; 賀川由美子; 高木哲; 高木哲; 鈴木定彦; 鈴木定彦; 岡川朋弘; 村田史郎; 大橋和彦, 日本獣医学会学術集会講演要旨集, 166th, 2023 - 牛伝染性リンパ腫ウイルス感染症における免疫チェックポイント因子TIM-3およびPD-L1を標的とした抗ウイルス効果の検討
中村隼人; 今内覚; 岡川朋弘; 前川直也; 村田史郎; 大橋和彦, 日本獣医学会学術集会講演要旨集, 166th, 2023 - クローナリティ解析による地方病性牛伝染性リンパ腫に対する発症予測法の開発
富永みその; 岡川朋弘; 嶋倉穂南; 斎藤益満; 松平崇弘; 直亨則; 山田慎二; 村上賢二; 前川直也; 村田史郎; 大橋和彦; 今内覚, 日本獣医学会学術集会講演要旨集, 166th, 2023 - マレック病ウイルスMeqタンパク質における挿入配列による病原性増強機構の解明
佐藤純平; 村田史郎; YEE Win Shwe; 瀬尾光里; もたい吉之介; 前川直也; 岡川朋弘; 今内覚; 大橋和彦, 日本獣医学会学術集会講演要旨集, 166th, 2023 - 新たに認められた欠損配列を持つマレック病ウイルスmeq遺伝子の性状解析
もたい吉之介; 村田史郎; 佐藤純平; 西明仁; 前川直也; 岡川朋弘; 今内覚; 大橋和彦, 日本獣医学会学術集会講演要旨集, 166th, 2023 - 乳酸菌Lactobacillus plantarum HOKKAIDO株による免疫制御機序の解明
池端 麻里; 今内 覚; 岡川 朋弘; 阿部 健太郎; 本間 満; 北村 亨; 前川 直也; 村田 史郎; 大橋 和彦, 日本獣医学会学術集会講演要旨集, 165回, [DI1A, 01], Sep. 2022
(公社)日本獣医学会, Japanese - ネコ腫瘍組織におけるprogrammed death ligand 1(PD-L1)の発現解析
青木 絵理; 今内 覚; 前川 直也; 岡川 朋弘; 竹内 寛人; 佐藤 純平; 浅野 裕美恵; 大塚 拓海; 賀川 由美子; 加藤 幸成; 高木 哲; 鈴木 定彦; 村田 史郎; 大橋 和彦, 日本獣医学会学術集会講演要旨集, 165回, [DI1A, 04], Sep. 2022
(公社)日本獣医学会, Japanese - ダニ媒介性脳炎の治療法開発に向けた血液脳関門透過性分子の研究
福田 美津紀; 深野 紗代; 小林 進太郎; 前川 直也; 高橋 侑嗣; 平野 港; 苅和 宏明; 今内 覚; 好井 健太朗, 日本獣医学会学術集会講演要旨集, 165回, [F1P, 12], Sep. 2022
(公社)日本獣医学会, Japanese - ワクモ(Dermanyssus gallinae)由来シスタチン様分子の抗ワクモワクチン抗原としての評価
藤澤 宗太郎; 村田 史郎; 伊勢崎 政美; 有泉 拓馬; 佐藤 匠; 大石 英司; 種子野 章; 前川 直也; 岡川 朋弘; 市居 修; 今内 覚; 大橋 和彦, 日本獣医学会学術集会講演要旨集, 165回, [E3P, 01], Sep. 2022
(公社)日本獣医学会, Japanese - 広範な有効性を示すワクチン開発のための鳥類寄生ダニ由来システインプロテアーゼの特性解析(Characterization of cysteine proteases from avian mites to develop a vaccine with broad efficacy)
Win Shwe Yee; 村田 史郎; 藤澤 宗太郎; 瀬尾 光里; 佐藤 純平; 佐藤 匠; 大石 英司; 種子野 章; 岡川 朋弘; 前川 直也; 今内 覚; 大橋 和彦, 日本獣医学会学術集会講演要旨集, 165回, [E3P, 02], Sep. 2022
(公社)日本獣医学会, English - ワクモ由来の2種類のアスパラギン酸ペプチダーゼの性状解析
瀬尾 光里; 村田 史郎; Shwe Yee Win; 藤澤 宗太郎; 北條 巧; 伊勢崎 政美; 佐藤 匠; 大石 英司; 種子野 章; 市居 修; 前川 直也; 岡川 朋弘; 今内 覚; 大橋 和彦, 日本獣医学会学術集会講演要旨集, 165回, [E3P, 03], Sep. 2022
(公社)日本獣医学会, Japanese - 鼻疽の診断抗原の探索
市川 世識; 飯沼 由希帆; 岡川 朋弘; 前川 直也; 村田 史郎; 今内 覚; 木下 優太; 丹羽 秀和; 青島 圭佑; 小林 篤史; 大橋 和彦; 木村 享史, 日本獣医学会学術集会講演要旨集, 165回, [DI1A, 09], Sep. 2022
(公社)日本獣医学会, Japanese - 牛伝染性リンパ腫ウイルス感染牛における分娩が及ぼす免疫抑制メカニズムの解析
富永みその; 今内覚; 佐治木大和; 岡川朋弘; 小原潤子; 似内厚之; 高橋博文; 窪田健太郎; 武田休史; 前川直也; 村田史郎; 大橋和彦, 北海道獣医師会雑誌, 66, 8, 251, 251, 2022
(公社)北海道獣医師会, Japanese - ワクモ(Dermanyssus gallinae)の吸血に対する宿主免疫応答の解明
藤澤 宗太郎; 村田 史郎; 伊勢崎 政美; 佐藤 匠; 大石 英司; 種子野 章; 前川 直也; 岡川 朋弘; 今内 覚; 大橋 和彦, 日本獣医学会学術集会講演要旨集, 164回, [DIO, 1], Sep. 2021
(公社)日本獣医学会, Japanese - 鼻疽に対する診断用抗原の探索および血清診断法の確立
飯沼 由希帆; 岡川 朋弘; 市川 世識; 陸 拾七; 前川 直也; 村田 史郎; 今内 覚; 木村 亨史; 大橋 和彦, 日本獣医学会学術集会講演要旨集, 164回, [DIO, 2], Sep. 2021
(公社)日本獣医学会, Japanese - Expression and functional analysis of swine PD-1/PD-L1 pathway(和訳中)
Otgontuya Ganbaatar; 今内 覚; 岡川 朋弘; 野島 裕太郎; 前川 直也; 市川 世識; 小林 篤史; 芝原 友幸; 柳川 洋二郎; 鈴木 定彦; 村田 史郎; 大橋 和彦, 日本獣医学会学術集会講演要旨集, 164回, [DIO, 3], Sep. 2021
(公社)日本獣医学会, English - ウシCTLA-4ならびにPD-L1を標的とした抗体併用法による免疫増強効果の検討
渡 慧; 今内 覚; 岡川 朋弘; 前川 直也; 村田 史郎; 鈴木 定彦; 大橋 和彦, 日本獣医学会学術集会講演要旨集, 164回, [DIO, 4], Sep. 2021
(公社)日本獣医学会, Japanese - 牛伝染性リンパ腫発症母牛における子宮内感染の解析
嶋倉 穂南; 今内 覚; 岡川 朋弘; 中村 隼人; 神谷 可菜; 齋藤 麻矢; 前川 直也; 村田 史郎; 大橋 和彦, 日本獣医学会学術集会講演要旨集, 164回, [DVO, 5], Sep. 2021
(公社)日本獣医学会, Japanese - マレック病ウイルスMeqタンパク質における挿入および欠損配列の病原性への影響
佐藤 純平; 村田 史郎; 藤澤 宗太郎; 瀬尾 光里; 前川 直也; 岡川 朋弘; 今内 覚; 大橋 和彦, 日本獣医学会学術集会講演要旨集, 164回, [DVO, 25], Sep. 2021
(公社)日本獣医学会, Japanese - ワクモ(Dermanyssus gallinae)由来システインプロテアーゼの抗ワクモワクチン抗原としての評価
有泉 拓馬; 村田 史郎; 藤澤 宗太郎; 伊勢崎 政美; 佐藤 匠; 大石 英司; 種子野 章; 市居 修; 前川 直也; 岡川 朋弘; 今内 覚; 大橋 和彦, 日本獣医学会学術集会講演要旨集, 164回, [EO, 6], Sep. 2021
(公社)日本獣医学会, Japanese - イヌ腫瘍細胞株におけるProgrammed cell death-ligand 1の発現機序の解析
大脇 稜; 出口 辰弥; 今内 覚; 前川 直也; 細谷 謙次; 金 尚昊; 須永 隆文; 奥村 正裕, 日本獣医学会学術集会講演要旨集, 164回, [HSO, 19], Sep. 2021
(公社)日本獣医学会, Japanese - 牛伝染性リンパ腫の病態発生機序解析を基盤とする新制御法の試み
今内覚; 岡川朋弘; 前川直也; 村田史郎; 大橋和彦, 家畜衛生学雑誌, 47, 3, 2021 - 犬の口腔内悪性黒色腫に対する抗Programmed death-Ligand 1抗体療法と放射線治療におけるアブスコパル効果の誘導解析
大脇稜; 出口辰弥; 細谷謙次; 今内覚; 前川直也; 立花由莉加; 中村基司; 金尚昊; 須永隆文; 奥村正裕, 北海道獣医師会雑誌, 65, 8, 260, 260, 2021
(公社)北海道獣医師会, Japanese - ワクモにおける定量的PCR法確立のための内在性コントロール遺伝子の探索
有泉 拓馬; 村田 史郎; 藤澤 宗太郎; 伊勢崎 政美; 前川 直也; 岡川 朋弘; 種子野 章; 大石 英司; 今内 覚; 大橋 和彦, 日本獣医学会学術集会講演要旨集, 163回, 248, 248, Oct. 2020
(公社)日本獣医学会, Japanese - ネコCytotoxic T-lymphocyte antigen-4(CTLA-4)を標的とした新規免疫抑制剤の開発における基礎的検討
大塚 拓海; 今内 覚; 前川 直也; 渡 慧; 岡川 朋弘; 村田 史郎; 大橋 和彦, 日本獣医学会学術集会講演要旨集, 163回, 221, 221, Oct. 2020
(公社)日本獣医学会, Japanese - 牛白血病ウイルス感染症における免疫抑制受容体TIM-3の発現解析および機能解析
中村 隼人; 今内 覚; 岡川 朋弘; 佐治木 大和; 渡 慧; 神谷 可菜; 齋藤 麻矢; 前川 直也; 村田 史郎; 大橋 和彦, 日本獣医学会学術集会講演要旨集, 163回, 221, 221, Oct. 2020
(公社)日本獣医学会, Japanese - 【分子標的薬2020 いま知っておくべき獣医療における分子標的療法の現在と未来】将来の展望 免疫チェックポイント阻害薬を用いた腫瘍免疫療法
前川 直也; 今内 覚; 岡川 朋弘; 村田 史郎; 大橋 和彦, Veterinary Oncology, 7, 2, 89, 94, Apr. 2020, [Invited]
(株)エデュワードプレス, Japanese - Immune exhaustion during mycoplasma infection in cattle
今内 覚; 後藤 伸也; 岡川 朋弘; 前川 直也; 村田 史郎; 大橋 和彦, 日本マイコプラズマ学会雑誌 = Japanese journal of mycoplasmology, 46, 46, 31, 33, Mar. 2020, [Invited]
日本マイコプラズマ学会事務局, Japanese, Report scientific journal - 動物用抗体医薬品の開発および臨床研究
今内 覚; 岡川 朋弘; 前川 直也; 中島 千絵; 鈴木 定彦; 山本 啓一; 戸田 幹洋; 村田 史郎; 大橋 和彦, JVPA digest : 日本動物用医薬品協会会報, 67(2), 67, 1, 10, Feb. 2020
日本動物薬事協会, Japanese - 動物のがん免疫療法
前川直也, 日本再生医療学会総会(Web), 19th, 2020 - Tick factors associated pathogen transmission ~Tick immunosuppressants in saliva~
Satoru Konnal, Med. Entomol. Zool., 70, 4, 189, 197, Dec. 2019, [Invited]
Tick saliva exhibits several biological functions such as adhesion, cytolysis, vasodilation/vasoconstriction, angiogenesis, anti-platelet aggregation, anti-blood coagulation, anti-complement activity, anti-inflammatory, and immunosuppressive activity, and so on. The saliva is secreted by salivary gland, and the injected saliva facilitates blood uptake during the tick bite. Tick-borne pathogens are transmitted to vertebrate hosts via the saliva. This means that the tick saliva plays a key role in the pathogen transmission. In this session, we would like to introduce the ‘Immune-modulatory factors including immunosuppressant’ in the tick saliva., The Japan Society of Medical Entomology and Zoology, Japanese, Introduction scientific journal - 【悪性黒色腫-理解を深め、明日の診療への自信を磨く!】北海道大学動物医療センターにおける臨床研究の紹介 悪性黒色腫に対する抗PD-L1抗体を用いた免疫療法
前川 直也, Veterinary Oncology, 6, 4, 94, 100, Oct. 2019, [Invited]
(株)エデュワードプレス, Japanese - ワクモ由来Adipocyte plasma membrane-associated proteinの抗ワクモワクチン抗原としての評価
森田 鮎; 竹原 昌生; 村田 史郎; 伊勢崎 政美; 藤澤 宗太郎; 種子野 章; 酒井 英史; 宇野 有紀子; 小川 遼; 市居 修; 前川 直也; 岡川 朋弘; 今内 覚; 大橋 和彦, 日本獣医学会学術集会講演要旨集, 162回, 412, 412, Aug. 2019
Japanese - イヌ腫瘍組織およびイヌ腫瘍由来細胞株におけるイヌHER2の発現解析
吉武 志江奈; 今内 覚; 前川 直也; 賀川 由美子; 西村 麻紀; 岡川 朋弘; 鈴木 定彦; 高木 哲; 中川 貴之; 村田 史郎; 大橋 和彦, 日本獣医学会学術集会講演要旨集, 162回, 380, 380, Aug. 2019
(公社)日本獣医学会, Japanese - イヌ腫瘍由来細胞株におけるCKLF-like MARVEL transmembrane domain containing protein 6(CMTM6)および4(CMTM4)の発現解析
竹内 寛人; 今内 覚; 岡川 朋弘; 前川 直也; 村田 史郎; 大橋 和彦, 日本獣医学会学術集会講演要旨集, 162回, 380, 380, Aug. 2019
(公社)日本獣医学会, Japanese - BLV感染症に対するCOX-2阻害剤と抗PD-L1抗体併用法の抗ウイルス効果の検討
佐治木 大和; 今内 覚; 岡川 朋弘; 前川 直也; 後藤 伸也; 小原 潤子; 山田 慎二; 加藤 幸成; 鈴木 定彦; 村田 史郎; 大橋 和彦, 日本獣医学会学術集会講演要旨集, 162回, 381, 381, Aug. 2019
(公社)日本獣医学会, Japanese - Mycoplasma bovis感染症に対する抗PD-L1キメラ抗体を用いた臨床試験
後藤 伸也; 今内 覚; 平野 佑気; 小原 潤子; 岡川 朋弘; 前川 直也; 鈴木 定彦; 加藤 幸成; 村田 史郎; 大橋 和彦, 日本獣医学会学術集会講演要旨集, 162回, 381, 381, Aug. 2019
(公社)日本獣医学会, Japanese - RNA-Seqを用いたワクモ(Dermanyssus gallinae)の吸血状態別における遺伝子発現解析
藤澤 宗太郎; 村田 史郎; 竹原 昌生; 伊勢崎 政美; 小川 遼; 宇野 有紀子; 種子野 章; 前川 直也; 岡川 朋弘; 今内 覚; 大橋 和彦, 日本獣医学会学術集会講演要旨集, 162回, 412, 412, Aug. 2019
(公社)日本獣医学会, Japanese - COX-2阻害剤の併用による抗PD-L1抗体を用いたイヌ腫瘍免疫療法の効果増強に向けた基礎的検討
前川 直也; 今内 覚; 浅野 裕美恵; 岡川 朋弘; 高木 哲; 村田 史郎; 大橋 和彦, 日本獣医学会学術集会講演要旨集, 162回, 460, 460, Aug. 2019
(公社)日本獣医学会, Japanese - ネコのアクロメガリー関連インスリン抵抗性糖尿病のコントロールを目的とした成長ホルモン受容体/Fc融合タンパク質の作製
鈴木 理紗; 和泉 雄介; 前川 直也; 今内 覚; 高木 哲; 森下 啓太郎; 細谷 謙次; 滝口 満喜, 日本獣医学会学術集会講演要旨集, 162回, 469, 469, Aug. 2019
(公社)日本獣医学会, Japanese - 免疫チェックポイント分子Programmed death‐ligand 1(PD‐L1)を標的とする抗体薬による免疫療法が奏功した肺転移のある口腔内悪性黒色腫の犬の1例
竹内寛人; 前川直也; 今内覚; 高木哲; 細谷謙次; 賀川由美子; 岡川朋弘; 鈴木定彦; 鈴木定彦; 山本啓一; 山本啓一; 村田史郎; 大橋和彦, 北海道獣医師会雑誌, 63, 8, 343, 343, Aug. 2019
(公社)北海道獣医師会, Japanese - ロタウイルス実験感染子牛モデルを用いた3.5倍発酵代用乳の腸炎抑制効果の検証
茅先史; 今内覚; 久保田学; 岡川朋弘; 佐治木大和; 渡慧; 小原潤子; 前川直也; 村田史郎; 大橋和彦, 北海道獣医師会雑誌, 63, 8, 302, 302, Aug. 2019
(公社)北海道獣医師会, Japanese - 免疫学的解析を基盤とした動物用創薬研究
Satoru Konnal, 臨床獣医, 37, 3, 37, 41, Mar. 2019, [Invited]
(株)緑書房, Japanese, Introduction scientific journal - 免疫チェックポイント阻害剤による犬の悪性腫瘍に対する新規治療法
高木哲; 前川直也; 今内覚, 日本獣医師会獣医学術学会年次大会講演要旨集, 2018, 2019 - 動物難治性疾病に対する創薬研究
今内 覚; 岡川朋弘; 前川直也; 中島千絵; 鈴木定彦; 山本啓一; 戸田幹洋; 村田史郎; 大橋和彦, MPアグロジャーナル, 35, 10, 22, 25, Oct. 2018, [Invited]
Japanese, Introduction scientific journal - 【小動物医療における腫瘍の免疫療法2 治療篇】免疫チェックポイント分子を標的とした腫瘍免疫療法-抗PD-1/PD-L1抗体療法
前川 直也; 今内 覚; 村田 史郎; 大橋 和彦; 高木 哲, 獣医畜産新報, 71, 9, 659, 663, Sep. 2018, [Invited]
文永堂出版(株), Japanese, Introduction scientific journal - イヌ腫瘍における免疫チェックポイント分子の解析と新規免疫療法樹立への応用研究
前川 直也, 日本獣医学会学術集会講演要旨集, 161回, 172, 172, Aug. 2018
(公社)日本獣医学会, Japanese - 免疫抑制因子PD‐1およびPD‐L1を標的としたイヌ腫瘍に対する新規免疫療法の検討
前川直也; 今内覚; 村田史郎; 大橋和彦, 日本獣医学会学術集会講演要旨集, 161回, 233, 233, Aug. 2018
(公社)日本獣医学会, Japanese - 地方病性牛白血病の簡易鑑別診断基準の確立と若齢発症牛の実態調査
田中晶菜; 今内覚; 岡川朋弘; 西森朝美; 前川直也; 戸塚知恵; 千葉由純; 池田昌穂; 村田史郎; 大橋和彦, 日本獣医学会学術集会講演要旨集, 161回, 353, 353, Aug. 2018
(公社)日本獣医学会, Japanese - ヨーネ病におけるプロスタグランジンE2(PGE2)動態解析及びCOX‐2阻害剤の免疫活性化効果の検討
佐治木大和; 今内覚; 岡川朋弘; 西森朝美; 前川直也; 後藤伸也; 永田礼子; 川治聡子; 森康行; 村田史郎; 大橋和彦, 日本獣医学会学術集会講演要旨集, 161回, 341, 341, Aug. 2018
(公社)日本獣医学会, Japanese - ウシCytotoxic T‐lymphocyte antigen‐4(CTLA‐4)の機能解析および慢性感染症における発現解析
渡慧; 今内覚; 岡川朋弘; 前川直也; 後藤伸也; 佐治木大和; 村田史郎; 鈴木定彦; 大橋和彦, 日本獣医学会学術集会講演要旨集, 161回, 340, 340, Aug. 2018
(公社)日本獣医学会, Japanese - 肺転移のある悪性黒色腫罹患犬に対するPD‐L1を標的とした抗体薬の治療効果
前川直也; 今内覚; 高木哲; 細谷謙次; 賀川由美子; 岡川朋弘; 和泉雄介; 出口辰弥; 鈴木定彦; 山本啓一; 村田史郎; 大橋和彦, 日本獣医学会学術集会講演要旨集, 161回, 429, 429, Aug. 2018
(公社)日本獣医学会, Japanese - 牛白血病における新規病態進行評価マーカーの検索
渡慧; 今内覚; 佐治木大和; 岡川朋弘; 前川直也; 後藤伸也; 村田史郎; 大橋和彦, 北海道獣医師会雑誌, 62, 8, 282, 282, Aug. 2018
(公社)北海道獣医師会, Japanese - イヌCytotoxic T‐lymphocyte antigen‐4(CTLA‐4)を標的としたバイオ医薬品の開発に向けた基礎的検討
石原悠太郎; 今内覚; 岡川朋弘; 前川直也; 鈴木定彦; 大田寛; 村田史郎; 大橋和彦, 日本獣医学会学術集会講演要旨集, 161回, 430, 430, Aug. 2018
(公社)日本獣医学会, Japanese - Mycoplasma bovis感染症における免疫抑制機序の解析
後藤伸也; 今内覚; 岡川朋弘; 前川直也; 佐治木大和; 渡慧; 樋口豪紀; 小岩政照; 田島誉士; 鈴木定彦; 村田史郎; 大橋和彦, 日本獣医学会学術集会講演要旨集, 161回, 342, 342, Aug. 2018
(公社)日本獣医学会, Japanese - 地方病性牛白血病若齢発症牛におけるプロウイルス挿入部位の網羅的解析
岡川朋弘; 今内覚; 西森朝美; 田中晶菜; 前川直也; 戸塚知恵; 千葉由純; 池田昌穂; 村田史郎; 大橋和彦, 日本獣医学会学術集会講演要旨集, 161回, 351, 351, Aug. 2018
(公社)日本獣医学会, Japanese - 牛マイコプラズマ感染症における免疫抑制機序の解明
後藤伸也; 今内覚; 岡川朋弘; 西森朝美; 前川直也; 樋口豪紀; 小岩政照; 田島誉士; 小原潤子; 加藤幸成; 鈴木定彦; 村田史郎; 大橋和彦, 日本獣医学会学術集会講演要旨集, 160回, 370, 370, Aug. 2017
(公社)日本獣医学会, Japanese - PD‐L1を標的としたイヌ用キメラ抗体医薬の作製と悪性黒色腫および未分化肉腫罹患犬における抗腫瘍効果の検討
前川直也; 今内覚; 高木哲; 賀川由美子; 岡川朋弘; 西森朝美; 池渕良洋; 和泉雄介; 出口辰弥; 加藤幸成; 鈴木定彦; 村田史郎; 大橋和彦, 日本獣医学会学術集会講演要旨集, 160回, 460, 460, Aug. 2017
(公社)日本獣医学会, Japanese - BLV感染症をモデルとした抗ウシPD‐L1キメラ抗体の臨床応用試験
西森朝美; 今内覚; 岡川朋弘; 前川直也; 池渕良洋; 後藤伸也; 佐治木大和; 鈴木定彦; 小原潤子; 小笠原諭; 加藤幸成; 村田史郎; 大橋和彦, 日本獣医学会学術集会講演要旨集, 160回, 370, 370, Aug. 2017
(公社)日本獣医学会, Japanese - COX‐2阻害薬と抗PD‐L1抗体の併用によるイヌ腫瘍疾患の制御法の検討
浅野裕美恵; 今内覚; 岡川朋弘; 前川直也; 西森朝美; 後藤伸也; 高木哲; 村田史郎; 大橋和彦, 日本獣医学会学術集会講演要旨集, 160回, 371, 371, Aug. 2017
(公社)日本獣医学会, Japanese - B細胞性リンパ腫罹患犬における免疫チェックポイント分子発現解析
倉島千尋; 田川道人; 高木哲; 前川直也; 今内覚; 新坊弦也; 富張瑞樹; 松本高太郎; 猪熊壽; 川本恵子; 宮原和郎, 日本獣医学会学術集会講演要旨集, 159回, 462, 462, Aug. 2016
(公社)日本獣医学会, Japanese - ウシCytotoxic T‐lymphocyte antigen‐4(CTLA‐4)の機能解析と特異抗体の樹立
渡慧; 今内覚; 前川直也; 岡川朋弘; 西森朝美; 鈴木定彦; 村田史郎; 大橋和彦, 日本獣医学会学術集会講演要旨集, 159回, 365, 365, Aug. 2016
(公社)日本獣医学会, Japanese - 家畜における免疫チェックポイント関連因子の遺伝子比較解析とウシ用抗体を用いた動物種横断的研究
野島裕太郎; 今内覚; 西森朝美; 前川直也; 岡川朋弘; 森康行; 賀川由美子; 鈴木定彦; 村田史郎; 大橋和彦, 日本獣医学会学術集会講演要旨集, 159回, 364, 364, Aug. 2016
(公社)日本獣医学会, Japanese - ウシ腫瘍壊死因子(TNF‐α)デコイレセプターによる新規抗炎症剤の開発
藤澤宗太郎; 今内覚; 岡川朋弘; 西森朝美; 前川直也; 村田史郎; 鈴木定彦; 大橋和彦, 日本獣医学会学術集会講演要旨集, 159回, 364, 364, Aug. 2016
(公社)日本獣医学会, Japanese - 組織球性肉腫罹患犬における末梢血中免疫状態の解析
田川 道人; 前川 直也; 今内 覚; 高木 哲, 日本獣医学会学術集会講演要旨集, 158回, 407, 407, Aug. 2015
(公社)日本獣医学会, Japanese - 牛白血病ウイルス感染症における疲弊化T細胞の動態とその再活性化
岡川朋弘; 今内覚; 西森朝美; 前川直也; 池渕良洋; 村田史郎; 大橋和彦, 日本獣医学会学術集会講演要旨集, 158回, 324, 324, Aug. 2015
(公社)日本獣医学会, Japanese - イヌ腫瘍浸潤リンパ球におけるPD‐1発現解析と免疫チェックポイント分子を標的とした新規腫瘍免疫療法の検討
前川直也; 今内覚; 池渕良洋; 岡川朋弘; 足立真実; 高木哲; 賀川由美子; 賀川由美子; 村田史郎; 大橋和彦, 日本獣医学会学術集会講演要旨集, 158回, 405, 405, Aug. 2015
(公社)日本獣医学会, Japanese - シュルツェマダニ(Ixodes persulcatus)唾液腺由来免疫抑制因子sL2の同定および機能解析
越智晶絵; 今内覚; 岡川朋弘; 西森朝美; 前川直也; 村田史郎; 大橋和彦, 日本獣医学会学術集会講演要旨集, 158回, 301, 301, Aug. 2015
(公社)日本獣医学会, Japanese - ウシ制御性T細胞の機能解析および慢性感染症における動態解析
大平浩輔; 今内覚; 岡川朋弘; 西森朝美; 前川直也; 中原綾子; 村田史郎; 大橋和彦, 日本獣医学会学術集会講演要旨集, 157回, 388, 388, Aug. 2014
(公社)日本獣医学会, Japanese - イヌ免疫抑制因子PD‐1およびPD‐L1を標的とした新規腫瘍免疫療法の検討
前川直也; 今内覚; 池渕良洋; 岡川朋弘; 足立真実; 高木哲; 賀川由美子; 村田史郎; 大橋和彦, 日本獣医学会学術集会講演要旨集, 157回, 483, 483, Aug. 2014
(公社)日本獣医学会, Japanese - イヌ免疫抑制因子PD‐1およびPD‐L1の同定と新規免疫療法樹立への基礎研究
前川直也; 今内覚; 池渕良洋; 岡川朋弘; 高木哲; 村田史郎; 大橋和彦, 日本獣医学会学術集会講演要旨集, 156回, 257, 257, Aug. 2013
(公社)日本獣医学会, Japanese
- 免疫チェックポイント阻害薬によるイヌのがん免疫療法
第169回日本獣医学会学術集会 司宰機関企画, 08 Sep. 2026
[Invited] - イヌの悪性黒色腫に対する抗PD-L1抗体の臨床研究
前川直也
第26回日本獣医皮膚科学会学術大会, 12 Mar. 2023
[Invited] - Clinical study of an immune checkpoint inhibitor for canine malignant melanoma.
Naoya Maekawa
The 21st Federation of Asian Veterinary Associations (FAVA) Congress, 11 Nov. 2022, Invited oral presentation
11 Nov. 2022 - 13 Nov. 2022, [Invited] - 犬の腫瘍疾患に対する免疫チェックポイント阻害抗体薬の臨床研究
前川直也
第12回 動物用ワクチン・バイオ医薬品研究会 シンポジウム, 21 May 2021
[Invited] - 動物のがん免疫療法
前川直也
第19回日本再生医療学会総会, 18 May 2020, Japanese, Invited oral presentation
18 May 2020 - 29 May 2020, [Invited] - 免疫チェックポイント阻害抗体を用いた免疫療法
前川直也
第3回獣医がん分子生物研究会, 09 Sep. 2019, Japanese, Invited oral presentation
[Invited] - 腫瘍免疫の基礎と応用-免疫チェックポイント阻害剤を用いたイヌ腫瘍治療の試み-
前川直也
第14回日本獣医再生医療学会年次大会, Japanese, Invited oral presentation
02 Feb. 2019 - 03 Feb. 2019, [Invited] - 免疫抑制因子PD-1およびPD-L1を標的としたイヌ腫瘍に対する新規免疫療法の検討
前川直也; 今内覚; 村田史郎; 大橋和彦
第161回日本獣医学会学術集会 臨床分科会(小動物)シンポジウム, Japanese, Invited oral presentation
11 Sep. 2018 - 13 Sep. 2018, [Invited] - イヌ腫瘍における免疫チェックポイント分子の解析と新規免疫療法樹立への応用研究
前川直也
第161回日本獣医学会学術集会 日本獣医学会企画(奨励賞), Japanese, Invited oral presentation
11 Sep. 2018 - 13 Sep. 2018, [Invited]
■ Research Themes
- 高機能型抗体を基盤とした動物用分子標的薬の作製技術の確立とがん免疫療法への応用
科学研究費助成事業
01 Apr. 2025 - 31 Mar. 2028
前川 直也
日本学術振興会, 基盤研究(B), 北海道大学, 25K02163 - Development of novel control strategy for livestock malignant infectious diseases targeting immune disruptors
Grants-in-Aid for Scientific Research
08 Sep. 2023 - 31 Mar. 2027
今内 覚; 前川 直也; 岡川 朋弘
Japan Society for the Promotion of Science, Fund for the Promotion of Joint International Research (International Collaborative Research), Hokkaido University, 23KK0124 - Elucidation of the mechanism of tumorigenesis in bovine leukemia by comprehensive genomic analysis of proviral integration sites
Grants-in-Aid for Scientific Research
Apr. 2024 - Mar. 2027
Tomohiro Okagawa; Satoru Konnai; Naoya Maekawa
Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research (B), Hokkaido University, 24K01918 - イヌ腫瘍に対する次世代型免疫チェックポイント阻害抗体薬の創出とその応用研究
科学研究費助成事業 若手研究
01 Apr. 2021 - 31 Mar. 2023
前川 直也
日本学術振興会, 若手研究, 北海道大学, 21K14983 - Analysis of the molecular mechanism for immunosuppression in malignant infectious diseases of livestock and the development of a novel control method
Grants-in-Aid for Scientific Research Fund for the Promotion of Joint International Research (Fostering Joint International Research (B))
07 Oct. 2019 - 31 Mar. 2023
今内 覚; 前川 直也; 岡川 朋弘
家畜やヒトの外部寄生虫であるマダニは、吸血により家畜の生産効率を低下させたり人獣共通感染症を含む多くの重要な病原微生物を媒介するため世界各国で対策が重要視されている。マダニによって媒介される牛の悪性感染症には、バベシア原虫やタイレリア原虫の感染によるピロプラズマ症、リケッチアによる感染症であるアナプラズマ症などがある。これらの感染症は罹患動物の致死率が高く、日本の監視伝染病のうち、極めて重要な疾病として法定伝染病に指定されている。ピロプラズマ症およびアナプラズマ症に対する有効なワクチンはなく、世界中で甚大な被害を与え続けている。これらの起因病原体は、オウシマダニをはじめとするマダニによって媒介されることからマダニの駆除が最も重要である。しかし現在のところ、マダニに対する効果的な防除法は十分には確立していない。マダニに対する防除法として、駆虫剤(殺ダニ剤)による駆除が一般的であるが、殺マダニ効果には限界があり、コストの面の問題に加え使用薬剤に対する耐性マダニの出現、薬剤散布による環境汚染、畜産製品への薬剤残留など多くの問題点が指摘されている。そこでマダニが媒介する病原体の伝播機序の解明、家畜悪性感染症の病態発生分子機序の解明及び新規制御法の開発を目的にブラジル・リオグランデドスール連邦大学と共同研究を行った。
Japan Society for the Promotion of Science, Fund for the Promotion of Joint International Research (Fostering Joint International Research (B)), Hokkaido University, 19KK0172 - Development of antibody drugs for dogs against immune checkpoint molecules etc. with effector functions
Grants-in-Aid for Scientific Research
01 Apr. 2019 - 31 Mar. 2021
Maekawa Naoya
In order to develop novel therapeutic agents for canine cancers, this study used genetic engineering techniques to produce antibody drug candidates for dogs with effector functions such as antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC) activities. The antibodies were tested for antigen binding and effector activities, demonstrating expected biological activities in vitro, and no safety concerns were observed after repeated administration to dogs. We are now in the process of detailed analysis of the safety. This study has demonstrated the feasibility of producing antibody drugs for dogs with effector functions and has paved the way for their clinical application.
Japan Society for the Promotion of Science, Grant-in-Aid for Early-Career Scientists, Hokkaido University, 19K15969 - 伴侶動物の腫瘍における免疫抑制因子を標的とした新規免疫療法の開発
科学研究費助成事業 特別研究員奨励費
24 Apr. 2015 - 31 Mar. 2018
前川 直也
本研究では、イヌの腫瘍治療を目的として免疫抑制因子Programmed death-1(PD-1)およびPD-ligand 1(PD-L1)の発現解析・機能解析を行う。さらに治療用抗PD-L1抗体を作成し、腫瘍罹患犬を用いた臨床研究を行い、その治療効果を評価することが最終目標である。
前年度までにPD-L1発現解析による対象腫瘍の決定、必要な量の治療用抗体の準備を終え、臨床研究を開始した。本年度は臨床試験を継続することとし、腫瘍罹患犬に治療用抗PD-L1抗体を投与し、安全性や治療効果を評価したところ、悪性黒色腫または未分化肉腫罹患犬の一部で腫瘍が明確に縮小したほか、肺転移のある悪性黒色腫罹患犬では生存期間が延長された可能性が示された。この臨床試験では延べ9頭の腫瘍罹患犬に対し各々複数回の抗体投与を行ったが(総数63回)、タンパク質製剤を投与したことに起因するアレルギー反応等の有害事象は観察されなかった。また治療に起因すると考えられる自己免疫疾患等の免疫関連有害事象も観察されなかった。上記臨床研究の成果を原著論文にまとめ、Scientific Reports誌に誌上発表並びにプレスリリースを行った。さらにマウス腫瘍モデルにおいて抗PD-1/PD-L1治療と相乗効果を示し、イヌでの安全性がこれまでに確認されていた低分子医薬品2種類について併用治療を各2頭ずつ実施したが、明確な効果の増強は観察されなかった。本研究成果は抗PD-L1抗体がイヌ難治性腫瘍の治療薬として有用であることを明らかとし、さらなる評価の実施を強く後押しするものである。
日本学術振興会, 特別研究員奨励費, 北海道大学, 15J01989
